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ABSTRACT 
INFLUENCE OF PRODUCTION SYSTEMS ON ANIMAL PERFORMANCE, 
CARCASS CHARACTERISTICS AND MEAT QUALITY, ENVIRONMENTAL 
IMPACTS, PRODUCTION ECONOMICS, AND CONSUMER PREFERNCE FOR 
BEEF 
MEGAN JEAN WEBB 
2018 
The overall objective of this study was to determine if the level of growth 
promotant technology used among production systems influence animal and carcass 
performance, meat quality, production economics, the environmental impact, and 
determine consumer preferences and perception. Angus  Simmental steer calves (n 
=120) were stratified by birth date, birth weight, and dam age in a completely randomized 
design and assigned to one of four treatments: 1) no antibiotics (NA, receiving no 
technology); 2) non-hormone treated (NHTC, fed monensin and tylosin); 3) implant 
(IMPL, administered a series of three implants), and 4) implant plus fed a beta-agonist 
(IMBA, administered the same implant strategy as IMPL plus, fed ractopamine-HCI for 
the last 30 d prior to harvest). Animal weight, production expenses, and environmental 
factor data were collected from the production segments including: cow-calf, 
backgrounding, and finishing. During the finishing segment, animal feed intake, average 
daily gain (ADG), and efficiency was obtained. Carcass meat quality and yield 
performace was assessed. Striploins were collected for analyses post fabrication. Steaks 
were designated to specific postmortem aging periods, utilized for Warner-Bratzler shear 
force (WBSF), crude fat, and consumer sensory analyses. The consumer analyses 
   
 
 
xx
 
evaluated beef production system information undisclosed and disclosed or simiply, 
without and later with information to assess palatability only, perception only, and 
perception plus palatability among untrained consumer panelists.  
IMPL had the greatest (P < 0.01) ADG and gain to feed (G:F). The final 
calculated body weight and hot carcass weight was similar (P > 0.05) and heavier (P < 
0.01) for IMPL and IMBA in comparison to NA and NHTC, which were similar (P > 
0.05). The actual branded carcass value was similar (P > 0.01) for NA and IMPL and 
greater (P < 0.05) than NHTC and IMBA, which was similar (P > 0.05). Excluding the 
cost of the calf, production costs were similar (P > 0.05) and lowest (P < 0.05) for NA 
and IMPL, NHTC was intermediate (P < 0.05), and IMBA had the greatest (P < 0.05) 
production cost. Net return was similar (P > 0. 01) between NA and IMPL, which was 
greater (P < 0.01) than NHTC and IMBA, which were similar (P > 0.01). In the 
environmental analysis, IMPL reduced GHG (CO2e/kg HCW) emissions by 8%, energy 
use (MJ/kg HCW) by 6%, water use (kg H2O/kg HCW) by 6%, and reactive N loss (g 
N/kg HCW) by 6%. The IMBA reduced GHG emissions by 7%, energy use by 3%, and 
reactive N loss by 1%. 
Meat quality analyses for marbling score and crude fat among NA and NHTC did 
not differ (P > 0.05) but were greater (P < 0.05) than IMPL and IMBA, which were 
similar (P > 0.05) and lower in crude fat. Steaks from NA and NHTC did not differ (P > 
0.05) for WBSF though were more tender (P ≤ 0.05) than IMPL and IMBA, which were 
similar (P > 0.05) and tougher (P ≤ 0.05). During the Undisclosed without Meat panel, 
NA was most preferred (P ≤ 0.05) and IMBA was least preferred (P ≤ 0.05) while NHTC 
and IMPL were intermediate and similar (P > 0.05). All samples differed (P ≤ 0.05) 
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during the Disclosed with Meat panel where, NHTC was most preferred followed by NA, 
IMPL, and IMBA. Despite improvements from use of monensin, tylosin, growth 
promoting implants with and without ractopamine HCl, cattle within IMPL and IMBA 
resulted in greater animal and carcass weights, were most effective at minimizing the 
environmental impact, and improved producer net return (IMPL only). However, 
consumers may have detected reductions in tenderness and palatability as IMPL and 
IMBA were least preferred. Consumers preferred the palatability of meat raised with 
judicious use of antimicrobials and antibiotics to ensure animal health when production 
information was disclosed (NHTC).
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CHAPTER I 
Review of Literature 
Megan J. Webb 
Department of Animal Science 
South Dakota State University, 57007 
INTRODUCTION 
As of January 2016, there are approximately 13.1 million fed cattle in the US 
(NCBA, 2016) and it is estimated that 95% are implanted with growth hormones 
(Campiche, et al. 2004) and 60% - 80% are provided a beta-andrenergic agonist 
(Chichester, 2017). These technologies along with monensin and tylosin are commonly 
utilized in beef production because collectively they repeatedly demonstrate prevention 
of digestive ailments and improved animal growth, body weight gain, feed efficiency, hot 
carcass weight, and carcass yield (Bergen and Bates, 1983; Goodrich et al., 1984; 
Schanbacher, 1984; Bartle et al., 1992; Nagaraja and Chegappa, 1998; Platter et al., 2008; 
Stackhouse et al., 2012; Johnson et al., 2014; Johnson and Beckett, 2014). With a 
growing world population that is expected to reach over 9 billion by 2050 and an 
increasing gross domestic product, more people will demand meat (AgMRC, 2012; 
Gerbens – Leenes et al., 2013). In order to feed a larger and wealthier population, net 
food production must increase by 70% (FAO, 2009). Use of growth promotant 
technologies have provided more efficient meat production for over 50 years while 
offering producers an economic benefit and consumers an economically affordable 
product (Lawrence and Ibarburu, 2007; Machen, 2010; Johnson et al., 2013). These 
technologies also have environmental benefits as they have been shown to mitigate NH3 
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and greenhouse gas emissions (Stackhouse et al., 2012) however, this is not well 
understood by consumers. Beef purchasers are demanding specific credence attributes 
related to animal raising and management practices that are less efficient (Caswell and 
Mojduszka, 1996; Umberger et al., 2009), but marketed with a social benefit. These 
demands include a growing segment of beef that is raised without growth enhancing 
technologies and without use of antibiotics (Sparling, 2001; Perrone, 2012). Given the 
dichotomy between providing more beef with improved resource management versus the 
consumer demand to decrease growth promotant technology, it is critical to understand 
the influence of production systems on meat quality and palatability, consumer 
preferences, and measures of sustainability (Platter et al., 2003; Mathews and Johnson, 
2013). 
Growth Promotant Technologies Used in Beef Production 
Anabolic Steroids 
Current Use  
Anabolic steroids cause a growth promoting effect responsible for the 
morphological, physical, behavioral, and biochemical changes that occur during growth 
and development (Raun and Preston, 1997). This growth promoting effect shifts the 
transfer of nutrients consumed more directly to muscle development and bone deposition 
(Zobell et al., 2000). Due to this efficiency, anabolic steroids have been commercially 
available for over 50 years and used widely in all segments (suckling, growing, and 
finishing) of beef production (Preston, 1999; Bruns et al., 2005). Anabolic steroids are 
administered as implants to improve feed efficiency (5-15%) and weight gain (10-30%) 
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from weaning to finishing and yield more (5 - 8%) carcass weight (Perry et al., 1991; 
Preston, 1999; Nichols et al., 2002; Pritchard, 2008). 
Endogenous hormones (estradiol, progesterone, and testosterone) are naturally 
occurring (Kerr and Hobbs, 2002) though, exogenous or synthetic hormones can be 
administered to cattle. The endogenous hormones are derived from the testes, pancreas, 
adrenal cortex, thyroid, adenohypophysis, and ovaries (Lone, 1997) whereas, the 
exogenous hormones (trenbolone acetate, melengestrol acetate) are produced to emulate 
the binding affinity of protein receptors like endogenous hormones. Anabolic steroids are 
considered either estrogenic (estradiol, progesterone, and zeranol) or androgenic 
(testerosterone and trembolone acetate) compounds (Preston, 1999; Stewart, 2013). Once 
administered, there is no withdrawal because the compound is absorbed into the 
bloodstream and metabolized by the liver, so the meat products are recognized as safe 
(Zobell et al., 2000; Pritchard, 2008). If residue testing is desired, the hepatic tissue (liver 
and kidneys) would have the greatest detectable level of the steroid (Lone, 1997). It is 
understood that implanted cattle produce beef with slightly elevated hormone levels 
(Lone, 1997). A 3 oz. serving of beef from an implanted cow contains 1.9 estrogen 
nanograms and is much less than a pregnant woman (90,000,000 estrogen nanograms 
produced /d), a non-pregnant woman (5,000,000 estrogen nanograms produced/d), an 
adult male (100,000 estrogen nanograms produced/d), and a pre-pubertal child (40,000 
estrogen nanograms produced/d; Preston, 1997). In fact, if an animal was administered 10 
times the manufacture’s recommended amount, estrogen produced in beef would be only 
1/1000th of the endogenous level of a pre-pubertal girl (Johnson and Beckett, 2014). 
Further, the Joint Expert Committee on Food Additives (JECFA) of the World Health 
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Organization (WHO) and the Codex Committee on Residues of Veterinary Drugs in Food 
conclude there is no evidence of health risk associated from the consumption of beef 
produced with anabolic steroids (Kerr and Hobbs, 2002). 
Application and Transfer of Steroid into the Animal 
 Anabolic steroids can be delivered in many implant matrices including a 
compressed pellet, an impregnated polymer or, a compressed pellet with a time-release 
exterior coating (Preston, 1999; Pritchard, 2008). For an implant to achieve a response 
over a period of time, the carrier matrix dissolves slowly and releases the steroid into the 
blood stream (Bartle et al., 1992). There are two efficient carrier matrixes that impact the 
payout period of the implant. The first, with a slower release rate (60 – 80 d) is lactose 
based and the second with a faster release rate is cholesterol (Istasse et al., 1988; Bartle et 
al., 1992; Preston, 1999). The US Food and Drug Administration (FDA) only allows 
implants to be injected into the ear because it is removed from the head and discarded at 
slaughter (Zobell et al., 2000; Gadberry, 2008; Pritchard, 2008; Stewart, 2013). Improper 
implanting techniques can crush an implant, which may inadvertently cause negative side 
effects such as: raised tail heads, udder development, bulling, and vaginal or rectal 
prolapses (Pritchard, 2000; Zobell et al., 2000). When administered, implants should be 
given subcutaneously in the middle third of the cartilaginous ridge of the ear (BQA, 
2010). In addition to proper implantation, sanitation of the implant needle is important. A 
common sanitizer used to prevent the contamination and spread of coliform bacterial 
from fecal matter is Nolvasan (chlorhexidine acetate; Zobell et al., 2000). 
Mechanism of Action 
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Anabolic steroids function predominantly on the ruminants’ metabolism by 
stimulating the growth hormone (GH) to ultimately increase insulin growth factor – 1 
(IGF-1) and corresponding hepatic tissue receptors. Insulin-like growth factor-1 is a 
somatotropin (ST)-dependent anabolic peptide that stimulates the proliferation and 
differentiation of muscle cells (Florini et al., 1991). Somatotropin not only regulates IGF-
1 but also the action of insulin like growth factor binding proteins (IGFBP; Baxter, 1991; 
Thomson et al., 1996). Research has determined that implantation of TBA + estradiol-
17β (E2) increases serum IGF-1 concentrations and circulating concentrations of IGFBP 
in comparison to non-implanted cattle (Johnson et al., 1996b; Preston, 1999). 
After implantation, the size of the pituitary and the number of acidophils increase 
(Nichols et al., 2002). An acidophil is a chemical substance that affects metabolic 
functions (anabolism and catabolism) resulting in greater nitrogen retention and body fat 
utilization (Lone, 1997). The anabolic effect of growth promoting hormones in ruminants 
occurs very fast. It has been determined that post administration, cellular changes signal 
the anterior pituitary to cause animal growth and carcass differences within 7 - 40 d 
(Preston, 1999). These responses are due to circulating hormones in the blood that 
increase the size of the anterior pituitary, acidophilic vessels, GH secretion and 
circulation, and insulin response (Preston, 1999). The stimulated GH causes protein 
accretion without any apparent effects on protein degradation (Hart and Johnson, 1986). 
Additionally, stimulation of GH inhibits GLUT4 from causing lipogenesis so that adipose 
can be mobilized and glucose can be conserved for lean tissue accretion. Stimulated GH 
actively passes through the lipophilic outer cellular membrane and binds to the 
designated protein receptor inside of the cell nucleus (Johnson, 2015). Once stabilized in 
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the nucleus by co-activator enzymes, RNA polymerase up-regulates gene transcription 
(Johnson, 2015). Appreciable growth is achieved due to promotion of myogenic 
differentiation and inhibition of adipogenic differentiation (Johnson, 2015). Ultimately 
lean accretion occurs from hypertrophy of satellite cells located in the nuclei between the 
sarcolemma and basement membrane (Dayton and White, 2014; Jiang and Ge, 2014). In 
postnatal muscle tissue, satellite cells are quiescent until degradation occurs causing 
signaling for proliferation and differentiation. The myoblasts fuse and generate myofibers 
to provide addition DNA resulting in more protein synthesis (Dayton and White, 2014; 
Jiang and Ge, 2014). Lean accretion occurs because of a net increase in DNA to protein 
ratio from the recruitment of satellite cells and nuclei between the sarcolemma and the 
basement membrane. The accretion of satellite cells causes muscle hypertrophy or 
enlargement of existing muscle fibers and fusing of myotubes. 
Historical Use in Beef Production 
 Although implanting has been approved for more than 50 years, only 33% of 
cow-calf producers utilize the technology nationwide (Stewart, 2013). In 1956, the first 
estradiol based implant was introduced for use in steers (Synovex-S; Lone, 1997). In 
1969, zeranol (Ralgro) became the first estrogen like implant approved for both sexes 
(Lone, 1997). Almost twenty years later in 1987, trenbolone acetate (TBA) became an 
approved androgenic implant (Zobell et al., 2000). In 1991, the FDA approved the 
combination implant (TBA and E2) to provide synergistic effects and ultimately increase 
rate of gain and lean tissue deposition more than a single steroid (Bruns et al., 2005, 
Scheffler et al., 2003). 
Effects of Anabolic Estrogens 
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 Estrogen, the female sex hormone, has a cyclopentanoperhydro-phenanthrene ring 
containing18-C (phenolic A-ring; Lone, 1997). Estradiol causes protein deposition by 
secreting ST from the anterior pituitary and increases secretion of IGF-1 from the β-cells 
of the pancreas (Trenkle and Marple, 1983; Zobell et al., 2000). Estrogenic compounds 
interact with the estrogen cytosolic proteinous receptor causing binding inside of the 
nucleus (Johnson, 2015). The accelerated protein deposition is due to increased ST and 
insulin circulation from the pituitary and b-cells (Johnson, 2015). Synthetic E2, 
Zearalenone (ZEA) is a nonsteroidal estrogenic metabolite found in natural products 
known as β-resorcylic acid lactones isolated from a number of cereal crops including: 
maize, barley, oats, and wheat (Lone, 1997; R.L. Preston, 1999). Zearalenone acts by 
binding to the E2 receptors in the cytosol and nucleus. Reduction of ZEA produces a 
mixture of 7α and 7β-zeralenols containing at least 98% 7α –diastereoisomer, sold 
commercially as zeranol (Ralgro - Tradename; Merck Animal Health, Madison, NJ; 
Lone, 1997). Ralgro is an estrogenic implant that is classified as “estrogen like” 
containing 36 to 72 mg per dose (Johnson, 2015). The direct mode of action of estrogen 
is less understood than androgens. 
Effects of Anabolic Androgens 
 Androgens have 19-C and contain an oxygen at C-3 and -17 (Lone, 1997). Unlike 
estrogenic steroids, the androgens do not stimulate the production of ST but increases the 
circulatory levels of IGF-1 (ZoBell et al., 2000). Androgens decrease muscle protein 
breakdown by occupying the corticosteroid cell receptor (Preston, 1999). Androgen 
receptors are unique because they work with direct muscle cellular receptors (Herscher et 
al., 1995). Androgens cause lean muscle accretion from pregnenolone biosynthesis in the 
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leydig cells (Lone, 1997). Androgens directly effect skeletal muscle and are often 
referred to as “true anabolic compounds” because androgenic enzymes cannot convert 
testosterone to dihydrotestosterone as their action is not mediated like estrogens (Lone, 
1997). The anabolic activity of testosterone has a 3 - 5 fold response compared with the 8 
- 10 fold response of TBA (Preston, 1999). 
Effects of Trenbolone Acetate 
The most potent anabolic steroid is TBA, a synthetic androgen compound known 
to decrease protein degradation (or muscle turnover). Moreover, TBA works 
synergistically with E2 and testosterone to ultimately increase IGF circulation. 
Trenbolone acetate increases the rate of protein synthesis while slowing protein 
degradation resulting in a greater net increase of protein deposition (Dayton and White, 
2014; Duckett and Pratt, 2014; Johnson, 2015). Trenbolone acetate is an excellent growth 
promotant on heifers (ADG ≥ 20%) but causes marginal effects on steers (ADG ≤ 5%; 
Dayton and White, 2014; Duckett and Pratt, 2014; Johnson, 2015). Trenbolone acetate 
inhibits the thyroid gland circulation of T4 and T3 hormones. These effects are dose 
dependent, the lower the dose the more anabolic while higher doses are more catabolic 
(biphasic response; Lone, 1997). At the cellular level, thyroid hormones may have dual 
action including long-term increases in protein synthesis through the transcriptional 
processes and short-term effects on energy metabolism through activation of respiratory 
enzymes in the mitochondria (Lone, 1997). 
Combinational Anabolic Steroids and Re-implantation 
 When E2 is combined with TBA, the gain efficiency and leanness effect is 
synergistic (Preston, 1999). As mentioned, lower doses of TBA increase protein synthesis 
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by causing the glucocorticoid receptor to reduce the catabolic effects of protein 
degradation (Trenkle, 1983; Buttery and Sinnett-Smith, 1984; Muir, 1985). Research has 
determined that post administration, hormone blood levels peak then gradually decline 
over time (Preston, 1999) during the payout period. Re-implantation is generally 
scheduled to coincide with the declining hormonal level (Lone, 1997; Zobell et al., 2000) 
to provide an additive response from the previous implant (Preston, 1999). A “biphasic” 
concentration pattern of two GH curve components result from the initial and secondary 
concentration of GH circulation (Preston, 1999). 
Anabolic Steroid Effects on Live Performance 
Performance of a Calfhood Zeranol Implant 
 Zeranol, an estrogenic steroid provides minimal growth effects on heifers but is a 
well documented growth promotant for steers (Duckett and Pratt, 2014; Johnson, 2015). 
Calfhood research trials have shown that implanting nursing beef calves with Ralgro 
improved daily gains (4 - 6%) at weaning and resulted in more BW gain (6.8 - 13.6 kg; 
Selk, 1997; Gadberry, 2008; Stewart, 2013; Dunn, N.D.). A study conducted by Pritchard 
(1981) concured; calves implanted with Ralgro were heavier (9 kg at 150 DOA) and 
remained heavier (16 kg heavier at 205 DOA) at weaning versus non-implanted calves. 
McReynolds (1979) also found a similar result for suckling calves after comparing 18 
different implant sequences of Ralgro and Synovex-S during the suckling, growing, and 
finishing segment. Though McReynolds (1979) found calves implanted with Ralgro at 
suckling to have a negative finishing performance. More recently, research conducted by 
Webb et al. (2017) determined suckling calves implanted with Ralgro at 60 DOA (at 
branding) or 120 DOA (at pre-weaning) did not improve final animal or carcass 
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performance compared with a non-implanted control. An economic analysis conducted 
by Zimmerman (2012) used Superior Livestock Auction data to compare the value of 
different calf programs and discovered weaned steer calves with certified health 
programs sold between $3 – $5 more per cwt. versus implanted calves that were 
discounted more than $2 per cwt. 
 Performance of a Combination and Re-Implantation of a Terminal Combination Implant  
Historically research has found combination (TBA/E2) implants to increase 
growth rate (20%) and feed efficiency (15%) compared with a non-implanted control 
(Schanbacher, 1984; Bartle et al., 1992). Though there are different combination 
potencies that can be used dependent upon factors such as breed, sex, and estimated days 
on feed (DOF; Johnson and Beckett, 2014). For example, a large-frame Continental 
animal likely requires a lower dose of TBA/E2 to provide adequate anabolic steroids to 
achieve weight gain without causing quality grade (QG) to be negatively impacted 
whereas, a smaller-framed British animal is likely to experience a greater benefit from a 
higher dose of TBA/E2 to improve weight gain, feed efficiency, body size, and not 
negatively impact QG because of the breed’s propensity for greater deposition of 
marbling (Johnson and Beckett, 2014). Surprisingly given the vast amount of literature on 
TBA/E2, specific data directly evaluating animal performance using Revalor-IS is 
limited. Johnson et al. (1996a) used a moderate potency combination implant containing 
120 mg TBA and 24 mg E2 on finishing steers with a similar payout (100 – 140 d) 
duration as Revalor-IS. Crossbred steers were evaluated at 3 time periods to represent 
either the maximum growth response to the implant (d 0 - 40), the recommended 
slaughter time by the manufacturer (d 41 - 115) or, advanced time of the payout period (d 
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116 - 143). Collectively, implanted steers improved ADG by 18% and feed efficiency by 
13% between d 0 - 40 post implantation versus a non-implanted control. Though, dry-
matter intake (DMI) was not influenced. During the second period (d 41 to 115) ADG 
was still effectively greater (24%) than the control, though feed efficiency and DMI only 
exhibited a trend. The final period (d 116 – 143) resulted in no differences in animal 
performance indicating that the greatest advantages from the combination implant 
occurred during a typical feeding period (d 0 and 115).   
 Overall, it is well established that cattle administered a combination implant 
containing a high potency TBA and a low to moderate E2 have improved ADG, feed 
efficiency, muscle accretion, and result in increased box beef value (Johnson et al., 
1996a; Foutz et., 1997; Scheffler et al., 2003). Parr et al. (2011; in experiment 1) 
implanted steers with Revalor-IS followed by Revalor-S (cumulatively administered 200 
mg TBA and 40 mg E2) at d 68 - 74 of the initial payout period. For this experiment, 
final carcass adjusted BW was greater (11 kg) and gain to feed (G:F) was improved for 
the combination compared with a single Revalor-S implant (120 mg TBA and 24 mg E2). 
Although DMI did not increase in Parr et al. (2011), DMI is often greater in implanted 
cattle (Rumsey et al., 1992). Historically in a consecutive re-implantation strategy, 
TBA/E2 improved ADG 10 - 30% and BW gain 5 – 15% compared to a single 
combination implant (Duckett et al., 1997; Preston, 1999). From a management aspect, it 
is important to consider the duration of time on feed and the plane of nutrition because 
implants promote lean muscle deposition and cattle tend to take longer DOF to achieve 
the same marbling as non-implanted cattle (Johnson and Beckett, 2014). Further, Parr et 
al. (2011) recommended that re-implantation should occur just after the initial implant 
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decline to optimize ADG, G:F, and moderates negative effects on QG. Waiting too long 
to re-implant hinders cattle performance and re-implanting too soon enhances cattle 
performance at the expense of QG. Other factors that may influence timing of re-
implantation include cattle type, BW, caloric intake, cattle handling, and environmental 
conditions (Parr et al., 2011). After review of the literature, it is apparent that most 
research has either not indicated how harvest date was decided upon or utilized DOF as a 
constant variable, which is not a reflection of body composition. Research is needed 
evaluating the use of two consecutive TBA/E2 implants that are specifically Revalor-IS 
and Revalor-200 to better estimate animal performance outcomes. 
Beta-Andrenergic Agonist, Ractopamine HCI 
Current Use 
The theory of adrenotropic receptors action on catecholamines repartitioning lipid 
to protein was first introduced by Ahlquist (1948). In the biomedical community, 
tremendous interest has revolved around the production of andrenergic molecules that 
bind to bronchial-tracheal musculature to relieve human asthma. Beef production in 
North America also utilizes andrenergic molecules as a supplement in a majority (60% - 
80%) of cattle finishing diets (Chichester, 2017). Johnson et al. (2014) describes beta-
adrenergic agonists (β-AA) as, “receptor-mediated enhancers of protein synthesis and 
inhibitors of protein degradation.” The supplementation of β-AA can be added as a top-
dress, complete mixture, or a liquid feed (Ricks, 1984; Elanco, 2011). The use of β-AA in 
feeedyards promotes live weight gain, heavier BW, greater feed efficiency, increased hot 
carcass weight (HCW), and a improved dressing percentage (DP; Platter et al., 2008; 
Elanco, 2011; Johnson et al., 2014). There are two adrenergic repartitioning agents 
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approved by FDA for use in finishing beef cattle: 1) zilpaterol HCI (Zilmax – 
Tradename, Merck Animal Health, DeSoto, KS (ZH)) and 2) ractopamine HCl 
(Optaflexx – Tradename, Elanco Animal Health, Greenfield, IN (RH)). Though in 
August 2013, Merck Animal Health voluntarily removed ZH from retail commerce. 
Therefore, this discussion will focus on RH which was first approved by FDA in 2003 
and is approved for supplementation of 70 - 430 mg • hd-1 • d-1 during the final 28 - 42 d 
of the feeding period prior to harvest (Platter et al., 2008; Elanco, 2011). Additionally, 
there is no withdrawl period when feeding RH therefore, cattle can be harvested 
immediately (Elanco, 2011).   
Mechanism of Action 
Observed differences in animal performance and carcass composition are 
complex to understand and not fully understood (Johnson et al., 2014). Supplementation 
of β-AA can be influenced by species, available cellular receptor type, animal age, feed 
intake, and diet (Mersmann, 1998; Johnson et al., 2014). The β-AA organic molecule 
functions because of the corresponding beta-andrenergic agonist receptors (β-AAR) that 
exist in mammalian cells (Mersmann, 1998). Though the animal response to β-AA are 
dependent upon the number of receptors available for activation (Mersmann, 1998). In 
mammalian cells, the β-AAR availability varies among anatomical location within specie 
(Mersmann, 1998). In bovine adipose, transcripts for b1-AAR, b2-AAR, and b3-AAR 
exist (Casteilla et al., 1994). Though b3-AAR is the predominant transcript found in 
brown adipose of fetuses and is greatly reduced after thermogenesis (Casteilla et al. 
1994). The β-AAR have more than 400 amino acids and seven hydrophobic 
transmembrane domains that anchor the receptor to the plasma membrane (Mersmann, 
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1998: Johnson et al., 2014). Once anchored, catecholamines, norepinephrine and the 
biosynthesized epinephrine cause a physiological increase in muscle and reduce lipid 
(Mersmann, 1998). Both norepinephrine and epinephrine stimulate a- and b-AAR (b1-
AAR, b2-AAR: Johnson et al., 2014) as they are both members of G protein-coupled 
receptors (GPCR). Though a-AAR do not exist in cell membranes of adipose tissue in 
beef cattle therefore, this regulation is not meaningful to adipose tissue metabolism 
(Johnson et al., 2014). Norepinephrine, is responsible for the catecholamine sympathetic 
nervous system neurotransmitter molecule and is more potent on b1-AAR. Ractopamine 
HCl functions more effectively on these b1-AAR (Garmyn and Miller, 2014) though 
unfortunately only a small population (1% to 4%) of b1-AAR mRNA are present in 
bovine tissue (Johnson et al., 2014). Epinephrine secreted from the adrenal medulla 
circulates in serum at lower concentrations to promote b2-AAR (Mersmann, 1998), which 
are abundant in skeletal (99%) and adipose (90%) tissues of cattle. Further, type II, 
glycolytic muscle fibers are most responsive to b2-AAR stimulation by ZH. 
Consequently, ZH is more effective than RH at increasing the cross-sectional area of 
muscle (Johnson et al., 2014).  
Beta-andrenergic agonists (β-AA) function as repartitioning agents by reducing 
lipogenesis, protein degradation, and simultaneously increasing lipolysis and protein 
synthesis (Ricks et al., 1984; Johnson et al., 2014). Specific to RH, muscle protein 
accretion is because of increased protein synthesis but has no influence on the rate of 
protein degradation (Johnson et al., 2014). This is due to a series of events that occur 
once the β-AA binds to the β-AAR and activates Gs proteins, which in turn, elevates 
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adenylyl cyclase (enzyme producing cyclic adenosine monophosphate, CAMP; 
Mersmann, 1998; Johnson et al., 2014). The Gs proteins disassociate and with ATP, 
initiate the cAMP response element binding protein (CREB) and Protein Kinase A. Once 
bound, a catalytic subunit causes phosphorylation of enzymatic proteins and activation of 
enzymes such as hormone sensitive lipase (HSL) a rate limiting enzyme for adipocyte 
triacylglycerol degradation (Mersmann, 1998). Other enzymes become inactivated once 
phosphorylated (acetyl-CoA carboxylase, a rate limiting enzyme for long-chain fatty acid 
biosynthesis (Mersmann, 1989). After supplementation, adipose tissue has an increased 
lipolytic rate (Mills and Mersmann, 1995) and elevated plasma nonesterified fatty acid 
concentration (Eisemann et al., 1988). However if chronic or long-term exposure (greater 
than 42 d) occurs, the response is halted due to internalization or loss of the cell surface 
receptor (Eisemann et al., 1988; Hausdorff et al., 1990). Limited evidence suggests that 
β-AA increase muscle and reduce lipid via somatotropin, which has no structural 
relationship to β-AA (Mersmann, 1998). Unlike anabolic steroids that increase muscle 
mass through hypertrophy, the β-AA has hypertropic effects restricted to skeletal and 
cardiac muscle (Reeds and Mersmann, 1991).  
The general function of a β-AA is to use stored triglycerides within adipose tissue 
as circulating energy substrates for partitoning of muscle (Etherton and Meserole, 1982; 
Ricks, 1984; Moody et al., 2000). This results in an increase in protein synthesis at the 
expense of lipolysis. Use of b-AA increases the amount of mRNA transcribed in skeletal 
muscle proteins with b1 or b2-AAR and myosin heavy chain IIX (Johnson et al., 2014). 
Ultimately, β-AA cause an up-regulation of myofibrillar protein gene transcription 
(Johnson et al., 2014). The net result is an increase in protein:DNA ratio as the muscle 
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responds with promotion of protein synthesis and a minimal reduction of protein 
degradation while adipose is used as an energy substrate. Supplementation of RH is not 
as prolific as ZH for inhibiting protein degradation (Moody et al., 2000; Johnson et al., 
2014). 
Live Performance 
 During finishing, β-AA have been shown to promote ADG, final BW, and G:F 
(Moloney et al., 1991; Schroeder, 2004; Laudert et al., 2005; Avendaño-Reyes et al., 
2006; Platter et al., 2008; Elanco, 2011; Johnson et al., 2014). In a summary of six studies 
supplementing RH, ADG and G:F increased by 17.4% and 15.9%, respectively (Laudert 
et al., 2005). Scramlin et al. (2010) fed crossbred steers RH at 200 mg • hd-1 • d-1 for 33 d 
compared with a non-supplemented control. The crossbred steers fed RH had a .23 kg 
greater ADG than CON and resulted in a heavier (7 kg) final BW. However, Scramlin et 
al. (2010) did not detect (P > 0.05) an improvement in average daily feed intake (ADFI) 
or G:F ratio. Unlike ZH, RH has been shown to be less effective at reducing ADFI. Some 
β-AA such as clenbuterol are hypothesized to reduce ADFI because of excessive 
stimulation of the central nervous system which suppresses rumen motility (Graham et 
al., 1982). In a separate study, Strydom et al. (2009) fed Bonsmara steers RH at 30 ppm 
for 30 d prior to harvest and determined no difference (P > 0.05) in final BW or HCW 
even though RH steers had a greater ADG (.5 kg) than control (CON). These results 
indicate some inconsistencies when supplementing RH perhaps due influences of breeds 
or environmental conditions. Consistent with Scramlin et al. (2010), Strydon et al. (2009) 
reported no difference in ADFI (CON, 13.3 vs. RH, 13.2; P > 0.05). In contrast, 
Avendaño-Reyes et al. (2006) supplemented crossbred cattle with 300 mg • hd-1 • d-1 of 
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RH compared with a non-supplemented CON 33 d prior to harvest. Steers fed RH 
consumed less (P = 0.03) DM than CON (8.37 kg vs. 8.51 kg, respectfully). However, 
similar to the previous studies, there was an improved G:F ratio (RH, 0.248 kg vs. CON 
0.015 kg). In a summary of ten trials conducted across the US, Schroeder (2004) 
concluded ADG, final BW, and G:F were improved by 26%, 20%, and 20.5%, 
respectively. Unique to β-AA there is no effect on frame score and bone growth 
(Schroeder, 2004). In review of these research studies, determination of how the terminal 
harvest endpoint was decided upon is limited in the information provided. Harsh et al. 
(2015) indicated harvest d (d 84) and a visual appraisal was conducted but specifically 
the deciding factor was not illustrated. Providing a repeatable method for designating 
terminal endpoint may eliminate some inconsisitencies in animal performance results 
among studies. Further, some studies (Garmyn et al., 2014) do not provide sufficient 
information about animal management procedures other than the supplemented treatment. 
Having available information about animal production methods, breed, and the 
environment is helpful when interpreting results as these factors may influence treatment 
outcomes. Overall, use of RH appears to provide positive outcomes for animal 
performance.  
Monensin and Tylosin 
Current Use 
Monensin (Rumensin 90 – Tradename, Elanco Animal Health, Greenfield, IN) is 
an oral ionophore fed to cattle during backgounding and/or finishing to improve G:F and 
reduce the incidence of digestive ailments such as coccidiosis (Stackhouse et al., 2012; 
Elanco, 2017a). Monensin has been approved by the FDA since 1975 and can be used in 
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a complete feed between 5 - 40 g/ton to provide 50 - 480 mg • hd-1 • d-1 for improved G:F 
and fed between 10 - 40 g/ton to provide a maximum of 480 mg • hd-1 • d-1 to manage 
coccidiosis in the feedyard (Elanco, 2017a).  Monensin enhances G:F, DM digestibility, 
reduces DMI, lactic acid production, bloat, heat production, assists with coccidiosis 
management, and may reduce methane loss (Goodrich et al., 1984).  
Tyslosin (Tylan 40 – Tradename, Elanco Animal Health, Greenfield, IN) is a 
feed-grade therapeutic antimicrobial fed to cattle during finishing to reduce the incidence 
of liver abscesses (Elanco, 2017b) because clinical signs are often not exhibited 
(Nagaraja and Chegappa, 1998). It is well accepted that ruminal lesions are the 
predisposing factor for liver abscesses (Jensen et al., 1954) because of the sudden 
transition to high-energy feeding patterns during finishing that initiate the colonization of 
Fusobacterium necrophorum and Aracanobacterium pyogenes anerobic bacteria causing 
liver abscesses. Liver abscesses are the direct result of feeding practices therefore, 
feedyard cattle tend to be the primary segment affected as the incidence of liver abscesses 
range from 12 - 32%. Nagaraja and Chegappa (1998) conducted a review of liver 
abscesses occurring from feedyard cattle and found therapeutic use of tylosin to reduce 
liver abscesses by 40 - 70%. Additionally, liver condemnations can cause postmortem 
economic losses at the beef packing plant in the form of decreased carcass yield and liver 
abscesses can impact antemortem economics from reductions in animal intake, ADG, and 
feed efficiency (Nagaraja and Chengappa, 1998). The macrolide tylosin can be supplied 
between 60 - 90 mg • hd-1 • d-1 to mitigate the presence of the anaerobic bacteria, 
previously described (Elanco, 2017b). 
Mechanism of Action 
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The well documented mode of action of monensin is the alteration of volatile fatty 
acid (VFA) production so there is decreased acetate and butyrate to propionate ratio in 
the rumen (Schelling, 1984). The VFA alteration caused by increased proprionate is due 
to a cell membrane leak because of a leaking cellular NA+ K pump. This leak is causesed 
by a depression of Gram-positive bacteria and a proliferation of Gram-negative bacteria 
(Goodrich et al., 1984). Elevated propionate increases gluconeogenesis and body glucose 
turnover (up to 14%) allowing greater energy to be released from feedstuffs through 
greater levels of glucose while reducing the amount of amino acids (AA) used for glucose 
synthesis and thus, results in a protein sparing effect (Schelling, 1984). Propionate is also 
more efficient because it requires a lower heat of fermentation and allows more protein 
into small intestine (SI) for digestion and absorption. 
The description of the mode of action for tylosin is rare, though it is well agreed 
upon that Gram-negative anaerobic bacteria (Fusobacterium necrophorum (the primary 
etiologic agent) and Aracanobacterium pyogenes) as mentioned, cause liver abscesses 
and are most inhibited by Tylosin compared with four other antimicrobials (bacitracin 
methylene disalicylate, chlortetracycline, oxytetracycline, and virginiamycin; Nagaraja 
and Chengappa, 1998). The anaerobic bacteria thrive on lactic acid as an energy substrate 
in the rumen and tylosin effectively stabilizes rumen bacteria and reduces lactic-acid 
production in the rumen. Consequently, tylosin inhibits both rumen bloat (acidosis) and 
these anaerobic bacteria from causing ulcerative lesions and strain on the liver, resulting 
in liver abscesses. 
Live Performance 
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As previously mentioned, monensin improves ADG, DMI, and G:F regardless of 
animal sex or weight and is why monensin is a widely accepted growth promotant in the 
cattle feeding industry (Goodrich et al., 1984; Schelling, 1984). Further, cattle provided 
diets high in carbohydrates are most noted to have reduced DMI and improved G:F 
whereas, when roughage is high improvements in ADG are most notable (Stock et al., 
1995). Monensin has been studied in cattle that have received anabolic steroids, Goodrich 
et al. (1984) summarized 7 trials utilizing implanted (zeranol, progesterone-estradiol or, 
testosterone-estradiol) steers and heifers and consistently found improvements in ADG 
and G:F from use of monensin. It is apparent that research specifically testing the 
combination of monensin, Revalor-IS and -200, and RH is limited or simply, the 
management detail is not transparently provided. 
 In regard to improvements in animal performance from use of tylosin, it is logical 
to speculate that if a large portion of the liver tissue were damaged due to abscesses the 
liver would function with much less efficiency and inhibit animal performance. In a 
meta-analysis conducted by Wileman et al. (2009) cattle receiving tylosin had an 8% risk 
of developing a liver abscess compared with cattle that were not fed tylosin and had a 
much greater (30%) risk of abscess development. Further, research has shown repeatedly 
that feeding tylosin improves ADG, G:F, and increases DP in comparison to cattle not fed 
tysosin in the feedyard (Brown et al., 1975; Vogel and Laudert, 1994). As mentioned 
earlier, economics should be considered if not effectively supplementing tylosin because 
of potential negative outcomes on cattle health, feed intake, ADG, G:F, and carcass yield 
grade (YG; Nagaraja and Chengappa, 1998; Stackhouse et al., 2012). 
Growth Promotant Technology Effects on Carcass Performance 
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Anabolic Steroid Administration and Ractopamine HCI Use on Cutability 
 The USDA YG for beef carcasses range from 1 to 5 and are calculated based 
upon correction factors for HCW, ribeye area (REA), 12th rib fat thickness (FT), and 
percent pelvic, kidney, and heart fat (KPH) to predict the estimated percentage of 
boneless, closely trimmed, retail cuts (% BCTRC). Fatter carcasses are stamped with a 
higher numerical USDA YG and USDA YG 4 and 5 can receive discounts at the packing 
plant. The distribution of YG 1 through 5 is: 1, >52%; 2, 52.3%-50%; 3, 50.0% - 47.7%; 
4, 47.4% - 45.4%; and 5, <45.4%. The 2011 National Beef Quality Audit (NBQA) found 
the mean YG to be 2.86 and the YG distribution to be: YG 1, 15.7%; YG 2, 41.0%; YG 
3, 33.8%; YG 4, 8.5%; and YG 5, 0.9% (Gray et al., 2011). 
 Anabolic steroids have been proven as a consistent technology to reduce FT, 
percent KPH, and USDA YG while increasing HCW and ultimately mitigate the 
occurrence of USDA YG 4 and 5 (Kuhl, 1992; Preston, 1999, Johnson, 2015; Bruns et 
al., 2005, Pritchard, 2008; Kuhl, 2002; Bruns et al., 2008). Research conducted by Bruns 
et al. (2008) determined implanted cattle were 8% leaner than non-implanted cattle. 
Additionally, Duckett et al. (1997) reviewed 77 research trials and determined that a 
single combination implant improved steer HCW and REA. Though Duckett et al. (1997) 
discovered an inverse relationship between a larger REA and a corresponding smaller 
marbling score. In meat science, this phenomenon is known as the “dilution effect” which 
occurs when REA increases and marbling score diminishes due to hypertrophy of skeletal 
muscle (Duckett et al., 1999). In a separate lifetime analysis conducted by Duckett and 
Andrae (2001), implanting during the suckling, grazing, and finishing period resulted in 
an increased value of $93 per animal and reduced the cost of beef production. Similarly, 
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Reinhardt (2007) determined that a stair-step implant program maximized YG value 
($85.68) on the rail compared to non-implanted carcasses. Re-implanting generally 
improves performance of cattle when sufficient nutrition is available (Pritchard, 2008; 
McCollum, N.D.). Overall, anabolic steroids generally improve animal performance in 
each segment of beef production however, a better understanding of the implications on 
carcass quality and skeletal maturity are needed to overcome quality and tenderness 
challenges (Perry et al., 1991; Preston, 1999; Duckett and Andrae, 2001; Jones et al., 
2012).  
In addition to providing anabolic steroids to improve postmortem efficiency, it is 
well documented that supplementation of β-AA generally increases HCW, DP (1-2%), 
and reduces FT (Platter et al., 2008; Elanco, 2011; Boler et al., 2012, Johnson et al., 
2014). Given the anticipated carcass performance advantage, it is recommended that 
cattle supplemented β-AA be marketed on a carcass basis to increase returns from the 
grid marketing system (Maxwell, 2014). In review of research supplementing β-AA, 
Johnson et al. (2014) found an increase in LM diameter (by 6% to 40%) in comparison to 
a unsupplemented control. In contrast, when feeding RH Schroeder (2004) found no 
influence on LM diameter. Perhaps RH supplementation is less consistent at ensuring a 
positive response. To further illustrate, Garmyn et al. (2014) fed British steers RH at 308 
mg • hd-1 • d-1 for 28 d and determined there was no significant difference in HCW, FT, 
percent KPH, YG, or marbling score. Though Garmyn et al. (2014) discovered a .3 cm2 
REA increase in supplemented RH carcasses. This result is inconsistent with Avendaño-
Reyes et al. (2006) that supplemented RH and found no influence on REA but a heavier 
HCW and a lower numeric YG (P < 0.05). Strydom et al. (2009) also found 
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inconsistencies when supplementing with RH in comparison to a CON as there were no 
influences on USDA YG, FT, REA or, KPH. In contrast, Schroeder (2004) reported an 
increase in HCW by 8.3 kg although LM area was not influenced (P = 0.132). In review, 
supplementing RH at a low dosage may not dramatically improve carcass performance. 
As previously described, some of these inconsistencies and/or lack of response may be 
due to the RH binding affinity for b1 receptors that are less abundant. To be able to make 
producer recommendations and have an accurate comparison among growth promoting 
technologies, an effective control is needed. 
Anabolic Steroid Administration and Ractopamine HCl Use on Marbling 
To predict carcass quality and assess the value of beef, the USDA-AMS provides 
a voluntary service to apply USDA QG at beef packing plants. The USDA-AMS Meat 
Grader and/or approved video image analysis (VIA) system evaluates carcasses for 
intramuscular fat (IMF) or marbling, a known predictor for eating satisfaction in cooked 
beef (Hankins and Ellis, 1939; Cole and Badenhop, 1958). Marbling is a palatability-
indicating characteristic and combined with physiological maturity (vertebral 
ossification, size and shape of the ribs, and color and texture of the LM at the 12th rib) a 
USDA QG (USDA Prime, USDA Choice, USDA Select) is assigned (Acheson et al., 
2014). Acheson et al. (2014) proposed that USDA QG assignment would be as effective 
if only marbling was used as the determining factor. Beef consumers rely on marbling 
because of its bulk density or lubrication effect that provides cooking insurance and 
ensured palatability (Savell and Cross, 1988). The theory behind the lubrication effect is 
that marbling present around muscle fibers lubricates the fibrils and results in a juicy beef 
eating experience (Savell and Cross, 1988). Thus, marbling level is an important part of 
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QG determination. As marbling scores increase from Practically Devoid to Moderately 
Abundant, the likelihood of an enjoyable beef eating experience increases (Smith et al., 
1985; Emerson et al., 2013).  
The administration of anabolic steroids has been well documented to decrease 
marbling scores and consequently result in fewer carcasses grading USDA Choice or, be 
stamped a lower USDA QG (Kuhl, 1992; Bartle et al., 1992; Foutz et al., 1997; Preston, 
1999; Platter et al., 2003; Bruns et al., 2005; Pritchard, 2008; Johnson, 2015). In a review 
of 37 trials examining steers administered an anabolic steroid while on a finishing diet, 
Duckett et al. (1996) detected mean reductions in marbling (24%) and carcasses grading 
USDA Choice (14.5%). Belk and Cross (1988) also found anabolic steroids to 
compromise USDA QG and increase the incidence of dark cutters. In contrast, some 
studies have found no difference even using successive implantation protocols 
(androgenic, estrogenic, and combinations) on deposition of IMF or beef tenderness 
(Nichols et al., 2002; Gerken et al., 2014). Duckett et al. (1999) found implanting to 
minimally reduced marbling score by one-half a marbling degree and re-implanting did 
not alter marbling scores. Gerken et al. (2014) evaluated bos indicus steers using a single 
implant of either E2, TBA or, a combination (E2 and TBA) and reported little affect on 
the IMF deposition. Other research agrees, implants have no negative affect on marbling 
score nor USDA QG (Johnson et al., 1996a; Scheffler et al., 2003, Smith et al., 2007).  
Feeding cattle 200 mg RH mg • hd-1 • d-1 has been shown to decrease marbling 
score minimally (10%) compared with an non-supplemented control (Winterholler et al., 
2006; Gruber et al., 2007). It is understood that cattle specie can influence marbling 
deposition and to evaluate RH use further, Gruber et al. (2007) compared carcasses from 
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English, Continental, and Brahma-cross cattle and only found a tendency (P = 0.07) for 
marbling reduction yet, this did not translate to an adverse influence on QG. Also, cattle 
specie did not influence marbling score suggesting that genetics for low (Brahma-cross) 
and high (English) propensities for IMF development were not affected by RH. In some 
contrast, Boler et al. (2012) reported no difference in USDA QG among RH carcasses 
however, carcasses supplemented with 300 vs. 200 mg RH • hd-1 • d-1 had numerically 
fewer USDA Choice carcasses and the higher supplementation rate produced more 
USDA select carcasses. Overall, a wide spectrum of studies (Schroeder et al., 2003; 
Laudert et al., 2005; Schroeder et al., 2005; Greenquist et al., 2006) have found little to 
no difference when supplementing RH on marbling score that translate to a reduced QG 
(Gruber et al., 2007; Boler et al., 2012). 
Anabolic Steroid Administration and Ractopamine HCl Use on Tenderness 
Beef tenderness, juiciness, and flavor have been described as the three 
components that contribute to consumer beef palatability and drive purchase decisions 
(Reicks et al., 2011). Repeatedly data has demonstrated that tenderness is the most 
critical factor to beef palatability and consumer satisfaction (Miller et al., 2001; Savell et 
al., 1987). It is understood that there are several factors (decreased proteolytic activity, 
reduced protein degradation, decreased collagen solubility, and decreased sarcomere 
length) that decrease meat tenderness (Geesink et al., 1993; Vestergaard et al., 1994). As 
previously mentioned, the USDA QG system utilizes physiological maturity to estimate 
animal age-related differences that influence meat tenderness. Research has shown that 
QG and beef tenderness are related and propose that QG influences objective measures of 
beef tenderness (Smith et al., 1985; Gruber et al., 2007, and Garmyn et al., 2011). 
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Though other studies did not find a relationship between carcass maturity and beef 
tenderness when maturity groups were restricted to only include carcasses from grain-fed 
animals (Miller et al., 1983; Field et al., 1997).  
In regard to implantation, some studies have found no difference in the use of 
successive implantation (androgenic, estrogenic, and combinations) on the tenderness of 
beef (Nichols et al., 2002; Gerken et al., 2014). Whereas, other research confirms that the 
use of implants increases steak toughness (Morgan et al., 1997; Roeber et al., 2000). 
However, administration of exogenous estrogenic steroids may impart a significant 
influence on skeletal maturity. This is due to the influence of hyperestrogenism, or the 
acceleration of maturity as a result of the additive effects of estrogen. This may cause 
cattle that are less than 30 mo to be classified as B maturity and receive a carcass 
discount ($20 - $50/ cwt.; Acheson et al. 2014). Other concerns when administering 
anabolic steroids is an increase in objective measures of mean WBSF value and the 
potential to translate this effect into less desirable consumer tenderness ratings (Platter et 
al., 2003). In contrast, consumer acceptance ratings have been found to be similar for 
cattle successively implanted 2, 3, 4, or, 5 times (Platter et al., 2003).  Roeber et al. 
(2000) evaluated steaks produced from cattle receiving combination implants and 
discovered steaks were not considered tough based upon WBSF values. In contrast, Foutz 
(1997) determined steers implanted with various combinations of steroids tended to 
produce steaks with greater WBSF values than steaks from a non-implanted control. 
Nichols et al. (2002) summarized 19 studies evaluating single and successive 
implantation and confirmed the inconsistent results between WBSF values and consumer 
panelist responses. 
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 However, trained sensory panelists have been unable to detect differences in 
tenderness between implanted and non-implanted steers (Apple et al., 1991; Gerken et al., 
1995). Research has also shown that extended postmortem aging (21 d to 28 d) mitigates 
the effect of implanting such that implanted treatments were considered as tender as a 
non-implanted control after a sufficient aging period (Schneider et al., 2007; Igo et al., 
2011). However, a 14 d postmortem aging period was not effective at improving 
consumer tenderness acceptability of Select steaks from cattle implanted cumulatively 
with TBA and E2 compared with steaks from a non-implanted control (Igo et al., 2011). 
In contrast, some studies (Belk and Cross, 1988; Duckett et. al., 1996; Pritchard, 2000) 
indicate that implants have minimal influences on beef tenderness and both Igo et al. 
(2011) and Hutcheson (2008) agree that implant treatment effects can be mitigated with 
greater postmortem aging. The consistent use of implants for more than 50 yrs is likely 
due to consistent animal performance benefits and research has shown that when 
appropriate implant strategies are utilized impacts on meat quality are minimized (Bruns 
et al., 2005). Anabolic implants improve animal performance at each segment of 
production, however a better understanding of the implications on carcass quality and 
skeletal maturity are needed to improve tenderness of beef aged < 14 d and mitigate 
tenderness challenges at the retail case (Perry et al., 1991; Preston, 1999; Duckett and 
Andrae, 2001; Jones et al., 2012).  
It has been repeatedly established that beef tenderness can be negatively impacted 
by supplementing cattle with RH (Avendaño-Reyes et al, 2006; Gruber et al., 2007; 
Strydom et al., 2009; Scramlin et al., 2010; Boler et al., 2012; Arp et al., 2013). Though 
some studies (Schroeder et al., 2003; Arp et al., 2013) that supplemented steers with 200 
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mg RH• hd-1 • d-1did not negatively influence meat tenderness. Though higher dosages 
(300 mg RH• hd-1 • d-1) have resulted in greater WBSF values than a non-supplemented 
control. It is understood that the length of postmortem aging (28 - 42 d) and dosage level 
of RH can influence meat tenderness (Garymn et al. 2014). Johnson et al. (2014) reported 
supplementation of ZH 30 d prior to harvest increased the concentration of myosin heavy 
chain IIX in bovine skeletal tissue. Wheeler and Koohmaraie (1992) also found 
supplementation of β-AA to cause fractional protein degradation and cause an increase in 
calpastatin activity (Killefer and Koohmaraie, 1994). In a study evaluating cull cows that 
received a terminal combination implant and RH, type I fiber diameter was increased due 
to supplementation while type II was not influenced (Gonzalez et al., 2007). Woerner et 
al. (2011) evaluated the combination of providing an initial and terminal implant then, 
supplemented calf-fed steers and heifers 200 mg RH • hd-1 • d-1. Overall, WBSF values 
were not influenced by the initial or terminal implants however, RH supplementation 
increased mean WBSF value by 0.23 kg, which tended to cause a loss in predicted 
consumer acceptance. This increase in toughness may be due to the effects of b-AA on 
postmortem tenderization described by Goll (1997) and illustrated by Strydom (2009) 
causing greater calpastatin activity and potentially new collagen cross-links (Roy et al., 
2015).    
Negative influences from RH supplementation on steak tenderness are debatable 
but regardless, any challenges have been described as minimal and manageable with 
adequate postmortem aging (Gruber et al., 2007; Strydom et al., 2009; Scramlin et al., 
2010; Boler et al., 2012; Garymn et al., 2014). Scramlin (2010) and Garmyn (2014) 
found aging 14 d or more to mitigate differences in tenderness. In fact, Garymn (2014) 
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noted an interaction between β-AA supplementation and aging, where RH had a greater 
response to 21 d aging and consequently resulted in the lowest WBSF values compared 
with the control. Garmyn and Miller (2014) concluded that although objective measures 
of steak tenderness may occur, differenes in tenderness may not translate into a detection 
by a sensory panel. Therefore, consumers may be inconsistent in detection of differences 
in objective tenderness which may be due to the sample population tested, the 
aggressiveness of the implant protocol or, the level of RH supplementation. 
The ability for beef consumers to consistently detect influences on sensory 
attributes is not conclusively proven and may be dependent upon factors influencing the 
sample population. Given considerable variation in outcomes for palatability indicators, 
this necessitates further exploration for improved management practices from a common 
sample population. Even though postmortem aging may provide a solution, according to 
the 2010 National Beef Tenderness Survey more than one-third of beef marketed at retail 
was not aged more than 14 d (Guelker et al., 2013). Given potentially limited postmortem 
aging at retail, reports investigating the influence of several technologies (i.e. implants, 
beta-agonists) or the lack of technology use (i.e. NA, NHTC) on beef tenderness from the 
same study are limited. 
Monensin and Tylosin Use on Cutability, Marbling, and Tenderness 
 Specific data evaluating monensin on carcass performance is limited, though in 
regression models Goodrich et al. (1984) found monensin to decrease DP, FT, and 
marbling score. Montgomery et al. (2009) determined that when monensin and tylsosin 
were fed in combination with ZH, withdrawn from the diet 35 d prior to harvest that YG 
decreased more than when feeding ZH alone without ever supplementing monensin and 
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tylosin. Continuously feeding both components with ZH moderated negative effects of 
carcass quality. Feeding ZH decreased marbling score but withdrawal of monensin and 
tylosin caused marbling score to decrease further (Montgomery et al., 2009). This effect 
was substantial enough to influence USDA QG. Upon withdrawal, the number of 
Premium Choice carcasses decreased. Though tenderness was not evaluated in this 
publication, an extension of this project conducted by Hilton et al. (2009) determined 
withdrawal did not substantially harm carcass performance but improved some sensory 
characteristics. There was a tendency for decreased carcass protein percent upon 
withdrawal but no influence on expression of calpain and calpastatin, which also 
translated into no influences on objective measures of WBSF. As a positive impact of 
feeding monensin and tylosin until the terminal endpoint, consumer sensory ratings for 
juiciness were improved, though no other palatability attributes were affected.  
Panelist Attribute Ratings 
Tenderness 
The North American beef industry has adopted the use of anabolic steroids as a 
management practice to improve growth and reduce cost of gain (Roeber et al., 2000; Igo 
et al., 2011). There are many different implant strategies that can be used, though the 
administration of TBA in particular (Barham et al., 2003) may compromise beef quality 
grades (Belk and Cross, 1988). Given that the majority of cattle are implanted (Campiche 
et al., 2004) evaluating the subsequent effects on subjective measures of eating 
satisfaction to understand the influence on beef palatability is important (Wheeler et al., 
1997). General consumer sensory evaluations have determined that non-implanted steaks 
are more desirable for tenderness than steaks from implanted steers (Roeber et al., 2000; 
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Barham et al., 2003; Platter et al., 2003; Gruber et al., 2008; Igo et al., 2011). Moreover, 
aggressively implanting cattle (1 – 5 times) can reduce sensory tenderness ratings 
(Roeber et al., 2000; Platter et al., 2003; Barham et al., 2012). To better illustrate, 
untrained consumers rated steaks lower for tenderness from British crossbred steers 
assigned to 1 of 7 implant strategies compared with steaks from a non-implanted control 
(Roeber et al., 2000). Fortunately, postmortem aging of 7 and 14 d has been demonstrated 
to effectively mitigate any differences from implanting based on trained sensory analysis 
(Barham et al., 2003) though, it has been suggested to eliminate tenderness differences a 
21 d aging period should be conducted (Igo et al., 2011). In some contrast, Barham et al. 
(2003) originally detected reductions in tenderness among trained sensory panelists but 
did not detect a difference among implant strategies after 7 or 14 d postmortem aging on 
untrained consumer panelists, indicating that moderate (2 implants/reimplantation 
strategy in the feedyard) implanting does not negatively affect general consumer eating 
satisfaction. Wheeler (2004) determined untrained consumer panelists have the ability to 
repeatedly (0.80) conduct sensory analysis effectively for the beef longissimus and 
describe steaks as tender, intermediate, and tough. Among the literature reviewed, fewer 
studies (Apple et al., 1991; Gerken et al., 1995) utilizing trained panelists concluded that 
implanting did not influence tenderness ratings, suggesting that implanting had negligible 
effects on beef tenderness (Barham et al., 2012).  
To provide added beneficial effects, supplementing cattle while on feed with 
monensin and tylosin reduces previously described digestive ailments (Nagaraja and 
Chegappa, 1998; Stackhouse et al., 2012; Elanco, 2017a and 2017b) and feeding RH 
prior to harvest improves animal performance, though it is predicted to cause decreased 
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consumer acceptance (Woerner et al., 2011). Minimal data exists, but Hilton et al. (2009) 
determined trained panelist palatability ratings for initial and sustained tenderness were 
not influenced by supplementation of monensin and tylosin. In regard to feeding RH, 
supplementation level may slightly decrease tenderness. Gruber et al. (2008) determined 
RH supplementation at 200 mg RH • hd-1 • d-1 produced steaks that were rated less tender 
by trained panelists than steaks from non-supplemented steers. In contrast, other trained 
panelists were unable to detect tenderness differences between steaks from cattle that 
were fed RH (100 – 200 mg RH • hd-1 • d-1) compared wtih an unsupplemented control. 
However, upon feeding RH at a rate of 300 mg RH • hd-1 • d-1 steaks were rated slightly 
tougher (FDA, 2003). Although Arp et al. (2013) determined trained panelists were 
unable to detect variations in the level of RH supplemented (200 and 300 mg RH • hd-1 • 
d-1) on subsequent tenderness ratings. Untrained consumers panelists have not been able 
to detect differences in tenderness ratings for RH supplementation versus an non-
supplemented control (Garmyn et al. 2014; Harsh et al., 2015). Furthermore, extended 
postmortem aging (21 – 28 d) has improved both trained and consumer sensory 
tenderness ratings (Hilton et al., 2009; Leheska et al. 2009; Rodas-Gonzalez et al., 2012). 
It is understood that supplementation of RH may decrease objective tenderness, but 
minimal impacts on consumer acceptability are generally observed (Platter et al., 2008).  
Juiciness 
Aggressively implanted cattle can result in decreased trained sensory panelist 
ratings for juiciness when compared with a single, delayed implant strategy (Barham et 
al., 2012). In contrast, trained sensory panelists may not be able to detect differences in 
juiciness between implanted and non-implanted steaks (Barham et al., 2003; Barham et 
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al., 2012). Supplementing monensin and tylosin during the final 35 d prior to harvest has 
been shown to increase trained panelist ratings for steak juiciness (Hilton et al., 2009). 
Supplementation of RH during the final 28 – 42 d prior to harvest has been shown to 
have no influence on trained panelists ratings for juiciness (FDA, 2003; Arp et al., 2013). 
However, Gruber et al., (2008) did report RH supplementation (200 mg RH • hd-1 • d-1) 
reduced trained panel juiciness ratings, and other studies (Hilton et al., 2009; Leheska et 
al., 2009; Garmyn et al., 2010) determined ZH supplementation also negatively 
influenced sensory ratings for juiciness. However, untrained consumer panelists (n = 120) 
did not detected differences in juiciness between steaks from cattle supplemented with 
RH (308 mg RH • hd-1 • d-1) and a non-supplemented control (Garmyn et al., 2014). Still, 
more research is necessary, utilizing an untrained consumer audience, to determine how 
production management decisions influence steak juiciness. 
Beef Flavor 
Aggressively implanting cattle can lower trained sensory panelist evaluations for 
flavor ratings versus a single delayed implant (Barham et al., 2012) or, versus non-
implanted cattle (Apple et al., 1991). Untrained consumer panelists rated USDA Choice 
steaks aged 21 d from implanted cattle similar to non-implanted cattle for beef flavor (Igo 
et al., 2011). Moreover, untrained consumer panelists from five metropolitan areas have 
been unable to distinguish flavor differences among steaks from steers implanted 
consecutively with two implants in comparison with non-implanted cattle (Barham et al., 
2003). Though a relationship exists when consumer panelists like flavor as steaks tend to 
also be rated better in tenderness and juiciness whereas when consumers dislike flavor, 
steaks tend to be rated tough and dry (Roeber et al., 2000). Still in the same study, there 
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were no differences among consumer ratings for beef flavor and intensity for steaks 
produced from steers administered 1 of 7 implant strategies (combination of estrogenic 
and androgenic compounds) compared with non-implanted steers (Roeber et al., 2000). In 
some contrast, crossbred steers assigned to 1 of 10 implant strategies and were implanted 
2, 3, 4, or, 5 times from branding to reimplanting in the feedyard, had desirable consumer 
beef flavor ratings, though eating satisfaction was achieved from a majority (60 – 74%) 
of consumers (Platter et al., 2003).  
Limited literature exists on feeding monensin and tylosin on trained consumer 
palatability ratings, removal from the diet 30 d prior to harvest or, feeding to harvest did 
not affect beef flavor when β-AA (ZH) is fed (Hilton et al., 2009). Supplementation of 
RH at 200 - 400 mg RH • hd-1 • d-1 prior to harvest did not influence trained panelists 
ratings for beef flavor (FDA, 2003; Arp et al. 2013). In contrast, steers fed RH at a rate of 
200 mg RH • hd-1 • d-1 produced steaks that were rated slightly lower for beef flavor by 
trained panelists than steaks from unsupplemented steers (Gruber et al., 2008). Similarly, 
untrained consumer sensory ratings for beef flavor from RH supplementation (308 mg 
RH • hd-1 • d-1) have been intermediate to a non-supplemented control and ZH (8.3 mg/kg 
of DM) supplemented steers (Garmyn et al., 2014). 
Overall Acceptability  
Aggressively implanting cattle has decreased sensory panelist evaluations of 
overall mouthfeel (Kerth et al., 2003; Barham et al., 2012) and overall eating quality 
(Platter et al., 2003). As an example, crossbred steers assigned to 1 of 10 lifetime implant 
strategies that were successively implanted 2 to 5 times from branding to reimplanting in 
the feedyard and produced steaks that had reduced overall eating quality as evaluated by 
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consumer panelists (Platter et al., 2003). In contrast, Roeber et al. (2000) found steaks 
produced from steers subjected to 1 of 7 implant strategies (combination of estrogenic 
and androgenic compounds) to be rated similarly to the non-implanted control for overall 
liking (Roeber et al., 2000). Postmortem aging duration and QG has been reported to 
influence consumer panelist palatability ratings. For example, Select steaks aged 14 d 
from cattle that were implanted successively in the feedyard with 2 implants were rated 
lower in overall consumer acceptability versus a control (Igo et al., 2011). Though, in the 
same study, postmortem aging duration and QG improved consumer overall acceptability 
ratings. Choice steaks from successively implanted cattle aged 21 d were similar to the 
control (Igo et al., 2011). Also, the implant dosage can affect outcomes; moderately 
implanting (two implants in the feedyard) Bos indicus- influenced cattle did not result in 
detriments to overall mouthfeel and acceptability of steaks aged 7 and 14 d as rated by 
untrained consumer panelists from five metropolitan areas (Barham et al., 2003).  
Though limited literature exists about feeding monensin and tylosin on consumer 
palatability ratings, trained consumers described steaks from cattle fed β-AA (ZH), 
monensin and tyslosin as acceptable for overall quality (Hilton et al., 2009). However, 
there is some disparity among trained and untrained consumers’ ability to describe 
palatability (Harsh et al., 2015). As an example, untrained consumer panelists were 
unable to detect differences in overall liking of steaks from all-natural production (no 
growth promotants technologies) compared with steaks from steers implanted once 
(TBA/E2) in the feedyard, supplemented monensin, tylosin, and a β-AA (ZH; 6.76 
mg/kg) for 20 d prior to harvest, and ultimately ranked them higher in liking than steaks 
from steers implanted once (TBA/E2) in the feedyard (Harsh et al., 2015). Whereas 
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trained consumers in the same study rated steaks from all-natural production and steaks 
from steers implanted once (TBA/E2) in the feedyard and fed monensin and tylosin, 
similarly (Harsh et al., 2015). Garmyn et al. (2014) found steers supplemented with RH 
(308 mg RH • hd-1 • d-1) to be similar to a non-supplemented control for overall liking and 
Platter et al. (2008) suggests supplementing cattle with RH likely results in minimal 
impacts on consumer acceptability. Further, consumer panelists consuming steaks from 
the more aggressive β-AA (ZH) could not detect differences in overall palatability 
(Mehaffey et al., 2009; Hilton et al., 2009). Though, sensory analysis of RH is much 
more limited than ZH, especially when comparing treatments to an effective control that 
never received other growth promotants. It is understood that supplementation of RH 
may increase objective tenderness, but minimal impacts on consumer acceptability are 
generally observed (Platter et al., 2008). 
Evolving Consumer Preferences 
The Consumer 
 In 2018, US red meat consumption is forecasted to be 98.4 kg (USDA, 2009) and 
is three times greater than the global average (Daniel et al., 2011). While US beef 
consumption was 25.3 kg in 2016 (NCBA, 2016), demand is predicted to be strong in 
2018 (Haley, 2017). Given the importance of meat in American’s diet, it is integral to 
understand perceptions about animal production that influence consumer preferences 
(Olynk Widmar et al., 2013). It is understood that food consumption patterns have 
changed since the 1970s from the demand for processed foods to the current desire for 
“clean labels” (McCluskey, 2015). Different factors have contributed to this shift in 
preference but one major factor is the increasing age of the US population. Nearly 13% of 
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the US population is 65 years or older and this proportion is expected to increase to 21% 
by 2050 (McCluskey, 2015). The future expectancy is to continue to have an older 
population because of the health-conscious movement that is occurring. In 2015, 69% of 
adults were classified as overweight and obese (CDC, 2015). This national issue sparked 
media attention and reinforced concerns about human health politically, environmentally, 
and socially (Machen, 2010). Therefore, restaurants began posting calorie information 
and prominence of nutritional labeling arose (McCluskey, 2015). In addition to increased 
health awareness, another important factor is consumer education. The US population has 
become more educated as 34% of Millennials have at least a bachelor’s degree (Patten 
and Fry, 2015). From a study conducted by NCBA (2012), 85% of consumers ate at 
quick service restaurants, and of those, 95% were Millennials. Therefore, Millennials are 
driving the shift in marketing of many quick service restaurants (Chipotle, Elevation 
Burger, etc.), which are now providing beef raised without antibiotics (NRDC, 2015). 
Credence Attributes 
Perhaps greater access to disclosed information through the education system is 
contributing to consumers’ desire to make a difference with their purchases. Beef raised 
without the routine use of antibiotics is the fastest growing market (NRDC, 2015) in meat 
sales among beef, pork, chicken, and turkey, which experienced a 25% increase from 
2009-2012 (Perrone, 2012) despite a decline in per capita meat consumption (NRDC, 
2015). These marketing initiatives have caused USDA-FSIS (2016) to provide guidelines 
for label approval for Animal Raising Claims including “raised without antibiotics”, 
“raised without hormones”, etc. These credence attributes are specific to allowable 
practices for raising livestock for meat production and can include guidelines for raising, 
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handling, and housing livestock during the production process (Caswell and Mojduszka, 
1996). Overall, there is an increased abundance of food standards, certifications, and 
labels with claims about socially responsible production, geographical origin, organic, 
and many other attributes (McCluskey, 2015). These certifications or labels can be 
related to environmental and social preferences and have initiated marketing for 
“natural,” “organic,” “free-range,” “certified humane,” “environmentally friendly,” and 
“local” as consumers want to know more about where their food comes from (Umberger 
et al., 2009; McCluskey, 2015).  
Natural 
The perception of personal benefit and altruistic behavior have been found to 
drive the demand for “natural” beef (Umberger et al., 2009). However, the term 
“natural”, as regulated by the USDA-FSIS, only indicates the product is minimally 
processed with no added ingredients and does not have added benefits for consumer food 
safety (Umberger et al., 2009; Machen, 2010). An online survey evaluating 798 US 
households determined that food safety and animal welfare were the most important 
factors (52% and 69%, respectively) influencing ground beef purchases (Olynk et al., 
2013). The term “natural” can result in consumer confusion because companies often 
market multiple credence attributes together (Umberger et al., 2009). To reduce 
confusion, the term “raised without hormones” is now mandated by USDA-FSIS (2016) 
instead of the generic natural description. Consumers perceive “no hormones” important 
or very important in studies conducted by Sparling (2001) and Lusk and Fox (2002) who 
determined consumers were willing-to-pay (WTP) more (10% - 17%) for beef labeled as 
“not raised with growth hormones.”  
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Beef’s Role in Consumer Preference 
Education has been proven as an effective tool to shift priorities in consumer 
preference (Mennecke et al., 2007). Development of consumer education programs that 
teach consumers about the value of different characteristics (feed type, breed, USDA QG 
etc.) will improve consumers’ ability to make educated decisions (Mennecke et al., 
2007). To illustrate this point, animal science students placed more priority on intrinsic 
cues (cut, quality, and marbling) and ultimately made more informed decisions than 
business students. Consequently, education can change attitudes and product priorities 
(Mennecke et al., 2007). 
Consumers should not fear beef from an implanted animal, as the level of 
hormone in the product is minimal in comparison to the amount naturally produced by a 
human body. As previously mentioned, Johnson and Beckett (2014) illustrated that if a 
prepubescent girl ate 453.6 g (1 lb.) of meat daily, from an implanted animal 
administered 10 times above the manufacturer’s recommendation, she would be 
consuming 0.031µg of testosterone from meat, which is approximately 1/1000th of her 
daily production. Moreover, consumers should not fear subtherapeutic antibiotic use of 
monensin and tylosin as Thomas et al. (2017) discovered no correlation among presence 
of antimicrobial resistant genes in the gut microbiota from cattle administered antibiotic 
feed additives. 
In regard to consumer preference, there is a demand for lean beef from health-
conscious consumers. Recently in 2014, Laura’s Lean Beef became the largest natural 
beef brand in the US (BEEF Magazine, 2014). Non-branded lean beef (≤ 8.2g of total fat 
and ≤ 3g of saturated fat) can also be found in the retail case (McNeill et al., 2012). There 
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are several reasons for these availabilities including use of growth promoting 
technologies and faster access to genetics (McNeill et al., 2012). The utilization of both 
additive technologies and genetic predictors have optimized production for beef flavor 
and leanness (Field, 2007). Nevertheless, if consumer preferences continue to indicate a 
demand for natural beef production the abundance of lean beef may be reduced but this 
may result in greater of retention of beef consumers, which is a positive for the beef 
industry (Machen, 2010). However, it is important not to promote one type of beef 
product at the expense of another (Machen, 2010).  
Beef Labeling Regulations 
The Federal Meat Inspection Act (FMIA) requires food manufactures to obtain 
approval of labels for meat products prior to marketing (USDA-FSIS, 2014). To be 
approved, labels must adhere to the USDA Food Safety Inspection Service (USDA-FSIS) 
labeling guidelines for meat, poultry, and egg products (USDA-FSIS, 2017a). In addition 
to the USDA-FSIS labeling regulations for information that must be on the Principle 
Display Panel (PDP; product name, handling statement, legend/establishment number, 
net weight statement) and on the package (ingredients statement, signature line, 
nutritional facts, and mandatory safe handling instructions) labels may optionally contain 
a claim and a statement to portray product attributes (FDA, 2013). The statement is used 
to describe the claim and begins with an asterisk on the meat label (USDA-FSIS, 2016). 
The USDA-FSIS Labeling and Program Delivery Staff (LPDS) only needs to evaluate 
four types of labels: 1) labels for religious exempt products, 2) labels for export with 
deviations from domestic requirements, 3) labels with special statements and claims, and 
4) labels for temporary approval (USDA-FSIS, 2017b). Labels submitted for review can 
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either be sketch approved by the LPDS or generically approved if in immediate 
compliance of applicable regulations (USDA-FSIS, 2014). Some examples of special 
statements and claims that need to undergo sketch approval include: third-party animal 
raising claims, no antibiotics administered, Certified claims, gluten free, all natural, and 
non-genetically modified. (USDA-FSIS, 2014). Some examples of generically approved 
statements include: 100% pure, made with real cheese, environmental claims, and USDA 
Prime, etc. (USDA-FSIS, 2014). Upon label development, the amount of information 
provided is important to consider because if in excess, it risks panelist overload or may 
yield boredom and impatience (Sal-aün and Flores, 2001). Consumer cognitive capacity 
and desire to read and process information must also be considered (Caswell and 
Mojduszka, 1996). Consumers are unique and may have different types of quality desires 
that cause labels to not be preferred the same (BrunsÆ et al., 2005). In retail selection, 
consumers may make purchases based upon additional factors besides intrinsic quality 
cues, such as brand and price (Bredahl, 2004). For example, special statements and 
claims have been permitted for labeling without the use of antibiotics to provide more 
customer options (Levitt, 2015). Development of beef labels with claims and statements 
that indicate greater environmental responsibility (i.e. water reduction, reduced CO2 
emissions, etc.) will be appealing to targeted consumers at retail (Tonsor and Shupp, 
2009; White and Brady, 2014).   
Beef Marketing and Economics 
Beef Marketing and Management Options 
Currently the USDA-AMS has 91 certified beef programs such as Certified 
Angus Beef (USDA-AMS, 2017a), which was the first program to be certified. There are 
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also process verified programs (PVP) that offer producers the ability to qualify their 
cattle for certain domestic and export markets and increase production value. The USDA-
AMS (2017c) provides third-party auditing and has approved companies (IMI Global, 
Lindsay Ranch, Ranchers Connecting Ranchers, etc.) for auditing livestock feeding 
claims such as value-added calf (VAC) programs, NHTC, never fed beta-agonist, and 
grass-fed. These livestock feeding programs (NHTC, never fed beta-agonist, source 
verified (ASV)) were originally developed to market US beef internationally and meet 
trade barrier requirements, which have ultimately led to the development of cattle with 
specific production management characteristics (Zimmerman et al., 2012). The emerging 
of the NHTC market influenced calf prices and management practices of cow-calf 
producers (EN, 2012). 
 Value Added Calf Programs 
Within the cow-calf segment, control for animal health and feeding performance 
has also influenced the beef industry to offer premiums for abiding by calf management 
programs. These certified calf health programs or VAC programs (VAC24, VAC34, 
VAC34P, VAC45, VACPC) contain specifications for preconditioning practices 
(McNeill, 2001; Zimmerman et al., 2012). Though the broad term VAC can include 
credence attributes such as naturally raised, ASV and other value associations requiring 
third-party verification (Smith, 2007). In 2010, premiums for VAC34, VAC34P, and 
VAC45 programs ranged from $2 - $4 cwt and VAC45 calves received $2 - $5 more per 
cwt because they had been weaned 45 d. Producers that generically describe cattle as 
weaned, non-implanted, black hided, and with all vaccinations tend to miss these specific 
profit opportunities (Zimmerman et al., 2012). In addition to these certified calf health 
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programs, the NHTC market (data from 2010) has provided an economic incentive of $1 
- $2.75 per cwt (Zimmerman et al., 2012). In 2006, premiums for natural market steer 
calves were $0.81 - $1.09 and heifer calves were $0.73 per cwt. Further, the NHTC-
market eligible calf premiums were greater ($1.81 - $2.78) per cwt for both steers and 
heifers in 2010 (Zimmerman et al., 2012). Another method to add value to calves is 
implanting, consistent groups of implanted calves were not discounted and did not 
receive lower base calf prices suggesting that gains from implants would increase 
profitability (Zimmerman et al., 2012). Overall, providing third-party auditing or utilizing 
calf-implant strategies have provided greater profit advancements by allowing for 
improved weaning weight (WW), VAC, natural, NHTC or, certified cattle marketing 
programs to meet the demands of domestic and international consumers (Zimmerman et 
al., 2012).  
Beef Marketing Options 
To produce these classifications of cattle, a pricing mechanism must exist to 
afford production of offspring that matches consumer preferences (Gillespie et al., 2004). 
Traditional or conventional cash auction methods are useful for live beef animals 
(weaned calves, stockers, cull bulls, cows, and heifers; Gillespie et al., 2004) that are 
marketed by BW. Though specialty marketing programs, like Superior Livestock Auction 
(SLA), the oldest online video auction, provides private-treaty internet listings and started 
marketing for the Certified Natural Cattle program in 2004 and the NHTC program in 
2008 (Zimmerman et al., 2012). Another marketing option is a carcass grid-based system 
that exists to help producers receive higher prices for cattle that meet the specific grid 
criteria. Either breed associations or cattlemen firms formed beef carcass alliances 
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(BCA), which are predominately dominated by British breeds (Certified Angus, Certified 
Hereford) and some Continental breeds (Gelbvieh Alliance, Limousin Grid). These grids 
(Angus America, Angus GeneNet, Farmland Supreme, HiPro Producer’s Edge, US 
Premium Beef etc.) were developed to target high quality beef production (Sartwelle et 
al., 2014). Though the first BCA that existed was for Natural/implant-free (Coleman’s 
Natural Meats, Laura’s Lean Beef, Maverick Ranches Beef, and B3R Country Meats) 
carcasses that in some cases also banned ionophores, antibiotics, and other feed additives 
(Sartwelle et al., 2014). These specific types of BCA are likely to continue due to 
consistent higher returns compared with cash markets given that producers can progress 
the genetic makeup of the cowherd and/or conduct ASV (Sartwelle et al., 2014).  
Natural/implant-free BCA present some tradeoffs due to the potential to increase 
animal morbidity, mortality (because of prohibition of antibiotics and/or antimicrobials) 
and loss of gain efficiency (because of loss of implants and feed additives) affecting 
HCW and potential to fulfill specifications (Sartwelle et al., 2014). In an organic 
example, the loss of performance requires a 39% higher sale price (Fernandez and 
Woodward, 1999). From a meta-analysis, a naturally raised steer would require more 
incentive ($0.14/kg BW) to be as valuable as a conventionally raised steer due to the loss 
of performance (Gadberry, 2008; Wileman et al., 2009). To have a functioning value-
based marketing system, producers must be paid to raise what consumers demand (Cross 
and Savell, 1994). Selling NA or NHTC calves needs an assured incentive. Continuous 
and projected price reporting for cattle with credence attributes is needed so that 
producers can determine if retaining ownership is an option and have guidance to make 
management decisions. 
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Improvements from Growth Promotant Use in Beef Production 
In 2016, the economic impact of the US beef industry was $65.6 billion in farm 
cash receipts for cattle and calves (NCBA, 2016). The use of growth promotant 
technology improves efficiency and reduces the cost of production (Machen, 2010). 
Perhaps use of technology and improved efficiency explains why, in 2016, the average 
cost of USDA Choice beef sold $0.33 less in retail than in 2015 (NCBA, 2016). 
Optimizing cattle production efficiently while minimizing inputs such as feed costs 
(purchased or harvested) that account for nearly two-thirds of total operating costs are 
important for long-term sustainability and profitability of an operation (USDA-ERS, 
2010). Beef consumers benefit from use of growth promotant technologies to keep 
production costs low, which ultimately means more affordable beef prices and more lean 
and healthy beef options (Johnson and Beckett, 2014).  
Segment Costs of Production 
From a meta-analysis of 170 trials and use of the 2005 market prices, the 
estimated production and feed costs for each segment were: cow-calf, $183 - 
$247/cow/yr.; stocker, $0.30/d - $0.45/d; and feedyard, $0.04/lb. of feed (Lawrence and 
Ibarburu, 2007). The estimated labor cost at the stocker segment ranged from $6 - $24/hd 
and at the feedyard was $27/hd for feeding steers 184 d and heifers 201 d. Veterinary 
costs at the cow-calf segment ranged from $10 - $25/cow/yr. and cost at the stocker and 
feedyard was $10/hd (Lawrence and Ibarburu, 2007). 
Segment Economic Benefits of Technology Use 
At the cow-calf level, use of de-wormer had the greatest impact followed by calf-
implants on WW, though most cow-calf operations do not use ionophores or implants 
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(Lawrence and Ibarburu, 2007). At the stocker level, use of de-wormers and implants 
were most important followed by ionophores, subtherapeutic antibiotics, and fly control 
and collectively cost $80.79/hd. If these technologies were removed the represented cost 
would be $126/hd and if the management changed to a natural program (still using de-
wormer) the cost would be $101/hd (Lawrence and Ibarburu, 2007). Further, when feed 
costs are higher growth promoting technologies are more cost effective. In NE, removal 
of all mentioned technologies increased fed cattle prices by 20% or, $17/cwt. Overall, use 
of the five pharmaceutical technologies had a cost savings of over $365 per hd for the 
lifetime of the animal (Lawrence and Ibarburu, 2007). In a separate meta-analysis 
specifically evaluating implants, steers that were implanted had a $77 benefit and 
removing implants and all pharmaceutic technologies would cost $155/hd (Wileman et 
al., 2009). In a separate lifetime analysis, calves administered an implant during the 
suckling, grazing, and finishing period had an increased value of $93 per hd (Duckett and 
Andrae, 2001). Similarly, a stair-step implant program maximized quality and yield value 
($85.68) on the rail compared to non-implanted carcasses (Reinhardt, 2007). These 
studies illustrate the greater premiums obtained from improved efficiency from 
technology utilization versus non-implanted controls.  
In the feedyard, adoption of growth promotant technologies is the highest (95%) 
and along with implants this segment also takes advantage of another technology, β-AA 
(Campiche et al., 2004; Lawrence and Ibarburu, 2007). However, the use of β-AA usually 
has a greater input cost compared with implants. For example, use of ZH increased 
production costs by $20 per hd, but returned more ($0.06/kg/hd) due to growth 
improvement and increased ($0.04/kg HCW) the overall economic net return (Stackhouse 
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et al., 2012). However, cattle producers may obtain greater profit from adoption of 
management practices for naturally raised or NHTC cattle although premiums may vary 
dependent upon market conditions (Stackhouse et al., 2012; Zimmerman et al., 2012). 
Natural cattle can bring a similar net return to commercial cattle if sold at a 8% premium 
(Stackhouse et al., 2012). If consumer demand continues to increase for these specialized 
programs, premium variation could be reduced and there could be more consistent added 
profit. Still, traditional determinants of reduced BW and a greater potential for decreased 
animal health make use of growth promotant technology including Tylan, critically 
important. 
Retail Costs for Beef  
Various conditions such as weather, supply, access, and production volume 
influence the retail cost for beef. For example, drought conditions from 2008 – 2012 
caused high feed prices and resulted in decreased inventory of cattle (USDA-ERS, 
2017d). As feed became more affordable, cattle production rebounded slowly (USDA-
ERS, 2017d). The increased volume of cattle helped to stabilize beef price volatility at 
the retail case resulting in a drastic improvement in demand since 2010 (Speer, 2016). 
Consumer spending for beef in 2015 captured a record high at $340 per person, which is 
an increase by $80 in five years (Speer, 2016). Although total beef consumption has 
declined from 2000 – 2016 (29 kg – 25 kg, respectively) this is not a reflection of beef 
demand (Campiche, 2004; NCBA, 2016; Speer, 2016). Beef has strong pricing power due 
to the direct result of improved demand (Speer, 2016). In fact, since the 2000s wholesale 
beef prices have steadily trended upward and between 2016 – 2017 the USDA wholesale 
price spread has consistently been positive: rib, +1.79%; chuck, +9.33%; loin, +13.33%; 
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brisket, +0.45%, and round, +15.87% (USDA-ERS, 2017d). These trends from wholesale 
prices were reflected in the National Retail Report, which show stability and some 
increases (USDA-AMS, 2017b). These price trends from 2016 – 2017 for specific retail 
cuts include: ribeye steak +11.61%, flat iron + 10.75%, t-bone steak - 3.83%, brisket-flat 
+ 33.62%, and ground round + 11.41% (USDA-AMS, 2017b). These price spreads 
convey critical information to the beef supply chain about the distribution of cost along 
the marketing chain and efficiency of transforming cattle to retail beef (USDA-ERS, 
2017d). Demand for beef in 2018 should remain strong given firm packer margins, fed 
cattle prices, and continued growth in US beef exports (Haley, 2017). Though with the 
emergence of natural beef, NHTC beef, and beef raised without antibiotics in the retail 
case, reporting of the associated cost to the consumer is limited.  
 Consumer Willingness-to-pay 
In economics, a wide array of research has been conducted to evaluate the 
allocation of a food dollar used to purchase commodities sold in proportion to their 
annual share in the US market. In 2015, each 1$ expenditure on food contributed 15.6 
cents to the farm share (USDA-ERS, 2017c). The expenditure spent on food items are 
associated with private benefits such as nutrients, quality, taste or, physical appearance 
(White and Brady, 2014). Historically, consumers have demonstrated that beef tenderness 
is important to palatability (Dikeman, 1987; Savell and Shackelford, 1992) and have been 
WTP for steak tenderness (Boleman et al., 1997; Miller et al., 2001) and marbling 
guarantees (Killinger, 2004). Though, consumers are not always WTP a premium for 
steaks that should be more acceptable (Dransfield et al., 1998). Recent beef research 
efforts have been devoted to understanding how much consumers are WTP for niche 
   
 
 
49
 
retail products such as grass-fed, organic, natural, and local meat (Umberger et al., 2002; 
White and Brady, 2014). Consumers in North America have been WTP a 29.1% premium 
for niche grass-fed, all natural, and local beef (White and Brady, 2014). Other factors 
from production management decisions have influenced consumer WTP such as beef 
raised without antibiotics (Sneeringer et al, 2015). In a national survey, Farm News 
Media (2016) shared results from a Cargill Animal Nutrition survey that discovered 54% 
of US consumers were WTP more for beef raised without antibiotics. Other marketing 
and production factors such as labeling and organic certification have been found to 
increase WTP (Lyford, 2010). Organic beef labeling has increased beef cost by $6.56/kg 
and represents a 47% premium (White and Brady, 2014). Consumers that read labels and 
have positive attitudes towards the term natural are more likely to purchase natural beef 
(Campiche et al., 2004). Beef labels provide extrinsic and intrinsic quality cues that guide 
consumer inference about the product quality and allow them to form an expectation 
about the product, which relates to purchasing behavior, satisfaction, and future 
purchasing decisions (BrunsÆ et al., 2005; Grunert, 2005). The newest beef marketing 
evaluations have been conducted on environmental reduction efforts. In North America 
consumers were WTP a premium (14.8%) for pure environmental reduction efforts of 
water usage (White and Brady, 2014). This premium is less than the niche (29.1%) 
premiums mentioned earlier and when evaluated in-person, WTP decreased by 11.2% 
indicating that location and beef type influences WTP (White and Brady, 2014). Though 
from a farm-level economic analysis, the mid-west region has the greatest opportunity to 
reduce water use (41.4 L/kg) but to do this, consumers need to be WTP 10% greater 
premiums or $1.10 more per kg (White and Brady, 2014). Improved beef labeling is 
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needed that can successfully be appealing for the majority of beef consumers and assist 
with beef production being focused on environmental sustainabity (White and Brady, 
2014). Demand for environmentally friendly food products is already increasing in the 
UK (Gadema and Oglethorpe, 2011) and will most likely increase in the US. 
Environmental Sustainability 
The beef industry has defined beef sustainability as meeting the growing demand 
while balancing environmental responsibility (Rotz et al., 2015). Environmental 
responsibility can be improved by reducing the input needed for animal productivity and 
achieving the same or more volume of end product (Stackhouse et al., 2012). There are 
several ways these improvements can occur individually, or in combination of production 
practices: nutrition, reproduction, genetics, and management (Boadi et al., 2004). 
Management tools commonly used in the beef industry are the previously mentioned 
growth promoting technologies for enhance animal efficiency (Stackhouse et al., 2012). 
Moreover, the use of these technologies mitigate greenhouse gas (GHG) and ammonia 
(NH3) emissions from cattle production per unit of end product (Stackhouse et al., 2012). 
Therefore, growth promoting technologies can be employed to provide a cost-effective 
method for increased efficiency (Stackhouse et al., 2012) and environmental 
sustainability. In review of research, a meta-analysis determined implanted steers had 
greater ADG, DMI, and lower (-$77) per animal cost of production than non-implanted 
steers (Wileman et al., 2009). However, beef demand presents a challenge as consumers 
and retailers are desiring more “natural” beef products, which influence producer 
management decisions regarding the use of growth promoting technologies (Stackhouse 
et al., 2012). Other management decisions include the addition of by-products such as 
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distillers grains to replace corn in cattle diets for improved efficiency, though when 
overfed the reactive N increases (~10%) because of excess protein being excreted as urea 
and volatilized as ammonia (Rotz et al., 2013). In addition to by-product influences, other 
aspects that influence efficiency of production are the climate and topography that cattle 
are raised in. Overall, production of cattle with associated feed crops and the resulting 
impact on the environment is not well understood (Rotz et al., 2013).  
Integrated Farm Systems Model 
Measuring sustainability is challenging as the beef supply chain is very complex 
(Rotz et al., 2015). The Integrated Farm Systems Model (IFSM) is a tool used to asses 
environmental and economic sustainability of farming operations (Rotz et al., 2013; Rotz 
et al., 2015). The model provides a process-level simulation of performance, 
environmental impacts, and economics of farms, ranches, and feedyards (Rotz et al., 
2013). Energy, protein, and mineral requirements for cows, calves, replacement animals, 
stockers, and finishing cattle are determined from the Cornell Net Carbohydrate and 
Protein System (level 1; Fox et al., 2004; Rotz et al., 2015). Crop growth and 
development is estimated daily based upon soil water and nitrogen availability, ambient 
temperature, and solar radiation (Rotz et al., 2013). Allocation of feed and predicted 
animal response is dependent upon the nutrient content of the feeds available and the 
nutrient requirements of the cattle. These predictions can be conducted for cows, calves, 
replacement females, stocker, and finished cattle (Rotz et al., 2005). To determine annual 
carbon, energy, water, and reactive nitrogen footprints, a life cycle assessment (LCA) can 
be conducted (Rotz et al., 2013). Collectively these predictions represent the net GHG 
emissions, fossil energy use, water use, and reactive N loss from production systems from 
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the cow-calf segment to harvest (Rotz et al., 2015). This model accounts for inputs of 
resources such as fuel, natural gas, electricity, fertilizer, purchased feed, machinery, seed, 
and pesticides (Rotz et al., 2013). The total resources are divided by the volume of feed 
or, BW produced to determine the footprint (Rotz et al., 2013). Recent environmental 
focuses using this model have predicted: 1) GHG emissions from carbon dioxide, 
methane, and nitrous oxide tracked from crop, animal, and manure sources; 2) energy 
use; 3) water use; 3) and reactive nitrogen loss (Rotz et al., 2013).  
Carbon Footprint and Greenhouse Gas Emissions 
Improvements in beef production from the 1970s to 2007 have resulted in a 6% - 
16% decrease in C footprint or net GHG emission (Capper, 2011; Rotz et al., 2013). This 
is because GHG production per unit of meat is decreased and thus, results in lower C 
footprint (Boadi et al., 2004). Currently beef cattle production causes a C footprint 
ranging from 10 – 15 kg CO2 equivalent (CO2e)/kg BW (Beauchemin et al., 2010; 
Stackhouse et al., 2012; Rotz et al., 2013). Environmental conditions and climate widely 
influence these outcomes due to production system management decisions among 
simulated operations (Rotz et al., 2015). Specific to the upper Midwest, C footprint has 
ranged from 14.8 kg - 10.9 kg CO2e/kg BW according to Pelletier et al. (2010) and Rotz 
et al. (2013), respectively. Use of growth-promoting technologies has been shown to 
effectively increase animal performance (ADG (0.1 – 0.2 kg/d), final shrunk BW (42 kg), 
and G:F (0.01)) and measures of sustainability (Stackhouse et al., 2012). In CA, use of 
implants and β-AA have decreased C footprint by 4% - 9%, respectively (Stackhouse et 
al., 2012). This subtle decrease may be due to the fact that 68% - 74% of GHG emissions 
occur prior to application of growth promotant technology, while calves are still nursing 
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(Stackhouse et al., 2012). Still, these efficiencies in C footprint reduction are similar to 
the dairy industry use of recombinant bovine ST that has been determined to reduce C 
footprint of milk production by 7 – 9% (Capper et al., 2008; Rotz et al., 2010). To 
provide a more comprehensive tool that encompasses the beef supply chain C footprint, 
Rotz et al. (2015) conducted a cradle-to-farm gate study that provides a baseline for 
comparing technology utilization and sustainability of beef production systems with 
carcass weight (CW) as an end outcome. In this cradle-to-farm gate approach, total GHG 
emissions ranged from 14 – 26 kg CO2e/kg CW among regions in KS, OK, and TX (Rotz 
et al., 2015). 
Energy Utilization 
In comparison to 1970, beef cattle production has not improved the energy 
footprint (Rotz et al., 2013). This is because in the 1970s there was little irrigation and 
less corn production, which limited energy use. Today, more equipment is powered by 
gasoline engines that require more fuel, and more corn is grown and irrigated. To reduce 
energy footprint, placing more emphasis on reduction of fuel and feed use is necessary. In 
the cradle-to-farm gate analysis, energy use was reported as 51 MJ/kg CW (Rotz et al., 
2015). Though regional differences can influence fossil fuel use. Among the climates of 
KS, OK, and TX, production management decisions influenced fossil fuel energy use 
from 26 – 83 MJ/kg CW (Rotz et al., 2015). In another example, the annual energy 
footprint of beef produced at the Roman L. Hruska US Meat Animal Research Center 
(MARC) was 27.0 MJ/kg BW much less than 44.8 MJ/kg BW determined in an upper 
Midwestern US beef production system (Pelletier et al., 2010). This range in value stems 
from fertilizer production, fuel and electricity use, and other resources. Though, 
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comparing values should be cautioned as each system has unique pre-chain inputs (Rotz 
et al., 2013). Reports investigating the influence of growth promotant technology use on 
the energy footprint and practical improvements to reduce use are limited (Rotz et al., 
2013). 
Water Utilization  
Globally, agriculture accounts for 92% of freshwater and of that 29% is directly 
or indirectly used for animal production (Gerbens-Leenes et al., 2013). The water 
footprint for beef production has increased by 42% since 1970 due to greater irrigation of 
feed, when precipitation is not included, and feed is purchased (Rotz et al., 2013). 
Though the current water footprint is 5% less than 1970 when precipitation is included 
given the greater yield of corn (Rotz et al., 2013). The annual water footprint determined 
for the MARC production system, excluding precipitation was 2,789 ± 914 L/kg BW and 
with precipitation the water footprint was greater (21,340 ± 5,600 L/kg BW; Rotz et al., 
2013). Regardless, most of the water used was for feed production as cattle drinking 
water was 1% or less (Rotz et al., 2013). In the cradle-to-farm gate environmental 
footprint study, the water use with precipitation was 2,470 ± 455 L/kg CW. Most of the 
water use is associated with producing feeding for the finishing segment (Rotz et al., 
2015). Reports investigating the influence of growth promotant technology use on water 
reduction and practical improvements to reduce use, are limited (Rotz et al., 2013). 
Ammonia Emissions and Reactive Nitrogen Loss 
In comparison to the 1970s, the current beef production system has decreased 
reactive nitrogen loss by 3% due to offsetting effects (Rotz et al., 2013) such as improved 
corn yield and use of growth promoting technologies. To determine the reactive nitrogen 
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loss or simply the total nitrogen loss, the IFSM tracks nutrient flows to predict the 
environmental losses, accumulation, depletion or, emissions of ammonia from 
denitrification and leaching losses of N, erosion of sediment among farm boundaries, and 
runoff of N and P (Rotz et al., 2015). The first study to encompass total reactive nitrogen 
loss was simulated for MARC. There the annual reactive nitrogen footprint of beef 
production was 91.7 ± 18.4 g N/kg BW (Rotz et al, 2013). Most (61%) of the footprint 
was associated with cattle on pasture during the cow-calf segment of which ammonia 
emissions contributed to the majority (81%) followed by nitrate leaching (6%) and, 
nitrous oxide emission (9%; Rotz et al., 2013). The KS, OK, and TX cradle-to-farm gate 
study determined the reactive N loss was 138 ± 12 g N/kg CW though the variation is due 
to runoff and leaching of N. On the eastern side of the region, there was more rainfall 
compared with the western side, which had greater NH3 volatilization (Rotz et al., 2015). 
The total NH3 emission from all production segments was 88 g/kg CW. Emission was 
slightly greater (44%) from urine and fecal deposition during the cow-calf segment 
compared with the feedyard (43%) from manure deposition. This contributed to GHG 
emissions being greater during the cow-calf segment is due to breeding stock producing a 
calf and increasing the enteric emission from consumption of a high forage diets (Rotz et 
al., 2015). 
It is well understood that use of growth promotant technology has increased the 
efficiency of beef produced and can influence economic and biological efficiencies in 
addition to environmental and animal welfare issues (Wileman et al., 2009). In regard to 
reactive nitrogen loss, use of β-AA (receiving a TBA/E2 implant at the stocker and 
feedyard, and ionophore, and tylosin in the feedyard plus ZH 20 d prior to harvest) 
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reduced NH3 by 7% in an entire beef production system and in the feedyard by 4 - 9 g/kg 
CW (Stackhouse et al., 2012). This is the result of increased N efficiency due to the 
physiologic response of the β-AA (ZH) causing greater muscle mass and protein 
synthesis with less protein degradation (Mersman, 1998). The reduction in NH3 is 
important because protein is being spared leading to less concentration of urine urea 
nitrogen (UUN) that could be volatized as NH3 (Stackhouse et al., 2012). As expected, 
use of β-AA (ZH) reduce NH3 by 6% versus natural production and interestingly, reduced 
NH3 by 14% versus implanted cattle (receiving a TBA/E2 implant at the stocker and 
feedyard, and ionophore, and tylosin in the feedyard). Therefore, use of ZH at the 
feedyard 20 d prior to harvest serves as a NH3 and GHG mitigation tool (Stackhouse et 
al., 2012). However, ZH has not been commercially available since 2013. 
Future Improvements in Environment Sustainability  
 Utilizing livestock to support human nutritional needs is documented (White and 
Hall, 2017) to have some GHG emissions, though use of growth promoting technologies 
may reduce the GHG and NH3 emissions.  
CONCLUSION 
The adoption rate of growth promotant technologies by beef producers is high 
because of improvements in animal and carcass performance, economic viability, return 
on investment, improved resource management, and reduced environmental impacts. 
However, a majority of research that is available on growth promotant technologies has 
focused on carcass performance, meat quality, and sustainability utilizing zilpaterol 
hydrochloride, which is not commercially available. This necessitates research utilizing 
ractopamine hydrochloride to determine if the use of this technology combined with or 
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without monensin, tysolsin, and growth promoting implants influences animal and 
carcass performance, production economics, and environmental impacts. Additionally, 
there is limited information about the carcass performance and meat quality of carcasses 
from cattle raised as NHTC, or those raised with monensin and tylosin in combination 
with anabolic steroids and RH supplementation. Given that demand for Natural beef 
production is increasing, an improved understanding about how the management 
practices associated with producing NHTC cattle influence meat quality, consumer 
acceptability, economic profitability, and the environment, is needed.  
Additionally, an effective control is needed for adequate comparison among 
treatments such as cattle “raised without the use of antibiotics” to provide an adequate 
baseline for comparison. Moreover, the use of different levels of technology needs to be 
described more effectively to convey the impacts on animal efficiency and environment 
sustainability. Upon producing these beef products raised with different levels of growth 
promotant technology, consumer palatability and perception must be considered.  
A majority of consumer palatability research was conducted with trained 
panelists, which is not the beef industry’s target consumer. This necessitates the need for 
analysis of meat quality variables utilizing untrained consumers to determine if 
production systems influence beef palatability. These procedures should be tested without 
the consumer knowing what they are eating to serve as a baseline and then, test 
production information, and production information plus the product to better gauge 
consumer preference and change in preference. From the literature, no research effort has 
evaluated consumer palatability and label preferences when animal performance and 
environmental impacts are disclosed. Recent trends in beef marketing indicate that there 
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is a demand for beef produced without growth enhancement technologies such as “non-
hormone treated cattle” and cattle “raised without antibiotics.” This trend is not 
unexpected given that the average American beef consumer is several generations 
removed from production agriculture and may not understand the reason for these 
technologies to be used and the regulations in place to ensure that all meat is safe and 
wholesome. Previous research has shown that consumer panelists were unable to detect 
tenderness or palatability differences for beef produced naturally in comparison with beef 
produced with growth promotant technology. However, these cattle were not produced 
from a similar source or fed to the same compositional endpoint, which may influence 
sensory characteristics. Further, sensory characteristics may not be the primary driver of 
willingness-to-pay if consumers are concerned about how their food is produced 
including animal production method and the environmental impact. The beef industry has 
recognized this concern and has committed to “Grow Consumer Trust in Beef and Beef 
Production” however, how to best differentially market beef with full use of technology, 
remains a challenge.  
To ease this challenge and provide insight, a consumer focus group is needed to 
understand consumer desires for meat products and marketing. This topic is timely and 
important to the national beef industry as beef markets are undergoing rapid change due 
to the growth in alternative production systems and protein choices. Growth in these 
sectors is in direct response to consumer demands; however, the industry may have 
opportunities to differentiate beef products that are produced with technology as well as 
products raised without. 
Therefore, the objectives of this dissertation were to: 
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1. determine the influence of production systems on cattle and carcass performance, 
the environmental impacts and natural resource use, and the economic return of 
different levels of growth promotant technologies; 
2. determine the influence of production systems on objective measures of meat 
quality, steak tenderness and determine untrained consumer palatability 
preferences, willingness-to-pay, and palatability ratings for beef produced with 
different levels of growth promotant technology; 
3. determine the most effective marketing strategy for beef produced with different 
levels of growth promotant technology by testing label descriptions derived from 
scientifically analyzed production outcomes from the animal performance data for 
efficiency and sustainability. 
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CHAPTER II 
Cattle and carcass performance, economic return, and environmental life cycle 
analysis of production systems 
Megan J. Webb 
Department of Animal Science 
South Dakota State University, 57007 
ABSTRACT 
The objective of this study was to determine the impact of different production 
systems on animal and carcass performance, production economics, and environmental 
measures. Angus ´ Simmental crossbred steer calves (n =120) were stratified by birth 
date, birth weight, dam age, and assigned randomly to 1 of 4 treatments: 1) no antibiotics 
(NA, receiving no technology); 2) non-hormone treated cattle (NHTC, fed monensin and 
tylosin); 3) implant (IMPL, administered a series of three implants, and 4) implant plus 
fed a beta-agonist (IMBA, IMPL treatment plus, fed ractopamine-HCl for the last 30 d 
prior to harvest). Weaned steers were backgrounded in a drylot and finished in an 
individual feeding system to collect individual animal performance data. At harvest, 
standard carcass measures were collected for USDA Yield Grade (YG) and Quality 
Grade (QG) determination. Total production expenses and branded carcass value were 
obtained to conduct an economic analysis of each production system. Information from 
the cow-calf, backgrounding, and finishing phases were obtained to simulate production 
systems using the Integrated Farm System Model (IFSM) and conduct a farm gate life 
cycle assessment (LCA) of greenhouse gas (GHG) emissions, energy use, water use, and 
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reactive N loss. Hot carcass weight (HCW) and final calculated body weight (FCBW) for 
IMPL and IMBA were similar (P > 0.05) and heavier (P < 0.01) than NA and NHTC, 
which were similar (P > 0.05). The ADG was greatest (P < 0.05) for IMPL, while IMBA 
was intermediate (P < 0.05), and NA and NHTC were the lowest (P < 0.01) but did not 
differ (P > 0.05). The DMI for IMPL and IMBA were similar (P > 0.05) and greater (P < 
0.01) than NA, which was intermediate (P < 0.01) to NHTC. Gain to feed (G:F) was 
greatest (P < 0.01) for IMPL. No differences (P > 0.05) were detected for 12th rib backfat 
thickness, YG, or proportions of carcasses in each YG and QG. The marbling score for 
NA and NHTC was similar (P > 0.05) and greater (P < 0.01) than IMPL and IMBA, 
which were similar (P > 0.05). The actual branded carcass value was similar (P > 0.01) 
for NA and IMPL and greater (P < 0.05) than NHTC and IMBA, which were similar (P > 
0.05). The environmental analysis revealed that IMPL and IMBA reduced GHG (CO2e 
per kg HCW) emissions by 6.5 - 7.8%, energy use (MJ per kg HCW) by 3.4 - 5.5%, 
water use (kg H2O per kg HCW) by 4.4 - 5.8%, and reactive N loss (g N per kg HCW) by 
1.0 - 5.5% in comparison to NA. 
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INTRODUCTION 
By 2050 the world population is anticipated to be more than 9 billion and to feed 
this population, 80% of agricultural production must come from increased yield (FAO, 
2009). Accompanying this demand for increased food production is often conflicting 
demand for products, such as beef, to be raised without growth promotant technologies 
and antibiotics (AgMRC, 2012; Mathews and Johnson, 2013; Perrone, 2012). Growth 
promotant technologies have been known to improve animal productivity resulting in 
more efficient meat production (Lawrence and Ibarburu, 2007; Nagaraja and Chegappa, 
1998; Johnson et al., 2013). However, the average American beef consumer is several 
generations removed from production agriculture and given this disconnect, consumers 
often question technologies utilized to improve production efficiency, creating a growing 
demand for beef with credence attributes (Umberger et al., 2009) such as, “raised without 
the use of hormones” and “raised without antibiotics” (USDA-FSIS, 2016; USDA-PVP, 
2018). Cattle producers are faced with a dichotomy between producing more beef and 
producing beef without growth promotant technologies, which may have lasting impacts 
on operational longevity and sustainability. The implications of not utilizing growth 
promotant technologies including hormone-based implants, ractopamine HCl (RH), 
monensin, and tylosin on animal performance, economic return, and the environmental 
impact of cattle fed to a similar compositional endpoint is unclear (Machen, 2010; 
Stackhouse et al., 2012b). Therefore, the aim of this research was to test the hypothesis 
that raising cattle with growth promoting technologies would result in improved animal 
performance, profitability, and reduce environmental impacts compared with naturally 
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raised cattle. Therefore, the objective of this study was to determine if production 
systems using different levels of growth promotant technology influence animal and 
carcass performance, production economics, and the use of natural resources and 
environmental emissions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
85
MATERIALS AND METHODS 
Animals and Experimental Design 
All animal care and experimental protocols were approved by the South Dakota 
State University (SDSU) Animal Care and Use Committee (approval number 15-091E). 
One hundred and twenty Angus ´ Simmental calves born within a 45 d period at the 
Antelope Range and Livestock Reserach Station near Buffalo, SD, were utilized. A 
completely randomized designed was used to stratify calves by birth date, birth weight, 
and dam age to 1 of 4 treatments: 1) no antibiotics (NA; receiving no technology); 2) 
non-hormone treated cattle (NHTC; fed 300 mg monensin  [Rumensin 90, Elanco Animal 
Health, Greenfield, IN]) and 90 mg tylosin [Tylan 40, Elanco Animal Health] during the 
finishing phase March 29 to harvest); 3) implant (IMPL; same technologies as NHTC and 
administered a series of three implants including a low-potency calf implant [36 mg 
zeranol; Ralgro, Merck Animal Health, Madison, NJ] at an average of 74 ± 12 d of age 
on June 29, a moderate-potency initial feedyard implant [80 mg trenbolone acetate and 16 
mg estradiol; Revalor-IS, Merck Animal Health] at an average of 235 ± 12 d of age on 
December 8, and a high potency finishing re-implant [200 mg trenbolone acetate and 20 
mg estradiol; Revalor-200, Merck Animal Health] at an average of 330 ± 12 d of age on 
March 11) and 4) all previous technologies plus fed a beta-agonist (IMBA; same 
technologies as IMPL and fed 200 mg RH steer-1 d-1 [Optaflexx 45; Elanco Animal 
Health] for the last 30 d prior to harvest. Beef Quality Assurance (BQA) protocols were 
used throughout the course of the study (BQA, 2010) and implants were administered 
subcutaneously in the middle third of the ear by a single technician for each 
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administration day. Implant needles were changed as needed to be effective and 
disinfected after each use with a sponge soaked in 2% chlorhexidine solution.  
Pre-Weaning Calf Management and Backgrounding 
Study initiation occurred on June 29, 2015. All steers were branded and 
individually weighed without shrink in a hydraulic squeeze chute with load cells mounted 
under the chute (Weigh-Tronix model 1015; Avery Weigh-Tronix, Fairmont, MN). Also, 
calves allocated to IMPL and IMBA received a pre-weaning implant and were managed 
as a common group with all other treatments. Calf weights were recorded again on 
September 16 and pre-weaning vaccinations were administered including a killed vaccine 
for clostridial diseases (Vision 7 Somnus with SPUR, Merck Animal Health) and a 
modified live vaccine for prevention of respiratory viruses and Mannheimia Haemolytica 
(Pyramid 5+ Presponse SQ, Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO). At 
weaning on October 26, steers were boosterd with the 5-way vaccine and weighed then 
shipped approximately 322 km to the SDSU Cottonwood Range and Livestock Field 
Station near Phillip, SD. Steers were acclimated to high quality grass hay and dried 
distillers grain as a common group for two weeks. On November 9, steers were 
dewormed (Dectomax Pour-On Solution, Zoetis, Parsippany, NJ) and initial 
backgrounding period weights were recorded. On November 10, steers were blocked by 
initial weight (November 9) sorted into 12 pens (9.1 m of bunk space per head (hd)) 
according to three weight blocks (light, medium, and heavy) per treatment for a 56 d 
backgrounding period (until January 5, 2016) on a high roughage ration (grass hay, 
concentrate pellets, dry corn cobs, glycerin, distillers grains, limestone, and minerals). 
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Feed was delivered with a mixer wagon (Farm Aid, model 340; Corsica, SD) each 
morning at 0900 h. On December 8 steers were weighed, and IMPL and IMBA steers 
were administered a moderate-potency initial feedyard implant. On January 4, steers were 
weighed, vaccinated for respiratory diseases (Bovi-Shield Gold 5, Zoetis, Parsippany, NJ) 
and then re-weighed (to account for variations in fill) on January 5 prior to being shipped 
approximately 430 km to the University of Nebraska-Lincoln West Central Research and 
Extension Center in North Platte, NE. 
Feedlot Management 
Upon arrival at the feedyard all steers were maintained within their original pen 
assignment and received four concentrate-adaptation diets over a period of 65 d (January 
6 - March 11) and fed for 7, 7, 40, and 11 d, respectively. On the morning of March 11, 
steers were dewormed (Ivermax Pour-On, Aspen Veterinary Resources Ltd., Greeley, 
CO), individual weight was recorded, IMPL and IMBA steers were re-implanted with a 
high potency finishing implant. After processing on March 11, all steers were placed into 
the GrowSafe feeding system (GrowSafe Systems Ltd., Airdrie, AB Canada) to collect 
individual feed intake. Steers were allowed an 18 d adaptation period to the feeders and 
data collection began on March 29 and continued to harvest. Steers were allocated to be 
fed in four groups according to treatment protocol (Group 1 = NA, Group 2 = ½ NHTC 
and ½ IMPL, Group 3 = ½ NHTC and ½ IMPL, and Group 4 = IMBA) and were rotated 
among four pens to mitigate the influence of pen on animal performance. Weights were 
recorded on March 28 and 29 after adaption in the GrowSafe feeding system. Each 
morning (0800 h) and evening (1600 h) a feed truck and delivery unit (Roto-Mix, model 
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274; Dodge City, KS) provided the final finishing diet (Table 2.1). Steers assigned to 
NHTC, IMPL, and IMBA were fed the finishing ration including Rumensin 90 and Tylan 
40 as a pre-mixed supplement from the beginning of the acclimated finishing period 
(March 29) to harvest for either 90, 71, or 90 d, respectively. To ensure that NA did not 
receive Rumensin 90 or Tylan 40 from the other treatments, during the evening feed 
delivery the delivery unit was flushed clean with ground hay prior to feeding the NA diet 
and that diet was fed first during the morning feeding. Steers within the NA treatment 
received the finishing ration for 71 d. Additionally, IMBA steers were supplemented 200 
mg RHsteer-1 d-1 in their ration for the last 30 d prior to harvest. A separate feed wagon 
(Roto-mix, 220; Dodge City, KS) was utilized to deliver the feed ration containing RH to 
the IMBA treatment to prevent any potential carry over to the other treatments. On April 
26, steers were weighed (Table 2.2) and ultrasounded by Cattle Performance 
Enhancement Company (CPEC, Oakley, KS) to predict the terminal harvest date for each 
treatment to achieve a common compositional endpoint [~1.53 cm 12th rib backfat 
thickness (FT)]. Two separate harvest dates were predicted as determined by ultrasound. 
Steers from NA and IMPL were harvested on June 8 and NHTC and IMBA were 
harvested on June 27. On the day of harvest steers were transported approximately 100 
km to Tyson Fresh Meats in Lexington, NE. Cattle were not weighed prior to being 
shipped to the processing facility to reduce the incidence of bruising and injury; 
therefore, the FCBW was determined as HCW divided by 0.635.  
From March 29 to harvest, animal performance data were collected for analysis of 
body weight (BW), average daily gain (ADG), dry matter intake (DMI), and gain to feed 
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(G:F). Throughout the study all cattle had ad libitum access to fresh water. Due to the 
animal health protocol, 3 NA steers were removed from animal and carcass performance 
analyses because they required an antibiotic for disease control. However, these 3 hd 
were included in the economic analyses to report the cost of antibiotic use and the 
opportunity loss from not achieving the no antibiotic beef program premium. Three steers 
died during finishing due to reasons unrelated to treatment including: right-sided 
congestive heart failure (1 steer from NA), chronic pneumonia (1 steer from NHTC), and 
hardware disease (1 steer from IMBA). A total of 117 steers were harvested (NA = 29, 
NHTC = 29, IMPL = 30, and IMBA = 29). 
Carcass Evaluation and Sample Collection 
 Carcasses (n = 117) were tracked individually through harvest and HCW was 
recorded. Following carcass chilling (approximately 24 h), trained SDSU personnel 
recorded FT, LM area, and KPH used to calculate USDA Yield Grade (YG), and 
determined marbling score and carcass maturity to calculate USDA Quality Grade (QG) 
for each carcass according to USDA guidelines. Plant assigned USDA YG and QG were 
utilized for analysis of the proportion of carcasses within each YG and QG category 
(Table 2.3). Total carcass value and carcass value per 45.4 kg (hundredweight) for each 
production system were determined using plant assigned grid base values, premiums, and 
discounts. Carcasses in the NA, IMPL, and NHTC treatment groups were marketed on 
the Gene Trac Grid (Tyson Fresh Meats). On June 8, the base carcass price per 
hundredweight for NA and IMPL was $206.31 and on June 27, NHTC received a base 
price of $188.24 per hundredweight. The IMBA was marketed on the True Value Grid 
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(Tyson Fresh Meats) on June 27, and received a base price of $187.74 per 
hundredweight. 
Economic Evaluation 
The total production cost of each treatment was determined by accounting for 
expenses including: total feed cost and yardage during backgrounding and finishing, 
technology costs as required by treatment, actual or adjusted cost of morbidity, third 
party auditing fee (NA and NHTC only), and transportation. The total production cost 
was also calculated with and without the initial cost of the weaned calf (Table 2.4). Table 
2.5 includes the plant assigned base carcass value per hundredweight, the branded beef 
premiums per carcass, and the total YG and QG premiums and discounts per treatment. 
The total branded carcass value was determined by calculating  
[(total QG and YG premiums/hundredweight – total QG and YG 
discounts/hundredweight) ´ (HCW/100) + (total plant premiums per hd – total plant 
discounts per hd)]. 
Total premiums and discounts per hd consisted of adjustments for performing above or 
below the YG and QG threshold set by the grid and also included the per carcass branded 
beef premiums (Table 2.5). The branded beef premiums provided by Tyson Fresh Meats 
were applied to NA ($275 per hd) and NHTC ($175 per hd) as if third party auditing was 
conducted to ensure the integrity of cattle “raised without antibiotics” and “raised without 
the use of hormones,” respectively. The cost of gain (COG) was calculated by:  
[(total production cost) / (final calculated body weight (FCBW (HCW/.635)) - shrunk 
(6%) weaning weight (WW)]. 
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The net return was calculated by:  
[(total branded carcass value – total production cost)].  
All costs and returns were calculated including and excluding the cost of the calf ($249 
per hundredweight), which was determined based on price reports on the day of weaning 
from the Faith Livestock Commission Company (located 174 km from the Antelope 
Range and Livestock Research Station; Table 2.6). As stated earlier, a total of 3 NA 
steers were treated with an antibiotic for respiratory disease and were excluded from the 
animal performance, carcass performance. Economic evaluation adjustments are 
described below. 
Economic Evaluation Adjusted for National Animal Morbidity 
Actual feedyard percent morbidity was 6.89%, 10.34%, 3.33%; and 13.79% for 
the NA, NHTC, IMPL, and IMBA treatments, respectively. Actual number of steers 
treated for illness during the finishing segment included 2, 3, 1, and 4 steers for the NA, 
NHTC, IMPL, and IMBA treatments, respectively. Considering that the study did not 
have sufficient numbers to adequately evaluate the influence of production systems on 
measures of animal health, adjustments were made according to the National Animal 
Health Monitoring System (NAHMS; USDA-APHIS, 2011). The total adjusted percent 
morbidity was made according to NAHMS and the actual morbidity percentage was not 
included in this total adjusted percent morbidity. The total adjusted percent morbidity 
was 25.8% according to feedyard morbidity data from feedyards in the Central region 
with greater than 8,000 hd (USDA-APHIS, 2011; Table 2.7). This morbidity adjustment 
was applied to all treatments and expenses were also adjusted according to NAHMS data 
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(USDA-APHIS, 2011) including treatment for: respiratory disease (17.90%; $23.10 per 
hd), pneumonia (2.9%; $21.80 per hd), and digestive issues (5.0%; $8.80 per hd). Given 
that the NA treatment was not provided antibiotics, adjustments were made to account for 
morbidity and therapeutic treatment according to NAHMS (USDA-APHIS, 2011). These 
adjustments were made to include the 25.8% morbidity rate and the adjusted treatment 
cost. In addition, a deduction of $70.95 (i.e. .258 ´ $275) was applied to each carcass 
receiving the NA branded beef premium ($275) to account for opportunity loss of cattle 
that would have to be treated and removed from the branded beef program (“raised 
without antibiotics”; Table 2.7). 
Surveys Among Beef Industry Segments for Environmental Simulation 
 To predict the environmental impact of each production system, information was 
gathered from in-person interviews at each industry segment where the cattle were raised 
using surveys (Major input parameters needed for the Integrated Farm Systems Model; 
IFSM) developed by Rotz et al. (2016). The survey parameters allowed for 
characterization of each segment’s soil and grazing conditions, animal and feeding 
information, and manure handling practices. Survey respondents were the University 
employed managers of each segment operation. By segment, the operations included: 
cow-calf (South Dakota State University, Antelope Range and Livestock Research 
Station, Buffalo, SD); backgrounding (South Dakota State University, Cottonwood 
Range and Livestock Field Station, Phillip, SD); and finishing (University of Nebraska-
Lincoln, West Central Research and Extension Center, North Platte, NE). Table 2.8 
provides soil information for each segment. 
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Simulation Modeling Procedure 
 Each segment was simulated using typical production practices for the Northern 
Plains region based upon the production information gathered for this study and 
supplemented with data reported by Asem-Hiablie et al. (2016). The IFSM is a software 
tool available through Internet download (USDA-ARS, 2016) for producers and 
researchers to assess the environmental impact of agricultural production systems 
including beef and dairy operations (Rotz et al., 2015). The IFSM simulates feed 
production, animal performance, manure production and handling, and over 25 years of 
weather data to estimate average annual emissions of production systems within the 
respective location (Stackhouse et al., 2012a). Each segment was assessed for crop 
production, feed use, animal performance, and return of manure nutrients back to the land 
(Rotz et al., 2016). 
 To determine the annual carbon emissions, energy use, water use, and reactive N 
footprint, a cradle-to-farm gate life cycle assessment (LCA) was conducted for each 
production system. Nutrients were tracked to predict the losses at each segment and 
potential accumulation or depletion in the soil (Rotz et al, 2015). These losses included: 
NH3 emissions, denitrification, and leaching losses of N; erosion of sediment across farm 
boundaries; and the runoff of N and P (Rotz et al., 2016). The production system 
simulation also allowed for prediction of annual emissions from pre-chain resources. Pre-
chain sources included emissions occurring during the production of purchased feed and 
energy. National emission factors were used to calculate pre-chain energy sources (Rotz 
et al., 2013; Table 2.9). The pre-chain emission factors for purchased feed were obtained 
   
 
 
 
94
from IFSM simulations of crop farms (Rotz et al., 2015). As described by Rotz et al. 
(2015), direct and pre-chain emission factors were collectively totaled then divided by 
each production system’s mean feedyard final shrunk body weight (SBW; Table 2.10). 
This final SBW was divided by the dressing percentage (DP, 63.5%) to determine the 
environmental footprint on a HCW basis. 
 Each segment was simulated over 25 yr using actual daily weather data to best 
estimate animal performance. The weather data used for each segment was obtained from 
the closest weather station. By segment, the weather station data were: cow-calf 
(Dickinson, ND), backgrounding (Phillip, SD), and finishing (North Platte, NE). For each 
of these segments, meteorological information was obtained hourly from the National 
Climatic Data Center (NOAA, 2014) and processed into daily values (needed for IFSM) 
utilizing AERMET (USEPA, 2004). Average annual solar radiation, temperature, 
precipitation, and wind are summarized by segment in Table 2.11. 
Equipment, Transportation, and Energy Simulation 
 Equipment and machinery were simulated per segment. The cow-calf segment 
included two tractors for a total use of 340 h per yr and one pickup truck used for a total 
of 150 h per yr. The backgrounding segment consisted of one tractor used 100 h per yr 
and a mixer wagon used 2,000 h per yr. The finishing segment used one tractor for a total 
use of 3,700 h per yr, a mixer wagon for 2,000 h per yr, two skid loaders used 550 h per 
yr and one pickup truck was used for 150 h per yr. Animal transportation between 
segments was included external to the IFSM simulation based upon actual total distances 
of 644, 876, and 203 km, respectively, to account for two semi-trucks. Energy use during 
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transportation assumed an energy consumption of 0.00122 MJ per km . kg which 
produced a carbon emission of 0.088 g CO2e per km . kg (Rotz et al., 2015).  
Fuel and electricity use simulated for each segment was compared to reported 
data (Asem-Hiablie et al., 2016) to verify that the LCA was representative of production 
practices in the Northern Plains region. Simulated fuel use was 33 L per cow, 7.7 L per 
animal, and 3.7 L per animal for the cow-calf, backgrounding, and feedyard segments, 
respectively. Electricity use was 65 kWh per cow, 15 kWh per animal, and 42 kWh per 
animal for the cow-calf, backgrounding, and feedyard segments, respectively. These 
average values from the simulated production segments were comparable with the data 
reported for the central plains regions (Asem-Hiablie et al., 2015; Asem-Hiablie et al., 
2016).  
Production System Animal Simulation 
 Within the IFSM model, the animal diets at each segment were simulated equally 
for all treatments. Diets were formulated to meet animal requirements for energy, protein, 
and mineral using the Cornell Net Carbohydrate and Protein System, level 1(Fox et al., 
2004; Rotz et al., 2015). Allocation among feeds was adjusted to approximately match 
the annual feed use reported for each segment to assure proper representation of feed use. 
Animal growth performance was set to meet initial and final SBW measured for each 
segment. When all treatments were applied in the finishing segment, animal performance 
was determined by the ADG calculated between the initial and final SBW. The model 
decreases ADG 10% linearly each month until reaching the final SBW (Rotz et al., 2005, 
2016). When a growth promoting implant is administered during any segment, the 
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potential ADG is increased by 10% while the target final SBW is increased 5% (Rotz et 
al., 2005). Further, a fiber ingestive capacity (FIC) is adjusted monthly for cattle groups 
receiving growth promoting implants and ionophores (Rotz et al., 2005). The FIC is used 
to provide a limit of the potential fiber intake and is a function of total body capacity 
affected by leanness (Tess and Kolstad, 2000; Rotz et al., 2005). The FIC increases 10% 
during each implant administration whereas use of an innophore decreases FIC by 3 - 
6%. Because the IMBA treatment provided no HCW improvement over implanting and 
supplementing Rumensin and Tylan alone (IMPL; Table 2.2 and 2.3), no further 
adjustments for RH supplementation were made as performance was proportionate to the 
initial and final SBW.  
All production systems were managed equally within each segment except for any 
deviations according to treatment described herein including, use of growth promotant 
technology. The simulated Angus cow-herd and bulls (270 and 14 hd, respectively), and 
replacement females (58 hd) were grazed on 1,103 ha of rangeland with a stocking rate of 
4.1 ha per cow per month. Annually the herd replacement rate was modeled as 20%, 
mortality was 3%, and the dressing percentage (DP) of cull cows was 55%. To predict the 
number of calves finished, a 2% twin rate, a 12% mortality rate, and a 2.5% post-weaning 
mortality rate were assumed during the cow-calf segment. Within the model, the IMPL 
and IMBA calves were administered an implant and all calves were weaned at 6 months 
(number of months is the closest accuracy available) of age and transported (322 km) to 
the backgrounding segment. All manure was returned to pasture and no manure was 
   
 
 
 
97
exported to other agricultural sectors, which is typical for a Northern Plains cow-calf 
operation (Asem-Hiablie et al., 2016). 
Per treatment, the backgrounding segment simulated 4,000 hd, which is a typical 
size for the Northern Plains region (Asem-Hiablie et al., 2016). For all treatments, the 
backgrounding segment lasted 3 months and cattle were fed grain prior to being 
transported (438 km) to the finishing segment. For both backgrounding and finishing, all 
of the manure was exported from the feedyard for other agricultural use, which is typical 
in this Northern Plains region (Asem-Hiablie et al., 2016).  
The feedyard was simulated with 5,000 hd, which is similar to feedyards found in 
the Northern Plains region (Asem-Hiablie et al., 2016). All treatments were on feed for 
either 5 (NA and IMPL) or 6 months (NHTC and IMBA) as the model simulates monthly 
information. Thus, 5 and 6 months captured the biological terminal endpoint goal of 1.53 
cm FT and best estimated the 19 d difference in harvest date among treatments. All 
treatments except NA received an ionophore, and IMPL and IMBA were implanted 
during the cow-calf, backgrounding, and feedyard segments. Unique to this analysis, the 
simulation used each production system’s actual initial and final SBW (Table 2.10) for 
the feedyard to predict animal response and environmental impacts for each production 
system. 
Life Cycle Assessment 
 Post simulation of each segment for each treatment, environmental impacts were 
integrated to form a LCA to account for all environmental impacts from the cow-calf 
segment to harvest per treatament. Therefore, the environmental impacts were summed 
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across the three segments and divided by the HCW to obtain the full production system 
environmental impacts per treatment. The environmental impacts included: net 
greenhouse gas emission (CO2e per kg HCW), energy use (MJ per kg HCW), non-
precipitation (blue water) water consumption (kg H2O per kg HCW), and reactive N loss 
(N per kg HCW). The non-precipitation water use primarily included water to irrigate 
feed crops and drinking water. The N loss accounted for all forms of reactive N loss 
including: ammonia emission, nitrate leaching and runoff, nitrous oxide emission, and 
NOx emitted through denitrification and the combustion of fossil fuels (Rotz et al., 2016).  
Statistical Analysis 
Treatments were evaluated in PROC MIXED of SAS 9.4 (SAS Inc., Cary, N.C.) in 
a completely randomized design with steer used as the experimental unit. Fixed effects 
included animal performance (FCBW, ADG, DMI, and G:F), carcass performance (HCW, 
FT, LM area, KPH, YG, marbling score, overall maturity, and QG), and economic 
performance (total branded carcass value, total production cost, COG, and net return). 
There were no random effects specified. The influence of treatment on the proportion of 
carcasses assigned to each USDA YG and QG were analyzed using a binary distribution 
in PROC GLIMMIX of SAS. Treatment was tested as a fixed effect and the intercept was 
specified as a random effect. All statistical analyses used dam age as a covariate and the 
denominator degrees of freedom were approximated using the Kenward-Roger option in 
the model statement. Least squares means and SEM were computed for all variables and 
separated using least significant differences (PDIFF) when tests for fixed effects were 
significant at P < 0.05. The environmental impacts were determined from treatment 
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production information to fulfill the major input parameters for simulation capacity within 
the IFSM using calculations according to USDA-ARS (2016). 
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RESULTS AND DISCUSSION 
Animal Performance 
Treatment did not influence (P > 0.05) pre-weaning, backgrounding, or initial 
feedyard BWs (Table 2.2). However, treatment influenced (P = 0.032) average BW at the 
initiation of the individual feed intake portion of the study on March 28 and 29. The 
IMPL and IMBA (477 ± 8.98 kg and 470 ± 8.81 kg, respectively) treatments were similar 
(P > 0.05) and heavier (P < 0.05) compared with NA and NHTC (450 ± 9.51 kg and 444 
± 8.81 kg, respectively), which were similar (P > 0.05). Twenty-eight d later, on April 26 
BW differences remained consistent as treatment influenced (P = 0.001) the final BW 
collected during the feeding period. The IMPL and IMBA (549 ± 9.58 kg and 549 ± 9.40 
kg, respectively) were similar (P > 0.05) and heavier (P < 0.05) in comparison with NA and 
NHTC (510 ± 10.14 kg and 505 ± 9.40 kg, respectively), which were similar. At harvest 
(either June 6 or 27), FCBW of steers with increased levels of growth promotant 
technology (IMPL and IMBA; 610 ± 9.72 kg and 612 ± 9.88 kg, respectively) was heavier 
(P < 0.05) than steers with lower levels of growth promotant technology (NA and NHTC; 
540 ± 10.45 kg and 557 ± 9.88 kg, respectively; Table 2.2). The increase in FCBW gained 
from implant administration is similar to BW increases reported by others (Duckett et al., 
1997; Bruns et al., 2005). Bruns et al. (2005) determined a single estradiol-TBA implant 
administered at either d 1 or d 57 in the feedyard increased BW by 2% from d 57 to 112 
compared with a non-implanted control. Growth promoting implants have been shown to 
improve growth rate by 8 – 30% (Preston, 1999; Johnson and Beckett, 2014) and 
consecutive re-implantation has been shown to improve growth rate by 5 – 20% (Preston, 
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1999). In the current study, IMPL improved FCBW by 13% (70 kg) compared with NA, 
and by 10% (53 kg) compared with NHTC. Use of RH has also been demonstrated to 
improve BW. In a meta-analysis evaluating 44 studies, final BW improved by 
approximately 8 kg compared with a non-supplemented control (Lean et al., 2014). 
Moreover, Scramlin et al. (2010) fed crossbred steers RH (200 mg RH hd-1 d-1 for 33 d) 
and also reported heavier (8 kg) final BW in comparison with a non-supplemented 
control. In the current study, FCBW of steers supplemented with RH did not differ (P > 
0.05) from IMPL but were heavier (P < 0.05) compared with NHTC and NA (by 55 and 
72 kg, respectively), which were similar (P > 0.05). Strydom et al. (2009) fed Bonsmara 
steers RH (at 30 ppm) for 30 d prior to harvest and also reported no influence of 
supplementation on final BW when compared with steers implanted (Revalor-S) at the 
start of the intensive growth period. 
Throughout the finishing segment (March 29 to harvest), ADG was greatest (P < 
0.05) for IMPL (2.11 ± 0.046 kg), while IMBA (1.79 ± 0.47 kg) was intermediate, but 
greater (P < 0.05) than NA and NHTC (1.54 ± 0.049 kg and 1.45 ± 0.047 kg, respectively), 
which were not different (P > 0.05). Johnson et al. (1996) determined the use of a single 
moderate potency combination implant (Revalor-S; 120 mg TBA and 24 mg E2) during 
finishing improved ADG by 16% for the entire finishing duration (143 d) compared with 
a non-implanted control. In the current analysis, IMPL increased ADG by 41% compared 
with NA and NHTC, which were similar (P > 0.05). Additionally, Goodrich et al. (1984) 
determined steers and heifers fed Rumensin and utilizing subsequent implants (zeranol, 
progesterone-estradiol or, testosterone-estradiol) consistently improved ADG and G:F. 
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Feeding tylosin has also repeatedly been shown to improve ADG compared with cattle 
not fed tylosin (Brown et al., 1975; Vogel and Laudert, 1994). Therefore, the combined 
effects of monensin, tylosin, and implants in this study may be additive and explain why 
IMPL steers had an increased ADG compared with NA and NHTC. In relation to the 
IMBA treatment, a summary of six studies concluded that supplementing RH increased 
ADG by 17.4% (Laudert et al., 2005) and in a meta-analysis of 49 studies, ADG of RH 
supplemented cattle was increased by 0.19 kg hd-1 d-1 (Lean et al., 2014). In the current 
study, use of RH in addition to successive implantation and supplementation with 
monensin and tylosin decreased ADG by 15% compared wtih IMPL. Given that IMPL 
improved ADG by 37% compared with NA, the lack of response of IMBA may be due to 
the limited number of available b1 cellular receptors (Mersmann, 1998; Johnson et al., 
2014) and no net increase in DMI other than implanting and feeding monensin and 
tylosin. Although Boler et al. (2012) did report an increase in ADG for cattle 
supplemented with RH in comparison with an non-supplemented control. Boler et al. 
(2012) credited that the improved response in this study, compared to others that also 
ulilized RH and multiple implants, had increased growth potential because steers only 
received one implant. Perhaps in the current study, successive implantation had 
maximized the response potential for ADG and G:F, minimzing the influence of RH. 
The DMI of IMPL and IMBA (12.88 ± 0.221 kg and 12.58 ± 0.225 kg, respectively) 
was similar (P > 0.05) and greater (P < 0.05) than NA (11.54 ± 0.237 kg), which was 
intermediate and greater (P < 0.05) than NHTC (10.81 ± 0.225 kg). Similarly, Boler et al. 
(2012) compared RH supplemented steers (200 and 300 mgsteer-1 d-1) to an implanted 
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(Component TE-S) control and reported no effect of RH on DMI. Avendaño-Reyes et al. 
(2006) also implanted and re-implanted steers (with Synovex-C and Synovex Plus) prior 
to feeding RH (300 mgsteer-1 d-1) and in contrast to the current study, determined RH 
steers consumed less (8.37 kg vs. 8.51 kg) dry matter compared with the control steers 
that were re-implanted. When comparing NA and NHTC in the present study, steers in 
the NHTC treatment had a reduction in DMI of 6%, which is similar to the 6.4% 
reduction in DMI reported by Goodrich et al. (1984) in a summary of 228 trials. Tylosin 
has been reported to be less effective at reducing DMI than monensin. Among 40 trials, 
cattle (6,971) fed tylosin (90 mghd-1 d-1) did not reduce DMI compared wtih a control 
(Vogel and Laudert, 1994). Therefore, the inclusion of monensin is likely the factor 
influencing the reduction in DMI of NHTC compared with NA (Goodrich et al., 1984; 
Stock et al., 1995). 
The G:F was greatest (P < 0.05) for IMPL (0.16 ± 0.003 kg) compared with NA, 
NHTC, and IMBA (0.13 ± 0.004 kg, 0.13 ± 0.004 kg, and 0.14 ± 0.004 kg, respectively), 
which were similar (P > 0.05; Table 2.3). The use of successive implantation (IMPL) with 
tylosin and monensin supplementation improved G:F by 0.03 kg or 23% in comparison with 
NA. Similarly, Johnson et al. (1996) determined implantation with a single combination 
implant (120 mg trenbolone acetate and 24 mg estradiol) improved G:F by 13% 
compared with a non-implanted control. In contrast to IMBA, Scramlin et al. (2010) 
supplemented crossbred steers with RH (200 mgsteer-1 d-1 for 33 d) and reported an 
improvement in G:F by 0.024 kg compared with a non-supplemented control. Moreover, 
Avendaño-Reyes et al. (2006) determined RH (300 mghd-1 d-1 for 33 d) improved G:F 
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by 0.06 kg compared with a re-implanted control. In the current study, RH 
supplementation did not improve (P > 0.05) G:F compared to NA and NHTC and 
decreased (P < 0.05) G:F by 0.02 kg or 12.5% compared with IMPL. Perhaps the 
suggestion by Boler et al. (2012) that successive implantation maximizes growth 
potential and reduces the opportunity for improvement in growth efficiency from RH 
supplementation explains the lack of improvement in ADG, DMI, and G:F for IMBA in 
comparison with IMPL. Moreover, it is understood that RH targets b1 cellular receptors 
that have limited cellular receptor availability as they only represent a small (1- 4%) 
population of mRNA in bovine tissue (Johnson et al., 2014) and vary anatomically 
(Mersmann, 1998). 
Carcass Performance 
Treatment did not influence (P > 0.05) FT, YG, or proportions of carcasses in 
each YG and QG (Table 2.3). The HCW of steers with greater levels of growth 
promotant technology (IMPL and IMBA, 387.38 ± 6.168 kg and 388.63 ± 6.271 kg, 
respectively) was heavier (P < 0.05) compared with NA and NHTC (343.10 ± 6.636 kg and 
353.69 ± 6.272 kg, respectively), which were similar (P > 0.05). Other studies have reported 
that supplementing steers RH caused a 5 - 14 kg increase in HCW compared with implanted 
controls (Avendaño-Reyes et al., 2006; Scramlin et al., 2010). Quinn et al. (2008) reported 
no difference in final BW, HCW, YG, or KPH between heifers that were implanted 
(Revalor-H) and heifers that were implanted and provided RH supplementation (200 mghd-
1 d-1 for 28 d). Moreover, while utilizing crossbred steers, Scramlin et al. (2010) reported 
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RH supplementation (200 mghd-1 d-1) did not influence YG in comparison with a non-
supplemented control. 
The NA, IMPL, and IMBA (1.78 ± 0.049 %, 1.75 ± 0.046, % and 1.85 ± 0.047 %) 
treatments did not differ (P > 0.05) in percent KPH but were lower (P < 0.05) than NHTC 
(2.19 ± 0.047 %), which had the greatest (P < 0.05) percent KPH. The LM area was greatest 
(P < 0.05) for IMPL (92.16 ± 1.393), NHTC and IMBA (83.91 ± 1.417 and 87.55 ± 1.416, 
respectively) were similar (P > 0.05) and IMBA was greater (P < 0.05) than NA (81.95 ± 
1.499), which was similar (P > 0.05) to NHTC. In regard to IMBA and IMPL, other 
research has also determined no influence of RH supplementation at a rate of 200 mghd-
1 d-1 on LM area in comparison with an implanted control (Quinn et al., 2008; Scramlin 
et al. 2010). In contrast, Boler et al. (2012) determined supplementing RH at 200 and 300 
mghd-1 d-1 improved LM area in comparison with a single implanted control (120 mg 
trenbolone acetate and 24 mg estradiol plus 29 mg tylosin tartrate).  
To further evaluate carcass performance, individual measures for carcass quality 
were assessed. Each treatment influenced (P < 0.001) advancements in overall maturity in 
the following order: IMBA (142.94 ± 1.569), NHTC (132.45 ± 1.570), IMPL (127.38 ± 
1.544), and NA (122.20 ± 1.661). Scramlin et al. (2010) and Woerner et al. (2011) 
determined RH supplementation (200 mghd-1 d-1) did not influence overall maturity in 
comparison with steers provided an initial implant and/or were re-implanted with a terminal 
implant. Limited information exists regarding the influence of monensin and tylosin on 
carcass maturity. Successive implantation has been reported (Platter et al., 2003) to linearly 
increase overall maturity. Using a similar successive (Ralgro, Revalor IS, and Revalor 200) 
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implant, RH (300 mghd-1 d-1), monensin (360 mghd-1 d-1), and tylosin (90 mghd-1 d-1) 
supplementation protocol, Webb et al. (2017) determined that the average overall maturity 
score was 144 (A44), which is numerically closest to IMBA (143, A43). In the current study, 
IMBA and NHTC were harvested (on June 27), 19 d after the IMPL and NA treatment 
groups were harvested (June 8). Perhaps, the difference in average age (14.6 and 13.9 mo) 
on harvest date influenced overall maturity. Nevertheless, all treatments produced A 
maturity carcasses, thus these differences did not affect quality grade determination (Table 
2.3). 
Treatment influenced (P = 0.004) carcass marbling scores. The lower levels of 
technology (NA and NHTC; 553.93 ± 18.140 and 561.61 ± 17.146, respectively) had 
similar (P > 0.05), but greater (P < 0.05) marbling compared with treatments using more 
growth promotant technology (IMPL and IMBA; 486.49 ± 16.861 and 503.67 ± 17.141, 
respectively), which were similar (P > 0.05; Table 2.3). Boler et al. (2012) also reported 
that RH supplementation did not influence marbling score compared with implanted 
steers. Further, Woerner et al. (2011) reported that steers re-implanted during finishing 
(with and without RH supplementation) produced carcasses with lower marbling scores 
compared to a control (receiving one implant during finishing). Morevover, in a review of 
37 trials examining steers administered an anabolic steroid while on a finishing diet, 
Duckett et al. (1996) detected a mean reduction (-24%) in marbling. In contrast, some 
studies have determined that implant administration caused decreased marbling scores in 
comparison with a non-implanted control (Johnson et al., 1996; Scheffler et al., 2003, 
Smith et al., 2007). In a review of 77 research trials conducted by Duckett et al. (1997), a 
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single combination implant improved carcass HCW, LM area, and identified an inverse 
relationship between larger LM area and a corresponding smaller degree of marbling in 
comparison with a non-implanted control. This “dilution effect” described by Duckett et 
al. (1999) occurs from hypertrophy of skeletal muscle and is likely responsible for the 
lower marbling score of carcasses from the IMPL treatment, which also had the largest 
LM area. In the current study, the NHTC and NA treatments were similar (P > 0.05) in 
marbling suggesting that monensin and tylosin  have no negative influences on marbling 
score (Table 2.3). Although there are few studies evaluating the use of monensin on 
carcass quality, Goodrich et al. (1984) conducted regression models from 60 trials and 
determined monensin decreased marbling score (-0.39%) in comparison with a non-
supplemneted control. 
Actual Economics of Carcass Performance 
Production system influenced (P < 0.05) total carcass value. The NA and IMPL 
treatments ($1,889.38 ± 31.207 and $1,826.36 ± 30.663, respectively) were similar (P > 
0.05) and greater (P < 0.05) in value than NHTC and IMBA ($1,771.10 ± 31.183 and 
$1,689.54 ± 31.178, respectively), which were similar (P > 0.05; Table 2.6). To determine if 
production systems influenced net return, an analysis of actual input costs for production 
and fiscal return from the carcasses were evaluated. Optimizing cattle production while 
minimizing input costs, such as feed that accounts for nearly two-thirds of total operating 
costs, are important for long-term sustainability and profitability of an operation (USDA-
ERS, 2010).  
Actual Production Cost 
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To emulate the purchase of weaned calves for a backgrounding operation, the cost of 
weaned calves was included and represented on a per hd basis including actual morbidity 
and treatment expenses (Table 2.6). Treatment tended (P = 0.09) to influence the total 
production cost. The NA treatment ($1,607.00 ± 29.542) had a lower (P < 0.05) total 
production cost compared with IMBA ($1,712.13 ± 29.515), though NHTC and IMPL 
($1,673.21 ± 29.519 and $1,645.25 ± 29.027, respectively) were similar (P > 0.05) and did 
not differ from all other treatments. To emulate retained ownership from the cow-calf 
segment onward, the cost of the weaned calf was excluded. In this analysis, treatment 
influenced (P < 0.05) the total production cost. The NA and IMPL treatment ($438.93 ± 
3.561 and $434.52 ± 3.499, respectively) were similar (P > 0.05) and had the lowest (P < 
0.05) total production cost, while NHTC ($495.35 ± 3.558) was intermediate (P < 0.05) and 
IMBA ($508.56 ± 3.558), had the highest (P < 0.05) total production cost (Table 2.6).  
Including the cost of the calf, NA, NHTC, and IMPL treatments were similar (P > 
0.05) for total production cost, while IMBA was the greatest (P < 0.05; Table 2.6). 
Excluding the calf cost, NA and IMPL were similar (P > 0.05) and had fewer days on feed 
than NHTC, which was intermediate (P < 0.05) and IMBA resulted in the greatest (P < 
0.05) total production cost. In some agreement, Stackhouse et al. (2012b) estimated that 
supplementing Holstein cattle ZH increased the feedyard production cost by $20 per 
animal in comparison with a non-implanted and non-supplemented control. In the present 
study, lack of growth promotant technology (NA) resulted in reduced (P < 0.05) production 
cost including and excluding the cost of the calf, by $103 and $67, respectively, in 
comparison with IMBA.  
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Actual Cost of Gain 
When including the cost of the calf at weaning, treatment influenced (P < 0.0001) 
COG. Treatments (NA and NHTC; $5.58 ± 0.105 and $5.55 ± 0.105, respectively) with 
lower levels of technology were similar (P > 0.05) and had higher (P < 0.05) COG in 
comparison with treatments (IMPL and IMBA; $4.74 ± 0.103 and $4.88 ± 0.105, 
respectively) using increased levels of growth promotant technology, which were similar (P 
> 0.05). Cattle receiving monensin, tylosin, growth promoting implants, with and without 
RH (IMBA and IMPL) had reduced COG by $0.76 per kg in comparison with cattle raised 
with and without monensin and tylosin (NHTC and NA). When not considering the cost of 
the calf and emulating retained ownership of cow-calf producers, treatment also influenced 
(P < 0.0001) COG. The IMPL treatment ($1.25 ± 0.032) had the lowest COG, NA and 
IMBA ($1.54 ± 0.033 and $1.45 ± 0.033, respectively) were similar (P > 0.05) and 
intermediate (P < 0.05), while NHTC ($1.65 ± 0.033) had the highest COG. The reduced 
days on feed, growth promotant technology cost, and adequate BW gain from weaning 
(October 26) to harvest (FCBW on June 8) of IMPL reduced COG and resulted in a lower 
total production cost in comparison with IMBA. The COG was highest for NHTC due to the 
cost of monensin and tylosin, and a longer duration on feed without significant 
improvements in BW gain (Table 2.6). 
Production management decisions that have a lower total production cost do not 
always result in a lower COG due to losses in BW performance and duration of time on 
feed. Treatments using more technology (IMPL) reduced COG more effectively due to 
improvements in BW gain and reduction in days on feed (19 d). The use of RH (IMBA) 
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was less consistent (depending upon if calf cost was included or excluded) in reducing 
COG in comparison with IMPL. Consistent with the current study, when excluding the 
cost of the calf, Stackhouse et al. (2012b) determined growth promoting implants 
decreased production cost by $0.25 per kg of HCW in comparison to a control not utilizing 
growth promotant technology. 
Actual Net Return 
Including the cost of the weaned calf, each treatment influenced (P < 0.0001) net 
return in the following descending order: NA ($282.38 ± 18.836); IMPL ($181.11 ± 
18.508); NHTC ($37.89 ± 18.822) and IMBA (-$22.59 ± 18.819; Table 2.6). When 
retaining ownership from the cow-calf segment onward and excluding the cost of the 
weaned calf, treatment influenced (P < 0.0001) net return. Treatments NA and IMPL 
($1,450.45 ± 31.606 and $1,391.84 ± 31.055, respectively) were similar (P > 0.05) and 
returned greater value (P < 0.05) than NHTC and IMBA ($1,215.75 ± 31.581 and $1,180.99 
± 31.576, respectively), which were similar (P > 0.05; Table 2.6). No difference (P > 0.05) 
in net return occurred when feeding monsinsin and tylosin, and providing growth promoting 
implants (IMPL) in comparison to not supplying growth promotant technology (NA). 
Treatments NA and IMPL either gained a benefit from the branded beef premium ($275; 
Table 2.5) or the improved FCBW, respectively. Further, NA, IMPL, and NHTC were sold 
on grids with higher base prices ($206.31, $206.31, $188.24, respectively) in comparison 
with IMBA ($187.74), which was discounted because of RH supplementation (as assigned 
by Tyson Fresh Meats). 
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 The decreased FCBW performance of NHTC in comparison with IMPL and IMBA 
required a longer time on feed (19 d). Additionally, NHTC carcasses received a lower 
branded beef premium ($175; Table 2.5) for “beef raised without the use hormones” than 
NA. A meta-analysis evaluating the economic perforamce of naturally raised steers 
determined that a greater ($0.14 per kg BW) incentive would be needed to return as much 
value as conventionally raised steers due to the loss in BW performance (Gadberry, 2008; 
Wileman et al., 2009). In another meta-analysis comparing conventional and 
nonconventional beef production in the feedyard, implanting steers provided more ($77) 
value, likely due to improvements in ADG and G:F (Wileman et al., 2009). When 
producing cattle for specific programs such as “raised without antibiotics” or “raised 
without the use of hormones”, it is important to ensure premiums can be captured to 
offset losses (40 kg on avg) in FCBW and HCW performance. In the current study, the 
premium ($275 per animal) for NA or beef “raised without antibiotics” substantially 
improved net return. Though, without this premium, or with reductions in the premium, 
implanting alone may provide a greater net return. However, IMBA had the lowest net 
return (including and excluding the cost of the calf) given the lack of greater 
improvements in BW gain and HCW (Table 2.7).  
Adjusted Economics of Carcass Performance 
 To determine if treatment within the geographic central region of the US influenced 
carcass value, adjustments for morbidity and treatment expenses were analyzed according to 
USDA-APHIS (2011). Similar to the actual analysis, treatment influenced (P = 0.002) total 
carcass value (Table 2.7). The NA and IMPL treatements ($1,818.43 ± 31.207 and 
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$1,826.36 ± 30.663, respectively) were similar (P > 0.05) and higher value than NHTC and 
IMBA ($1,711.10 ± 31.183 and $1,689.54 ± 31.178, respectively), which were similar (P > 
0.05). In the actual evaluation of NA, no morbidity was assumed (Table 2.6). The 
adjustment for morbidity in the central region caused a decline ($70.95) in per hd carcass 
value due to cattle not qualifying for the branded beef premium (that did not permit 
antibiotic usage). However, the statistical significance between the actual and adjusted 
analyses is consistent, suggesting NA and IMPL have the greatest carcass value ($1,840.13 
on avg) in comparison to NHTC and IMBA. 
Adjusted Total Production Cost 
To determine if treatment within the geographical central region of the US 
influenced total production cost, adjustments for morbidity and treatment expenses were 
analyzed according to USDA-APHIS (2011; Table 2.7). Analyses of input expenses and 
fiscal return from the carcasses were calculated (Table 2.4). These evaluations were 
conducted to emulate the purchase of a weaned calf by a backgrounding operation, therefore 
the cost of the weaned calf was included in the calculation. Similar to the actual analysis, 
treatment tended to influence (P = 0.09) total production cost. The NA treatment ($1,611.87 
± 28.972) had lower (P < 0.05) total production cost compared with IMBA ($1,714.38 ± 
28.944), while NHTC and IMPL ($1,678.84 ± 28.949 and $1,652.03 ± 28.972, 
respectively), were similar to all treatments (P > 0.05). 
To emulate retained ownership from the cow-calf segment onward, the cost of the 
weaned calf was also excluded. Each treatment influenced (P < 0.0001) total production cost 
in the descending order: IMBA ($510.81 ± 0); NHTC ($500.98 ± 0.00); NA ($443.80 ± 
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0.00); and IMPL ($441.29 ± 0.00). Overall, the total production cost for the adjusted 
analysis ($474.22) was higher ($4.88) per hd in comparison with the actual ($469.34) 
analysis. When including the cost of the calf, results between the actual and adjusted 
analyses for total production cost were statistically consistent. In the adjusted analysis, cow-
calf operations excluding the cost of the calf, caused NA to have an increased ($2.51) total 
production cost in comparison with IMPL. As expected, the adjustment for morbidity in NA 
increased the total production cost more than the actual analysis. 
Adjusted Cost of Gain 
As expected, in the adjusted analysis when including the cost of the calf at weaning, 
treatment influenced (P < 0.0001) COG. Cattle in the IMPL and IMBA treatments ($4.76 ± 
0.098 and $4.89 ± 0.100, respectively) were similar (P > 0.05) and more (P < 0.05) cost 
efficient in gain compared with NA and NHTC ($5.59 ± 0.010 and $5.57 ± 0.010, 
respectively), which were similar (P > 0.05). This result for COG including the calf cost is 
consistent with the actual analysis. Upon excluding the cost of the calf, each treatment 
influenced (P < 0.0001) COG in the descending order: NHTC ($1.67 ± 0.28); NA ($1.55 ± 
0.28); IMBA ($1.46 ± 0.028) and IMPL ($1.27 ± 0.028). In comparison to the actual 
analysis, the adjustment for morbidity and treatment expense caused NA to have a greater (P 
< 0.05, $0.09 per kg) COG in comparison with IMBA. This response is due to the 
adjustment for morbidity in NA and the loss in FCBW gain in comparison to IMBA.  
Adjusted Net Return 
Including the cost of the weaned calf in the adjusted analysis, treatment influenced 
(P < 0.0001) net return. The NA and IMPL treatments ($206.56 ± 17.580 and $174.34 ± 
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17.273, respectively) were similar (P > 0.05) and returned more (P < 0.05) profit than 
NHTC ($32.26 ± 17.566), which was intermediate (P < 0.05), while IMBA (-$24.84 ± 
17.563) was the least (P < 0.05) profitable (Table 2.7). In comparison to the actual analysis 
while including the calf cost, the adjustments for morbidity and treatment expense caused 
NA and IMPL to be similar (P > 0.05) in net return. Whereas in the actual analysis, NA was 
the most ($282.38) profitable treatment. Including the cost of the calf in the adjusted 
analysis, the net return is influenced by treatment, which is likely (P < 0.05) to cause 
variations (± $231.40) in revenue. Emulating retained ownership and excluding the cost of 
the calf in the adjusted analysis caused the net return to be consistent with the actual 
analysis. Treatment influenced (P < 0.0001) net return where NA and IMPL ($1,374.63 ± 
31.207 and $1,385.07 ± 30.663, respectively) were similar (P > 0.05) and more profitable 
than NHTC and IMBA ($1,210.10 ± 31.183 and $1,178.74 ± 31.178, respectively), which 
were similar (P > 0.05; Table 2.7). Upon retaining ownership from the cow-calf segment 
onward in the adjusted analysis, treatment (P < 0.0001) influenced variations (± $206.33) in 
revenue. Although there can be premiums associated with branded beef programs not 
allowing use of antibiotics, there are tradeoffs due to the potential of increased animal 
morbidity in addition to a loss of efficiency in BW gain and the risk of not fulfilling 
program specifications (Sartwelle et al., 2014). 
Environmental Impact of Production Systems 
Greenhouse Gas Emissions 
To encompass the beef supply chain, Rotz et al. (2015) evaluated C footprint 
emissions on a HCW basis among 28 production systems within KS, OK, and TX. The 
   
 
 
 
115
greatest GHG emission factor was from urine and fecal deposition during the cow-calf 
segment (44%) in comparison with the feedyard (43%). In the current study, a LCA 
estimated the GHG emissions for each treatment in the descending order: NA, 18.1 CO2e 
per kg HCW; NHTC, 17.9 CO2e per kg HCW; IMBA, 17.0 CO2e per kg HCW; and 
IMPL, 16.7 CO2e per kg HCW (Table 2.12). For beef production, the baseline GHG 
emission for a LCA was estimated to range between 13.8 – 25.8 kg CO2e per kg HCW 
among the regions of KS, OK, and, TX (Rotz et al., 2015). The GHG emission estimates 
within this study comply within Rotz et al. (2015) baseline estimates. Upon evaluating 
the efficiency of growth promotant technology utilization, NHTC, IMPL, and IMBA 
were predicted to reduce GHG emissions by 1.2%, 7.8%, and 6.4%, respectively in 
comparison with NA (Figure 2.1.). An analysis also utilizing the IFSM to simulate the 
environmental impacts of raising Angus cattle in California was conducted by 
Stackhouse et al. (2012a). In some similarity, use of an implant in the stocker segment, an 
ionophore, tylosin, and a re-implantation of estrogen and trenbolone acetate without and 
with ZH in the feedyard segment, decreased C footprint (by 4% and 9%, respectively) in 
comparison with a natural production system not utilizing growth promotant technology 
(Stackhouse et al., 2012a). In the current study, the use of implants in the cow-calf (36 
mg zeranol), backgrounding, (80 mg trenbolone acetate and 16 mg estradiol) and 
feedyard (200 mg trenbolone acetate and 20 mg estradiol, respectively) segments caused 
a greater reduction (7.8%) in C footprint in comparison to NA. However, 
supplementation of RH (200 steerhd-1 d-1) in addition to all growth promotant 
technologies used in the current study was 2.6% less effective in reducing GHG 
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emissions than the influence of ZH supplementation in Stackhouse et al. (2012a). In this 
study, C footprint was decreased by 1.2%, 7.8%, and 6.5% among NHTC, IMPL, and 
IMBA, respectively. The environmental impact from GHG emission is greater from 
losses in BW performance and the longer time on feed required to obtain the same 
compositional endpoint (1.5 cm). This study shows that the greatest improvement in 
reducing environmental impacts of GHG emissions is from IMPL in comparison to all 
other treatments. Use of monensin, tylosin, and successive implantation in the cow-calf, 
backgrounding, and finishing segments reduced GHG emissions most effectively.  
Energy Use 
An analysis conducted at the US Meat Animal Research Center (MARC) in Clay 
Center, NE estimated energy use for cattle production in 1970 in comparison with 2011 
and determined a slight reduction (0.17 MJ per kg BW or 5%) using current production 
systems (Rotz et al., 2013). However, energy usage is still relatively similar to 1970 
because there is less land available for increased corn production needs, which require 
fertilizer and greater combustion of fossil fuels from gasoline powered engines and 
potentially, increased irrigation (dependent upon the climate; Rotz et al., 2013). Rotz et 
al. (2013) encouraged new technology intervention to improve sustainability of cattle 
production. In the current study, a LCA estimated the energy used for each treatment in 
the descending order: NA, 43.3 MJ per kg HCW; NHTC, 43.1 MJ per kg HCW; IMBA, 
41.8 MJ per kg HCW; and IMPL 41.0 MJ per kg HCW. These ranges in energy 
utilization per HCW are within the LCA baseline (26 – 83 MJ per kg HCW) among the 
regions of KS, OK, and TX (Rotz et al., 2015). The NHTC, IMPL, and IMBA were 
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predicted to reduce energy use for beef production by 0.1%, 5.5%, and 3.4%, respectively 
(Figure 2.1.). Although there was a (3.4%) reduction in energy use from IMBA, the 
IMPL was 2% more efficient in comparison. The predominante factor for production 
efficiency is producing heavier HCW among the LCA. Although it is recommended to 
sell cattle fed β-AA by HCW (Maxwell, 2014) research has discovered no improvement in 
HCW from RH (200 – 308 mghd-1 d-1) supplementation (Quinn et al., 2008; Garmyn et 
al. 2014). Rotz et al. (2015) estimated total fossil energy inputs were 52 MJ per kg HCW 
and of that, 50% occurred during the cow-calf segment, whereas 26% occurred in the 
feedyard. Use of growth promoting implants during the cow-calf, backgrounding, and 
feedyard segments with supplementation of monensin and tylosin, (IMPL) provide 
greater reductions (5.5%) in energy utilization in comparison to no growth promotant 
technology use (NA). 
Water Use 
From the MARC analysis comparing beef production in 1970 to 2011, the current 
water footprint has declined by 5% due to improved corn yield and water use efficiency 
(Rotz et al., 2013). The annual water footprint determined by MARC excluding 
precipitation was 2,789 ± 914 L per kg BW and with precipitation the water footprint was 
greater (21,340 ± 5,600 L per kg BW; Rotz et al., 2013). Non-precipitated water use in 
beef production includes fresh water for irrigation to produce feed (Rotz et al., 2015) and 
drinking water for cattle, which is estimated to be less than 1% of total water use (Rotz et 
al., 2013). In the current study, a LCA estimated the use for each treatment in the 
descending order: NA, 2,997 L H2O per kg HCW; NHTC, 2,966 L H2O per kg HCW; 
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IMBA, 2,866 L H2O per kg HCW; and IMPL, 2,824 L H2O per kg HCW. Non-
precipitated water use within the regions of KS, OK, and TX, were estimated by the LCA 
excluding Holstein cattle, but included cull beef cows, and ranged between 976 – 7,630 L 
per kg HCW. Within the same study, the mean water footprint was estimated to be 2,180 
L per kg HCW and 57% of this use was estimated to be from the feedyard segment (Rotz 
et al., 2015). On average among all treatments, the current study utilized a greater volume 
of water (2,913 L per kg HCW) in comparison to Rotz et al. (2015) (2,180 L per kg 
HCW) most likely due to differences in the feeding duration and feed production. In the 
current study, steers were fed in the feedyard between 5 - 6 months vs. 4 – 5 months 
among the largest feedyard operations in Rotz et al. (2015). Additionally, Rotz et al. 
(2015) estimated larger (10,000 - 180,000 hd) feedyard operations that also had crop land 
for corn and grain silage production. The current study did not produce feed and relied 
upon irrigated purchased feedstuffs that required considerable amounts of water to 
produce (Rotz et al., 2015). However, use of growth promoting technologies among 
NHTC, IMPL, and IMBA reduced water use per unit of beef produced by 1.0%, 5.8%, 
and 4.4%, respectively in comparison to NA (Figure 2.1.). Studies evaluating water use 
have ranged in units reported (i.e. grey, blue, and green water footprint, or boneless beef 
per kg per animal) and the type of water used (i.e. precipitated versus non-precipitated) 
within the calculations, making comparisons difficult (Becket and Oltjen, 1993; Gerbens-
Leenes et al., 2013; Rotz et al., 2013). Although precipitated water is important for feed 
production, it varies with region and may or may not be used for the cattle thus, leaving it 
out of the model is justifiable for improved comparisons (Rotz et al., 2013). More 
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research investigating the influence of growth promotant technology on HCW 
performance to improve water use efficiency of pre-chain inputs is needed.  
Reactive N Loss 
Improving protein sparing is important to reduce the concentration of urine urea 
nitrogen (UUN) that can be volatilized as ammonia (NH3). The MARC study determined 
the reactive N loss for beef production was 91.7 ± 18.4 g N per kg BW and a majority 
(61%) of the footprint was from cattle grazing pastures during the cow-calf segment. In 
this analysis, NH3 contributed the greatest (81%) to the footprint, whereas nitrate (NO3) 
leaching and nitrous oxide (NOx) contributed 6% and 9%, respectively (Rotz et al., 
2013). Beef production has decreased reactive N loss by 3% in 2011 in comparison to 
1970 due to improved grain yield and animal ADG from genetic selection (Rotz et al., 
2013). Previous research (Mersman, 1998) has shown use of growth promotant 
technologies such as β-AA increase N efficiency due to the physiologic responses 
causing greater muscle mass and protein synthesis. In the current study, the LCA 
estimated the reactive N loss for each production system in the descending order: NHTC, 
137 g N per kg HCW; NA, 136 g N per kg HCW; IMBA, 135 g N per kg HCW; and 
IMPL, 129 g N per kg HCW. These results are within the range (75 - 222 N per kg) of the 
LCA analysis conducted among the regions of KS, OK, and TX with a mean reactive N 
loss of 135 ± 11 g N per kg HCW. In the current study, production systems utilizing 
growth promoting technologies from NHTC, IMPL, and IMBA reduced reactive N loss 
by 0.9%, 5.5%, and 1.1%, respectively in comparison to NA (Figure 2.1.). In some 
similarity, Stackhouse et al. (2012b) determined use of an implant in the stocker segment, 
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an ionophore, tylosin, and re-implantation of estrogen and trenbolone acetate with 
supplementation of ZH in the feedyard segment decreased NH3 emissions by 14 g per kg 
HCW in comparison with a natural production system not utilizing growth promotant 
technology (90 versus 104 g per kg HCW, respectively). In the current study a 1 g per kg 
HCW reduction in reactive N loss was detected for IMBA in comparison to NA. The 
greatest reduction occurred for IMPL, which reduced reactive N emissions by 7 g per kg 
HCW in comparison to NA. The 13 g per kg HCW greater reduction of reactive N loss 
from ZH supplementation experienced by Stackhouse et al. (2012b) in comparison to RH 
supplementation in the current study is likely due to the availability and affinity of the b2- 
beta-andrenergic agonist receptors (AAR) within the skeletal tissue of bovine 
(Mersmann, 1998). Although RH is a β-AA, it is more effective on the b1-AAR (Garmyn 
and Miller, 2014), which are less abundant (1 - 4%) in bovine tissue (Johnson et al., 
2014). However, use of anabolic steroids (implants) have been known to cause N 
retention (Lone, 1997) and improve efficiency because of the effects of the GH 
increasing acidophils (Nichols et al., 2002) and affecting metabolic anabolism and 
catabolism causing protein accretion without any apparent effects on protein degradation 
(Hart and Johnson, 1986). Thus, implanting can be an effective N loss mitigation tool. 
Evaluation of implant protocols among the industry segments for continued improvement 
to mitigate reactive N loss and cause greater pre-chain efficiency per HCW should be 
evaluated especially as ZH is not commercially available (Comerford, 2017). The current 
study used successive implantation in the calf, backgrounding, and finishing segments 
while providing monensin and tylosin during finishing and effectively decreased reactive 
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N loss by 7 and 8 g N per kg HCW in compariston to no growth promotant technology 
and use of only monensin and tylosin in the finishing segment, respectively. 
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IMPLICATIONS 
 Steers receiving monensin, tylosin, and growth promoting implants with and 
without ractopamine HCl had greater BW, DMI, HCW, reduced COG and GHG 
emissions (6.5 – 7.8%), energy use (3.4 – 5.5%), water use (4.4 – 5.8%), and reactive N 
loss (1.1 - 5.5%) in comparison to steers not receiving any growth promotant technology. 
Carcass marbling scores were greater for steers raised with less technology (no implant or 
β-AA). The net return was greater for steers branded as receiving no antibiotics and steers 
receiving monensin and tylosin, and growth promoting implants when excluding the cost 
of the weaned calf. This conveys that there are production management options for 
producers to maximize profitability including use of growth promoting implants, though 
when combined with a low-dose of ractopamine HCl a greater cost of production may be 
encountered, potentially resulting in the lowest net return. Steers branded as not receiving 
antibiotics, monensin, tylosin, or growth promoting implants may yield a high net return, 
but do not appear to be as environmentally sustainable as treatments utilizing growth 
promotant technolgy. Use of growth promoting implants with monensin and tylosin 
resulted in heavier, low choice carcasses that had an improved net return and minimized 
the environmental impact. Therefore, it may not be efficacious for producers to supply a 
low-dose of ractopamine HCl, or limit the use of growth promoting implants in order to 
maximize profitability and environmental sustainability under production conditions 
similar to those described in the study. 
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Table 2.1. Composition of finishing diet (% of DM) fed to steers1 
Item Composition2 
Ingredient composition  
Dry-rolled corn 47.76 
  Wet corn gluten 40.02 
Prairie hay 7.21 
Liquid supplement3 5.02 
Nutrient composition  
NEm, Mcal/kg 2.04 
NEg, Mcal/kg 1.38 
CP 13.93 
1 During finishing steers received four concentrate-adaptation diets over 
a period of 65 d (January 6 - March 11) fed for 7, 7, 40, and 11 d, 
respectively. 
2 Steers only within the treatment receiving ractopamine HCl (200 
mghd-1 d-1) were supplemented.   
3 Supplement contained 58.25% ground corn, 29.57% limestone, 5.59% 
iodized salt, 4.65% ammonia chloride, 0.93% trace mineral mix, 0.25% 
thiamine, and 0.21% Vitamins A, D, and E. Diet was formulated to 
provide 300 mg monensin (Elanco Animal Health, Greenfield, IN) and 
90 mg Tylan (Elanco Animal Health) per steer daily. 
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Table 2.2. Least squares means for production system influence on body weight (BW)  
 Treatment
1  
Weight, kg3 NA NHTC IMPL IMBA P-Value2 
Pre-Weaning      
Birth Weight4 40 ± 0.91 40 ± 0.84 41 ± 0.86 40 ± 0.84 0.959 
June 29, 2015 119 ± 6.94 122 ± 6.31 122 ± 6.43 127 ± 6.31 0.862 
September 16, 2015 204 ± 6.01 207 ± 5.57 208 ± 5.68 211 ± 5.57 0.868 
October 26, 2015 243 ± 6.38 246 ± 5.92 249 ± 6.03 251 ± 5.92 0.766 
Backgrounding5      
November 9 and 10, 2015 249 ± 6.63 254 ± 6.14 257 ± 6.26 258 ± 6.14 0.789 
December 8, 2015 264 ± 6.87 267 ± 6.48 271 ± 6.49 271 ± 6.37 0.860 
Feedyard6      
January 4 and 5, 2016 281 ± 6.96 280 ± 6.45 292 ± 6.58 286 ± 6.45 0.591 
March 11, 2016 411 ± 9.37 404 ± 8.68 425 ± 8.85 430 ± 8.68 0.154 
GrowSafe7      
March 28 and 29, 2016 450a  ± 9.51 444a ± 8.81 477b ± 8.98 470b ± 8.81 0.032 
April 26, 2016 510a ± 10.14 505a ± 9.40 549b ± 9.58 549b ± 9.40 0.001 
June 6 or 27, 20168 540a ± 10.45 557a ± 9.88 610b ± 9.72 612b ± 9.877 < 0.0001 
a,b Least squares means within row with different superscripts differ (P < 0.05). 
1 Calves were stratified by birth date, birth weight, and dam age to 1 of 4 treatments: 1) no antibiotics (NA, receiving 
no technology); 2) non-hormone treated cattle (NHTC), fed Rumensin (300 mg hd-1 d-1) and Tylan (90 mg hd-1 d-1) 
during finishing; 3) implant (IMPL), administered a series of three implants including a low-potency calf implant (36 
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mg zeranol), a moderate-potency initial feedyard implant (80 mg trenbolone acetate and 16 mg estradiol), and a high 
potency finishing re-implant (200 mg trenbolone acetate and 20 mg estradiol) and fed Rumensin (300 mg hd-1 d-1) 
and Tylan (90 mg hd-1 d-1) during finishing, and 4) IMPL plus fed a beta-agonist (IMBA), 200 mg ractopamine 
hydrochloride hd-1 d-1 for the last 30 d prior to harvest. 
2 Probability of a difference among least squares means. 
3 Dam aged used as a covariate. 
4Average calf birth date was April 17, 2015. 
5 Upon beginning the backgrounding period, initial two-day weights were obtained to account for variations due to fill 
and averaged to assign calves to pens based upon 3 (light, medium, and heavy) weight blocks within treatment, steers 
were fed over a period of 56 d on a high roughage ration. 
6 Upon arrival to the feedyard, initial two-day weights were obtained to account for variations due to fill and steers 
were maintained within their original pen assignment until March 11 when they were acclimated to the GrowSafe 
system in 4 pens (one treatment per pen) while receiving 4 step-up diets over a period of 65 d. 
7After a 17 d acclimation period to the GrowSafe system a high concentrate finishing ration was fed over a period of 
71 or 90 d dependent upon treatment harvest date, initial two-day weights were obtained to account for variations due 
to fill and steers were allocated to be fed in 4 groups according to treatment protocol (Group 1 = NA, Group 2 = ½ 
NHTC and ½ IMPL, Group 3 = ½ NHTC and ½ IMPL, and Group 4 = IMBA) so that steers were rotated 
approximately every 2 weeks during finishing within 4 GrowSafe pens to inhibit any chance of pen effect. 
8Steers were harvested at targeted 1.5 cm of 12th rib-fat thickness, steers finished earlier (NA and IMPL) within 
treatment were harvested June 8, 2016 and the remaining steers (NHTC and IMBA) were harvested June 27, 2016, to 
minimize bruising prior to harvest, final calculated body weight (FCBW) were conducted based upon hot carcass 
weight and 63.5% dressing percentage. 
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Table 2.3. Main effect least square means for effect of production system on feedlot performance and carcass 
characteristics1 
 Treatment1 P-value2 
Item NA NHTC IMPL IMBA   
Feedlot Performance           
   ADG, kg 1.54a ± 0.049  1.45a ± 0.047  2.11c ± 0.046  1.79b ± 0.047 < 0.0001 
   DMI, kg 11.54b ± 0.237  10.81a ± 0.225  12.88c ± 0.221  12.58c ± 0.225 < 0.0001 
   G:F 0.13a ± 0.004 0.13a ± 0.004 0.16b ± 0.003 0.14a ± 0.004 < 0.0001 
Carcass Characteristics3          
  HCW, kg 343.10a ± 6.636   353.69a ± 6.272 387.38b ± 6.168 388.63b ± 6.271 < 0.0001 
  Adj. 12th rib backfat, cm 1.51 ± 0.082 1.33 ± 0.077 1.49 ± 0.076 1.50 ± 0.768 0.294 
  LM area, cm2 81.95a ± 1.499 83.91ab ± 1.417 92.16c ± 1.393 87.55b ± 1.416 < 0.0001 
  Adj. KPH, % 1.78a ± 0.049 2.19b ± 0.047 1.75a ± 0.046 1.85a ± 0.047 < 0.0001 
  Yield grade 2.83 ± 0.108 2.66 ± 0.102 2.67 ± 0.101 2.93 ± 0.102 0.194 
Carcass Maturity5 122.20a ± 1.661 132.45c ± 1.570 127.38b ± 1.544 142.94d ± 1.569 < 0.0001 
  Marbling score4 553.93b ± 18.140 561.61b ± 17.146 486.49a ± 16.861 503.67a ± 17.141 0.004 
USDA Yield Grade6,7      
   Yield grade 2, % 0.27 ± 0.091 0.44 ± 0.096 0.53 ± 0.095 0.27 ± 0.085 0.144 
   Yield grade 3, % 0.65 ± 0.096 0.52 ± 0.954 0.37 ± 0.090 0.59 ± 0.094 0.205 
   Yield grade 4, % 0.06 ± 0.047 0.03 ± 0.032 0.06 ± 0.043 0.12 ± 0.064 0.602 
 USDA Quality Grade6,8      
   All Choice, % 0.82 ± 0.077 0.83 ± 0.071 0.90 ± 0.055   0.97 ± 0.032  0.352 
Low Choice, % 0.15 ± 0.073 0.16 ± 0.070 0.36 ± 0.092 0.30 ± 0.089 0.239 
CAB, % 0.65 ± 0.096 0.66 ± 0.090 0.40 ± 0.092 0.62 ± 0.092 0.181 
Upper 2/3rds Choice   
and CAB, % 0.65 ± 0.096 0.66 ± 0.090 0.54 ± 0.094 0.66 ± 0.090 0.740 
    Prime, % 0.17 ± 0.076 0.17 ± 0.071 0.06 ± 0.044 0.03 ± 0.031 0.252 
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a,b,c,d Least squares means within row with different superscripts differ (P < 0.05). 
1 Calves were stratified by birth date, birth weight, and dam age to 1 of 4 treatments: 1) no antibiotics (NA, receiving 
no technology); 2) non-hormone treated cattle (NHTC), fed Rumensin (300 mg hd-1 d-1) and Tylan (90 mg hd-1 d-
1) during finishing; 3) implant (IMPL), administered a series of three implants including a low-potency calf implant 
(36 mg zeranol), a moderate-potency initial feedyard implant (80 mg trenbolone acetate and 16 mg estradiol), and a 
high potency finishing re-implant (200 mg trenbolone acetate and 20 mg estradiol) and fed Rumensin (300 mg hd-1 
d-1) and Tylan (90 mg hd-1 d-1) during finishing, and 4) IMPL plus fed the beta-agonist (IMBA), ractopamine 
hydrochloride (200 mg hd-1 d-1) for the last 30 d prior to harvest. 
2 Probability of a difference among least squares means. 
3All measurements were determined by trained SDSU personnel using USDA-AMS grading standards except for 
proportions of USDA Quality Grade and USDA Yield Grade which were assigned by USDA-AMS grading officials. 
4 Marbling score: 300 = Slight0; 400 = Small0; 500 = Modest0; 600 = Moderate0. 
5 Combined skeletal and lean maturity: 100 = A0; 200 = B0; 300 = C0. 
6 Assigned by USDA grader; only one carcass received a USDA Select Quality Grade, and one carcass received a 
USDA Yield Grade 1 and there were no carcasses assigned Yield Grade 5.  
7 GLIMMIX analysis failed to converge for USDA Yield Grade 1 (n = 1) or yield grade 5 (n = 0). 
8 GLIMMIX analysis failed to converge for USDA Select Quality Grade (n = 1).  
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Table 2.4. Expense inputs and information per head within each beef production 
system 
 Treatment1 
Expenses, $ NA NHTC IMPL IMBA 
Cost of Calf 2 1,167.00 1,178.00 1,122.00 1,203.00 
Backgrounding DOF3 71 71 71 71 
Backgrounding Feed Bill4 44.75 44.75 44.75 44.75 
Backgrounding Yardage5 24.50 24.50 24.50 24.50 
Feedyard DOF6 154 173 154 173 
Finishing Feed Bill4 266.57 310.18 257.93 310.18 
Finishing Yardage5 53.90 60.90 53.90 60.90 
Total Anabolic Steroids7 0.00 7.81 7.81 7.81 
Monensin and Tylosin8 0.00 6.57 7.94 12.58 
Ractopamine HCl9 0.00 0.00 0.00 6.01 
Cost of Morbidity10 0.00 5.00 4.24 8.35 
Cost of Morbidity, Adjusted11 10.60 10.60 10.98 10.60 
Third Party Auditing Fee 10.00 10.00 0.00 0.00 
All Transportation 33.48 33.48 33.48 33.48 
1 Mean cost per head within treatment: 1) no antibiotics (NA, receiving no technology); 
2) non-hormone treated cattle (NHTC), fed Rumensin (300 mg hd-1 d-1) and Tylan 
(90 mg hd-1 d-1) during finishing; 3) implant (IMPL), administered a series of three 
implants including a low-potency calf implant (36 mg zeranol), a moderate-potency 
initial feedyard implant (80 mg trenbolone acetate and 16 mg estradiol), and a high 
potency finishing re-implant (200 mg trenbolone acetate and 20 mg estradiol) and fed 
Rumensin (300 mg hd-1 d-1) and Tylan (90 mg hd-1 d-1) during finishing, and 4) 
IMPL plus fed the beta-agonist (IMBA) ractopamine hydrochloride (200 mg hd-1 d-1) 
for the last 30 d prior to harvest. Two separate harvest dates occured to obtain 1.35 cm 
12th rib fat thickness including June 7 (NA and IMPL) and June 28 (NHTC and IMBA) 
among treatments. 
2 Cost of 250 kg calves October 26, 2015 at the Faith Livestock Commission 
Company. 
3 High roughage ration provided for the same days on feed (DOF). 
4 Cost of the diet during backgrounding was calculated from these prices of individual 
ingredients: corn ($118 per kg), distillers grain ($75 per 91 kg), hay ($270 per 91 kg), 
limestone $270 per 91 kg), and minerals ($806 per 91 kg) and the feedyard diet cost 
was determined from the actual total bill from the feedyard. 
5 Rate based upon $0.35/hd/d. 
6 Days on feed (DOF) started upon arrival and includes acclimation and step-up rations 
thru finishing to account for all costs of feed delivered. 
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7 Includes cost of 36 mg zeranol (Ralgro; $1.36), 80 mg trenbolone acetate and 16 mg 
estradiol (Revalor IS; $2.66), and 200 mg trenbolone acetate and 20 mg estradiol 
(Revalor 200; $3.79). Cost for dewormer and vaccination were not included in the 
analysis. 
8 Per head costs were determined by amount fed divided by number of head per pen 
and adjusted for days on feed (DOF). 
9 Beta-agonist mixed inclusion cost was $247.60 per 907 kg of total mixed ration fed, 
per head costs were determined by amount fed divided by number of head per pen and 
adjusted for days on feed (DOF). 
10 Actual cost of therapeutic antibiotic use for ailments including respiratory disease, 
pneumonia, and digestive issues. 
11 To account for national morbidity rate and cost of treatment, USDA-APHI (2000) 
was referenced for feedyards with greater than 8,000 head in the Central region. All 
treatments received a total 25.8% morbidity rate and when applied, treatment expenses 
including respiratory disease (17.90%) cost of $23.10 per hd treated, pneumonia 
(2.9%) cost of $21.80 per hd treated, and digestive issue (5.0%) cost of $8.80 per hd 
treated were calculated. Given that NA is except from antibiotics, adjustments were 
made according to USDA-APHIS (2000) for the 25.8% morbidity rate and 
consequently in addition to treatment cost per head ($53.70), a deduction of $70.95 
was applied to each NA branded carcass premium to account for opportunity loss. 
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Table 2.5. Plant assigned premiums and discounts for each beef production system 
 Treatment1 
Variable NA NHTC IMPL IMBA 
Base Carcass Value per 45 kg2 206.31 188.24 206.31 187.74 
Branded Beef Premium, per carcass3 275.00 175.00 0.00 0.00 
Total Branded Beef Premium, Adjusted     
Total Yield Grade Premiums 0.00 71.50 146.72 0.00 
Total Yield Grade Discounts 0.00 123.00 0.00 0.00 
Total Quality Grade Premiums 480.53 575.65 863.25 1,414.91 
Total Quality Grade Discounts 0.00 0.00 0.00 0.00 
1 Mean cost per head within treatment: 1) no antibiotics (NA, receiving no technology); 2) 
non-hormone treated cattle (NHTC), fed Rumensin (300 mg hd-1 d-1) and Tylan (90 mg 
hd-1 d-1) during finishing; 3) implant (IMPL), administered a series of three implants 
including a low-potency calf implant (36 mg zeranol), a moderate-potency initial feedyard 
implant (80 mg trenbolone acetate and 16 mg estradiol), and a high potency finishing re-
implant (200 mg trenbolone acetate and 20 mg estradiol) and fed Rumensin (300 mg hd-1 d-
1) and Tylan (90 mg hd-1 d-1) during finishing, and 4) IMPL plus fed the beta-agonist 
(IMBA) ractopamine hydrochloride (200 mg hd-1 d-1) for the last 30 d prior to harvest. Two 
separate harvest dates occured to obtain 1.35 cm 12th rib fat thickness including June 7 (NA 
and IMPL) and June 28 (NHTC and IMBA) among treatments. 
2 Dependent upon volatile market price of harvest date. 
3 Rate based upon $0.35/hd/d. 
4 Includes cost of 36 mg zeranol (Ralgro; $1.36), 80 mg trenbolone acetate and 16 mg 
estradiol (Revalor IS; $2.66), and 200 mg trenbolone acetate and 20 mg estradiol (Revalor 
200; $3.79). 
5 Adjusted for d on feed and amount fed. 
6 To account for morbidity rate among NA, adjustments were made based upon NAHMS 
(USDA-APHIS, 2000) for 25.8% morbidity and apply a deduction ($70.95) to each branded 
carcass premium. 
 
 
 
 
 
 
 
   
 
 
 
138 
Table 2.6. Profitability of technology use and branded programs including actual morbidity and associated expenses 
 Treatment 2     
Variable, $1 NA NHTC IMPL IMBA SEM3 P-Value4 
Total Carcass Value 1,889.38b 1,711.10a 1,826.36b 1,689.54a 31.060 < 0.0001 
Total Production Cost, Including Calf Cost5 1,607.00a 1,673.21ab 1,645.25ab 1,712.13b 29.400 0.085 
Total Production Cost, Excluding Calf Cost 438.93a 495.35b 434.52a 508.56c 3.544 < 0.0001 
Cost of Gain, kg Including Calf Cost5 5.58b 5.55b 4.74a 4.88a 0.104 < 0.0001 
Cost of Gain, kg Excluding Calf Cost 1.54b 1.65c 1.25a 1.45b 0.033 < 0.0001 
Net Return, Including Calf Cost5 282.38d 37.89b 181.11c (22.59)a 18.750 < 0.0001 
Net Return, Excluding Calf Cost 1,450.45b 1,215.75a 1,391.84b 1,180.99a 31.450 < 0.0001 
a,b,c,d Least squares means within row with different superscripts differ (P < 0.05) and tendencies were considered when P > 0.5 to P 
< 0.01. 
1Age of the dam was used as a covariate for all variables. 
2 Mean cost per head within treatment: 1) no antibiotics (NA, receiving no technology); 2) non-hormone treated cattle (NHTC), fed 
Rumensin (300 mg hd-1 d-1) and Tylan (90 mg hd-1 d-1) during finishing; 3) implant (IMPL), administered a series of three 
implants including a low-potency calf implant (36 mg zeranol), a moderate-potency initial feedyard implant (80 mg trenbolone 
acetate and 16 mg estradiol), and a high potency finishing re-implant (200 mg trenbolone acetate and 20 mg estradiol) and fed 
Rumensin (300 mg hd-1 d-1) and Tylan (90 mg hd-1 d-1) during finishing, and 4) IMPL plus fed the beta-agonist (IMBA) 
ractopamine hydrochloride (200 mg hd-1 d-1) for the last 30 d prior to harvest. Two separate harvest dates occured to obtain 1.35 
cm 12th rib fat thickness including June 7 (NA and IMPL) and June 28 (NHTC and IMBA) among treatments. 
3Standard error of the mean. 
4 Probability of a difference among least squares means. 
5Cost of 249.5 kg calves October 26, 2015 at the Faith Livestock Commission Company. 
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Table 2.7. Profitability of technology use and branded programs after National Animal Health Monitoring System 
(NAHMS; USDA-APHIS, 2011) adjustments for morbidity and associated expenses were applied1   
 Treatment 
3     
Variable, $ 2 NA NHTC IMPL IMBA SEM4 P-Value5 
Total Carcass Value 1,818.43b 1,711.10a 1,826.36b 1,689.54a 31.060 0.002 
Total Production Cost, Including Calf Cost6 1,611.87a 1,678.84ab 1,652.03ab 1,714.38b 28.833 0.088 
Total Production Cost, Excluding Calf Cost 443.80b 500.98c 441.29a 510.81d 0.000 < 0.0001 
Cost of Gain, kg Including Calf Cost6 5.59b 5.57b 4.76a 4.89a 0.993 < 0.0001 
Cost of Gain, kg Excluding Calf Cost 1.55c 1.67d 1.27a 1.46b 0.028 < 0.0001 
Net Return, Including Calf Cost6 206.56c 32.26b 174.34c (24.84)a 17.500 < 0.0001 
Net Return, Excluding Calf Cost 1,374.63b 1,210.12a 1,385.07b 1,178.74a 31.060 < 0.0001 
a,b,c,d Least squares means within row with different superscripts differ (P < 0.05) and tendencies were considered when P > 
0.5 to P < 0.01. 
1To account for national morbidity rate and cost of treatment, USDA-APHIS (2000) was referenced for feedyards with 
greater than 8,000 head in the Central region. All treatments received a total 25.8% morbidity rate and when applied, 
treatment expenses including respiratory disease (17.90%) cost of $23.10 per hd treated, pneumonia (2.9%) cost of $21.80 
per hd treated, and digestive issue (5.0%) cost of $8.80 per hd treated were calculated. Given that NA is except from 
antibiotics, adjustments were made according to USDA-APHIS (2000) for the 25.8% morbidity rate and consequently in 
addition to treatment cost per head ($53.70), a deduction of $70.95 was applied to each NA branded carcass premium to 
account for opportunity loss. 
2Age of the dam was used as a covariate for all variables. 
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3 Mean cost per head within treatment: 1) no antibiotics (NA, receiving no technology); 2) non-hormone treated cattle 
(NHTC), fed Rumensin (300 mg hd-1 d-1) and Tylan (90 mg hd-1 d-1) during finishing; 3) implant (IMPL), administered a 
series of three implants including a low-potency calf implant (36 mg zeranol), a moderate-potency initial feedyard implant 
(80 mg trenbolone acetate and 16 mg estradiol), and a high potency finishing re-implant (200 mg trenbolone acetate and 20 
mg estradiol) and fed Rumensin (300 mg hd-1 d-1) and Tylan (90 mg hd-1 d-1) during finishing, and 4) IMPL plus fed the 
beta-agonist (IMBA) ractopamine hydrochloride (200 mg hd-1 d-1) for the last 30 d prior to harvest. Two separate harvest 
dates occured to obtain 1.35 cm 12th rib fat thickness including June 7 (NA and IMPL) and June 28 (NHTC and IMBA) 
among treatments. 
4 Standard error of the mean. 
5 Probability of a difference among least squares means. 
6 Cost of 249.5 kg calves October 26, 2015 at the Faith Livestock Commission Company. 
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Table 2.8. Soil characteristics used for locations throughout each production 
segment1 
   Soil Texture1, % 
Segment Soil Type Clay Silt Sand 
Cow-Calf Medium Sandy Loam 15 25 60 
Backgrounding Shallow Clay Loam 34 33 33 
Finishing Medium Sandy Loam 15 25 60 
1 Soil texture based on typical soils found in each area as defined by USDA 
official soil series description (NRCS, 2015). 
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Table 2.9. Emission factors used in the life cycle assessment to represent the pre-chain emission 
occurring during the production of resources used in producing beef cattle within all industry segments 
and production systems generated from the Integrated Farm Systems Model1. 
Emission Source 
Greenhouse Gas 
Emissions, kg 
CO2e2, kg Energy Use, MJ 
Non-precipitated 
Water Use, L/kg3 N Loss, g N/kg4 
Purchased Feed5     
Corn 0.30 2.92 0.28 4.10 
Forage 0.15 2.01 0.30 0.20 
Protein Cubes6 1.00 4.00 0.18 2.00 
Crude Protein 0.34 3.99 0.13 1.84 
Non-Degradable Protein 0.41 4.40 0.18 2.60 
Minerals 1.52 12.23 0.05 1.00 
Energy Sources7     
Fuel 0.522/L 4.01/L - - 
Natural Gas 0.668/m3 2.46/m3 - - 
Electricity 0.629/kWh 5.00/kWh - - 
1 Derived through simulations among different production systems with the Integrated Farm System 
Model (IFSM; Rotz et al., 2016). 
2 CO2e = CO2 equivalent units. 
3 Non-precipitated water use primarily includes water to irrigate feed crops and drinking water. 
4 Includes all forms of reactive N loss, including ammonia, nitrate leaching and runoff, nitrous oxide 
and NOx from denitrification and combustion of fossil fuels (Rotz et al. 2016). 
5 Accounts for emissions and resource utilization per kg of DM fed. Utilized the US Meat Animal 
Research Center pre-chain emissions as a base for all beef production segments and systems (Rotz et al., 
2013), incorporated actual diet information from cow-calf, backgrounding, finishing, and simulated 
each segment according to the Cornell Net Carbohydrate and Protein System, level 1 (Fox et al., 2004). 
6 Accounts for cows supplemented with protein cubes during only the cow-calf segment. 
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7 Utilized the US Meat Animal Research Center pre-chain emissions as a base for all beef production 
segments and systems (Rotz et al., 2013). 
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Table 2.10. Feedyard initial and final shrunk body weights used per production system 
wt, kg Animals Simulated Treatments1 
Feedyard2 5,000 NA NHTC IMPL IMBA 
Initial wt3  269.96 269.16 280.14 274.84 
Final wt4  518.65 534.64 585.64 587.46 
1 1) no antibiotics (NA, receiving no technology); 2) non-hormone treated cattle (NHTC), fed 
monensin (300 mg hd-1 d-1) and tylosin (90 mg hd-1 d-1) during finishing; 3) implant (IMPL), 
administered a series of three implants including a low-potency calf implant (36 mg zeranol), a 
moderate-potency initial feedyard implant (80 mg trenbolone acetate and 16 mg estradiol), and a 
high potency finishing re-implant (200 mg trenbolone acetate and 20 mg estradiol) and fed 
Rumensin (300 mg hd-1 d-1) and Tylan (90 mg hd-1 d-1) during finishing, and 4) implant plus fed 
the beta-agonist (IMBA) ractopamine hydrochloride (200 mg hd-1 d-1) for the last 30 d prior to 
harvest. Two separate harvest dates (June 7 (NA and IMPL) and June 28 (NHTC and IMBA)) 
occurred to obtain 1.35 cm of 12th rib fat thickness among treatments.  
2 All weights were shrunk 4% to account for fill. 
3 The initial wt. was obtained from the average weight collected from each treatment between 
January 4 and 5 prior to arriving to the feedyard on January 5. 
4 To minimize bruising prior to harvest, a final calculated body weight (FCBW) was calculated 
based upon hot carcass weight and a 63.5% dressing percentage. 
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Table 2.11. Summary of 25 yr. of weather data (daily solar radiation, daily mean 
temperature, annual precipitation, and daily wind speed) used to simulate each segment of 
each production system1 
 Solar, MJ/m2 Temperature, °C      Precipitation, mm Wind, m/s 
Segment Mean SD Mean SD Mean SD Mean SD 
Cow-Calf 12.3 1.83 6.0 1.07 402 97.84 5.62 0.36 
Backgrounding 14.8 0.44 8.7 0.98 418.1 121.30 4.89 0.21 
Finishing 15.5 0.92 48.9 1.31 20.6 5.04 10.05 0.29 
1 Obtained from the Integrated Surface Database of the National Climatic Data Center, 
National Oceanic and Atmospheric Administration (NOAA, 2014). These meteorological 
data sets were processed using AERMET, a meteorological processor (USEPA, 2004). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
146 
Table 2.12. Greenhouse gas emissions and natural resource use for beef production systems utilizing different levels of 
growth promotant technology expressed per unit of final hot carcass weight (HCW) 
 Treatment1 
Production Component Unit NA NHTC IMPL IMBA 
Greenhouse Gas Emissions kg CO2e2/kg HCW 18.1 17.9 16.7 17.0 
Energy Use MJ/kg HCW 43.3 43.1 41.0 41.8 
Non-precipitated Water Use3 L/kg HCW 2,997 2,966 2,824 2,866 
Reactive N Loss4 g N/kg HCW 136.0 137.0 129.0 135.0 
1 1) no antibiotics (NA, receiving no technology); 2) non-hormone treated cattle (NHTC), fed monensin (300 mg hd-1 d-1) 
and tylosin (90 mg hd-1 d-1) during finishing; 3) implant (IMPL), administered a series of three implants including a low-
potency calf implant (36 mg zeranol), a moderate-potency initial feedyard implant (80 mg trenbolone acetate and 16 mg 
estradiol), and a high potency finishing re-implant (200 mg trenbolone acetate and 20 mg estradiol) and fed Rumensin (300 
mg hd-1 d-1) and Tylan (90 mg hd-1 d-1) during finishing, and 4) implant plus fed the beta-agonist (IMBA) ractopamine 
hydrochloride (200 mg hd-1 d-1) for the last 30 d prior to harvest. Two separate harvest dates (June 7 (NA and IMPL) and 
June 28 (NHTC and IMBA)) occurred to obtain 1.35 cm of 12th rib fat thickness among treatments. 
2 CO2e = CO2 equivalents. 
3 Non-precipitated water use primarily includes water to irrigate feed crops and drinking water. 
4 Includes all forms of reactive N loss, including ammonia, nitrate leaching and runoff, nitrous oxide and NOx from 
denitrification and combustion of fossil fuels (Rotz et al. 2016). 
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Figure 2.1. Influence of beef production system on measures of sustainability by USDA Integrated Farm System Model. 
Environmental outputs of steers provided Rumensin and Tylan (NHTC), steers administer a series of three implants, Rumensin, and 
Tylan (IMPL), and steers provided a beta-agonist, three implants, monensin, and tylosin (IMBA) were expressed relative to steers 
receiving no technology (NA), which served as the control1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1Environmental outputs were calculated as indicated per kg of hot carcass weight (HCW). Furthermore, CO2e = CO2 equivalent units, 
non-precipitated water use primarily includes water to irrigate feed crops and drinking water, and N loss includes all forms of reactive 
N loss, including ammonia, nitrate leaching and runoff, nitrous oxide and NOx from denitrification and combustion of fossil fuels 
(Rotz et al. 2016)
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CHAPTER III 
Influence of production systems on beef quality attributes 
Megan J. Webb 
Department of Animal Science 
South Dakota State University, 57007 
ABSTRACT 
 The objective of this study was to compare the influence of different beef 
production systems on end product quality. Angus ´ Simmental crossbred steer calves (n 
= 120) were stratified by birth date, birth weight, dam age, and assigned randomly to 1 of 
4 treatments: 1) no antibiotics (NA, receiving no technology); 2) non-hormone treated 
cattle (NHTC, fed monensin and tylosin); 3) implant (IMPL, administered a series of 
three implants, and 4) implant plus fed a beta-agonist (IMBA, IMPL treatment plus, fed 
ractopamine-HCl for the last 30 d prior to harvest). Muscle biopsy samples from the 
longissimus dorsi (LD) were extracted from a subset (n = 16) of steers to determine the 
influence of pre-harvest management on gene expression of µ-calpain, m-calpain, and 
calpastatin using real-time rt-PCR. Following carcass chilling (approximately 24 hr), 
marbling score, skeletal maturity, and objective color (L*, a*, and b*) were evaluated. 
The right strip loin of each carcass was removed and portioned into 2.54 cm steaks and 
designated to 7, 14, or, 21 d postmortem aging periods for analysis of cook loss and 
Warner-Bratzler shear force (WBSF). The anterior face of each sample was used for 
analysis of ether extractable fat and moisture. Expression of calpastatin was increased (P < 
0.05) in NHTC and IMBA treatments and there was a tendency for expression of m-calpain 
to be increased (P < 0.01) in NHTC compared to NA. Treatment influenced (P < 0.01) 
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marbling score, NA and NHTC were similar (P > 0.05) and had greater (P < 0.05) marbling 
compared to IMPL and IMBA, which were similar (P > 0.05). Skeletal maturity was greater 
(P < 0.01) for IMBA compared with all other treatments. Treatment influenced (P < 0.05) 
objective L*, a*, and b* color. The NA and IMPL treatments had increased (P < 0.01) L* 
values, NHTC was intermediate, and IMBA had the lowest (P < 0.01) L* values. The NA 
and IMPL treatments had increased (P < 0.01) a* values compared with NHTC and IMBA. 
The NA and IMPL treatments had increased (P < 0.01) b* values, NHTC was intermediate, 
and IMBA had the lowest (P < 0.01) b* values. Cattle in the NA and NHTC treatments 
produced steaks with an increased (P < 0.01) percentage of crude fat compared with the 
IMPL and IMBA treatments, which were similar (P > 0.05). Percent moisture of NA steaks 
were lower (P < 0.01) than all other treatments. No differences (P > 0.05) were detected for 
percent cook loss however, steaks from NA and NHTC treatments were more (P < 0.05) 
tender than IMPL and IMBA, which were similar (P > 0.05). Collectively, these results 
suggest that production systems with limited use of growth promoting technology produce 
carcasses with improved marbling score, and tenderness. However, the difference in 
tenderness is not explained by changes in expression of genes involved in the calpain 
system. 
 
 
 
 
 
 
  
 
 
150 
INTRODUCTION 
Demand for food production is increasing as the world population continues to 
grow (AgMRC, 2012). Use of growth promotant technologies such as feed-grade 
antimicrobials, antibiotics, implants, and beta-andrenergic agonists could be key to meet 
this demand through improved animal performance (Preston, 1999; Duckett and Andrae, 
2001; Jones et al., 2012). Use of ractomamine-HCl (RH) has been shown to improve 
ADG and feed efficiency of cattle (Avendano-Reyes et al., 2006; Walker et al., 2006), 
while implants increase protein deposition by enhancing both the rate and efficiency of 
muscle growth (Dayton and White, 2014). Therefore, these technologies could be key to 
efficiently provide more protein for the growing world demand. However, reports 
investigating the influence of these technologies on beef tenderness are mixed 
(Avendano-Reyes et al., 2006; Quinn et al., 2008; Strydom et al., 2009). Some research 
indicates that repetitive use of implants during various segments of production may 
negatively impact meat quality and tenderness (Platter et al., 2003). Tenderness 
variability a critical issue facing the beef industry (Morgan et al., 1991; Koohmaraie and 
Geesink, 2006) and it is necessary to fully understand the impact of pre-harvest 
technologies on this palatability trait.  
It is well established that tenderness is regulated by three intrinsic mechanisms: 1) 
sarcomere length, 2) collagen content and solubility and 3) postmortem proteolysis/aging 
(Geesink et al., 2006). Given that sarcomere length of the longissimus muscle 
postmortem is primarily associated with fixed skeletal attachments, it is unlikely that 
changes in sarcomere length are responsible for variations in tenderness associated with 
growth promoting technologies and differences in collagen are unlikely in cattle of a 
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similar age and genetic background. Therefore, the hypothesis that the use of growth 
promoting technologies would influence gene expression and resultant enzymatic 
function of the calpain system, which would alter proteolysis was tested. The calpain 
system is comprised of two calcium dependent proteases (µ– and m-calpain) that degrade 
structural proteins and their specific inhibitor (calpastatin). The objective of this study 
was to compare the influence of different levels of growth promoting technology use on 
expression of genes encoding for the calpain system (µ-calpain, m-calpain, and 
calpastatin), meat quality, and steak tenderness. 
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MATERIALS AND METHODS 
Animals 
All animal care and experimental protocols were approved by the South Dakota 
State University (SDSU) Animal Care and Use Committee (approval number 15-091E). 
One hundred and twenty Angus ´ Simmental crossbred male calves born within a 45 d 
period at the SDSU Antelope Field Station herd near Buffalo, SD, were utilized for this 
study. Prior to weaning, calves were stratified by birth date, birth weight, and dam age 
and assigned randomly to 1 of 4 treatments: 1) no antibiotics (NA; receiving no 
technology); 2) non-hormone treated cattle (NHTC; fed 300 mg monensin  [Rumensin 
90, Elanco Animal Health, Greenfield, IN] and 90 mg tylosin [Tylan 40, Elanco Animal 
Health] during the finishing phase March 29 to harvest); 3) implant (IMPL; same 
technologies as NHTC and administered a series of three implants including a low-
potency calf implant [36 mg zeranol; Ralgro, Merck Animal Health, Madison, NJ] at an 
average of 74 ± 12 d of age on June 29, a moderate-potency initial feedyard implant [80 
mg trenbolone acetate and 16 mg estradiol; Revalor-IS, Merck Animal Health] at an 
average of 235 ± 12 d of age on December 8, and a high potency finishing re-implant 
[200 mg trenbolone acetate and 20 mg estradiol; Revalor-200, Merck Animal Health] at 
an average of 330 ± 12 d of age on March 11) and 4) implant plus fed a beta-agonist 
(IMBA; same technologies as IMPL and fed 200 mg RH steer-1 d-1 [Optaflexx 45; 
Elanco Animal Health] for the last 30 d prior to harvest). Beef Quality Assurance (BQA) 
protocols were used throughout the course of the study (BQA, 2010) and implants were 
administered subcutaneously in the middle third of the ear by a single technician. Implant 
needles were changed as needed to be effective and disinfected after each use with a 
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sponge soaked in 2% chlorhexidine solution. Steer calves were managed from pre-
weaning to finishing as described in Chapter II.  Composition of the finishing diet is 
presented in Table 3.1.  
Muscle Biopsies  
Biopsy samples (approximately 40 mg) were collected from the LD for analysis 
of gene expression using a subset (n = 16) of steers. Steers with a BW closest to the 
treatment mean BW on April 26 were designated for the subsample. Biopsies were 
conducted for NA and IMPL 6 d prior to harvest and NHTC and IMBA 5 d prior to 
harvest. Steers were restrained and prepared for incision of the right LD between the 12th 
and 13th rib junction, 3 cm lateral from the midline. A 12.7 cm2 area was shaved, 
scrubbed with povidone-iodine solution, and wiped with a 70% alcohol solution prior to 
the incision. A total of 5 mL of lidocaine was injected subcutaneously in a circle around 
the incision cite depositing approximately 1 mL per 5 injections. Three minutes was 
allowed for establishment of the local anesthesia and a 10 mm incision was made using a 
sterile disposable No. 11 scalpel. A BARD Magnum Reusable Core Biopsy Instrument 
(C.R. Brad, Inc., Tempe, AZ) with a disposable 12G × 10 cm needle was inserted into 
the incision cite to collect tissue samples and repeated (5 - 7 times per steer). Tissue 
samples were immediately snap frozen in liquid N before storage at -80°C. After 
collection, the injection cite was sprayed with Vetericyn (Vetericyn, Rialto, CA) and 
steers were closely monitored. 
 RNA Extraction, cDNA Conversion, and real-time RT-PCR 
Snap frozen samples were powdered in liquid N using a mortar and pestle and 
approximately 60 mg of sample were placed into 1.5 mL tubes containing 700µL of QIAzol 
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Lysis Reagent. Total RNA was extracted from samples using the miRNeasy Mini Kit 
(Catalog No. 217004 QIAGEN, Germany). Following the miRNeasy Mini Kit quick-start 
protocol, RNA was separated from genomic DNA. The concentration and purity of RNA 
was evaluated spectrophotometrically (Nanodrop 2000, Thermo Scientific, Wilmington, 
DE) and RNA concentration was diluted to 200 ng/µL. A high-capacity cDNA Reverse 
Transcription Kit (Part #4368814, Applied Biosystems, Foster City, CA) was used to 
convert RNA to cDNA using a thermal cycler (MyCycler Thermocycler #170-9703, Bio-
Rad Laboratories, Hercules, CA) at the parameters recommended by the manufacturer set at 
1 cycle at 25ºC for 10 min, 37°C for 12 min, and 85ºC for 5 min. 
The cDNA was diluted to 50% using RNA-free water, rt-PCR was performed to 
evaluate the expression of genes associated with the calpain system (µ-calpain, m-calpain, 
and calpastatin) within the LD muscle. The National Center for Biotechnology 
Information (NCBI; United States Library of Medicine, Bethesda, MD) database was 
utilized to identify messenger RNA sequences. GeneBank accession numbers were then 
used to design primers using PrimerQuest software (Integrated DNA Technologies, 
Coralville, IA). Accession numbers, forward primer sequences, and reverse primer 
sequences for each housekeeping gene (EEF1A2 and SF3A1) are presented in Table 3.2. 
The relative quantity of the cDNA of interest was determined using RT2 Real-Time™ 
SYBR Green/ROX PCR Master Mix (PA-012-24, SABiosciences, Frederick, MD) with 
appropriate forward and reverse primers (10 nM), and 1 µL diluted cDNA. Assays were 
performed using a Mx3005P thermal cycler (Agilent Technologies, Stratagene Product 
Division, Waldbronn, Germany) with parameters recommended by the manufacturer, 
which included Segment 1: 95°C for 10 min and Segment 2: 40 cycles of (95ºC, 30 s; 
  
 
 
155 
55ºC, 60 s; 72°C, 60 s). Reaction specificity was determined by melting curves for each 
amplicon after completion of amplification.  
Carcass Evaluation and Sample Collection 
 Steers were tracked individually through harvest at a commercial processing 
facility in Lexington, NE. Following carcass chilling (approximately 24 h), carcass 
measurements for marbling score and skeletal maturity were determined and recorded by 
trained university personnel. After chilling, carcasses were ribbed between the 12th and 
13th rib and the exposed LD was allowed to bloom for approximately 30 min prior to 
objective color (L*, a*, and b*) measurements. A Minolta colorimeter (model CR-310; 
Minolta Corp., Ramsey, MJ; 50 mm diameter measuring space and D65 illuminant) was 
used to obtain the measurements recorded from two locations of the left LD (medial and 
lateral) and averaged for each carcass. Both striploins were collected from each carcass 
and transported under refrigeration (2.2°C) to the SDSU Meat Laboratory in Brookings, 
SD. Striploins were trimmed to 0.64 cm of external fat, the connective tissue, gluteus 
medius, and multifidus dorsi were removed so that only the LD remained. The most 
anterior portion of both LD muscles was faced to obtain a square anterior edge and the 
remaining portion of the LD was fabricated into 2.54-cm steaks. The left anterior face of 
the LD was aged for 14 d postmortem and utilized to determine crude fat percentage. 
Consistently, the 3 most anterior steaks from the right striploin were assigned to 7, 14, or 
21 d postmortem aging periods and vacuum-sealed for analysis of percent cook loss and 
Warner-Bratzler shear force (WBSF). Vacuum-sealed samples were aged in the absence 
of light at 2-3°C and immediately after each specified aging period was attained steaks 
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were frozen (-20°C) and checked regularly for seal integrity until thawed for evaluation 
of percent moisture, ether extractable fat, percent cook loss, and tenderness.  
Moisture and Ether Extractable Fat Percentage 
 As described by Webb et al. (2017) steaks were thawed slightly and prepared for 
powdering using a Waring commercial blender (model 51BL32; Waring Laboratory 
Division, Lancaster, PA) once powdered, individual samples were stored in bags 
(Whirlpack; Nasco, Fort Atkinson, WI) and frozen (-20°C). For analysis, duplicated 
powdered samples (5 g) were weighed into tins, covered with filter papers, and dried in 
an oven at 101°C for 24 h. Once dried, samples were placed into desiccators for 1 h prior 
to recording the nonextracted weight for calculation of percent moisture. Samples were 
extracted according to the AOAC International (Horwitz, 2000; method 960.39) with the 
exception that the Soxhlet extractor (model 80068-154; Chemglass Life Sciences LLC, 
Vineland, NJ) was used with petroleum ether instead of a Goldfisch apparatus. Ether 
extraction was conducted for 60 h followed by evaporating samples at room temperature 
before placing the tins into the oven for 4 h at 101°C (Bruns et al., 2004). Dried, 
extracted samples were put into desiccators for 1 h prior to re-weighing. Crude fat was 
calculated by determining the difference among the pre- and post-extraction sample 
weight and was expressed as a percent of the pre-extracted sample weight.     
Percent Cook Loss and Warner-Bratzler Shear Force 
Steaks designated for WBSF determination were thawed for 24 h at 4°C. Prior to 
cooking, each raw steak was weighed in g then placed on an electric clam shell grill (George 
Forman 9 Serving Classic Plate Grill, Model GR2144P, Middleton, WI) and the target 
internal peak temperature was 71°C. During cooking the MicroNeedle probe of a AquaTuff 
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thermometer (Model 35140, Cooper-Atkins Corporation, Middlefield, CT) was placed into 
the geometric center of each steak to continuously monitor the temperature, steaks were 
pulled from the heating element prior to reaching the target temperature and allowed to peak 
to obtain the final temperature recorded. After cooking, each steak was cooled for 1-2 h at 
4°C before removing 6 cores (1.27 cm in diameter) parallel to the muscle fiber orientation 
(AMSA, 2015). A single, peak shear force measurement was obtained for each core using a 
Warner-Bratzler machine (G-R Electric Manufacturing Company, Manhattan, KS). The 
peak shear force was recorded for each core and averaged to obtain a single shear force 
value per steak. 
Statistical Analysis 
Fold change differences in gene expression between NA, which served as the 
control, and NHTC, IMPL or IMBA were analyzed using the Relative Expression 
Software Tool (REST; 2008, Corbett Research & M. Pfaffl, Technical University 
Munich) according to the procedures of Pfaffl (2001). Relative expression is dependent 
upon the expression ratio of a target gene compared with a reference gene and is accepted 
for most investigations of physiological change in the level of gene expression 
(Mohrhauser et al., 2015). Target gene expression was standardized by a non-regulated 
reference-gene. The expression ratio occurs when the investigated transcripts are tested 
for significance using a Pair Wise Fixed Reallocation Randomization Test (Pfaffl et al., 
2002). In this study, EEF1A2 and SF3A1 were used as reference genes for each LD 
muscle biopsy sample. Means were tested to a predetermined significance level of P < 
0.05 with trends considered (P > 0.05 to < 0.10). 
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For all other analyses, the influence of production system was evaluated using 
PROC MIXED of SAS (version 9.4, SAS Inc., Cary, N.C.) in a completely randomized 
design with steer used as the experimental unit. Meat quality data (marbling score, 
skeletal maturity, objective color, percent moisture and crude fat) was analyzed by 
production system as the fixed effect and dam age was used as a covariate.  
Percent cook loss and WBSF were analyzed using production system as a fixed 
effect, and dam age and peak cooking temperature were used as covariates. Postmortem 
aging periods (7, 14, or 21 d) were denoted as a repeated measure and were further 
evaluated for their interaction with treatment. The variance-covariance structure for 
response variables was selected using the Schwarz’s Bayesian information criteria (BIC) 
fit statistic.  
For all statistical analyses conducted using PROC MIXED, no random effects 
were specified and denominator degrees of freedom were approximated by the Kenward-
Roger option in the model statement. Least square means and SEM were computed for all 
variables and separated using least significant differences (PDIFF) when tests for fixed 
effects were significant at P < 0.05. 
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RESULTS AND DISCUSSION 
Treatment did not influence (P > 0.05) the expression of µ-calpain (P > 0.10) 
compared with the control (NA). There was no difference in µ- and m-calpain, or 
calpastatin expression between the IMPL and NA treatments (P > 0.10; Table 3.3). 
Gerken et al. (1995) also determined implanting with either an estogenic, an androgenic, 
or a combination implant (estrogenic and androgenic) did not influence gene activity of 
µ- or m-calpain in comparison to a nonimplanted control. However, steers receiving 
either a single estrogenic or a combination implant had increased calpastatin activity 
compared to a non-implanted control (Gerken et al., 1995). Differences in calpastatin 
results of Gerken et al. (1995) and the present study may be related to differences in 
specific implants administered or the diffence between assays utilized to quantify 
differences in calpastatin (activity versus gene expression).  
Expression of calpastatin was upregulated (P < 0.05) and m-calpain expression 
tended to be upregulated (P < 0.10) in samples from the NHTC treatment compared to NA. 
Limited research exists evaluating the effect of monensin and tylosin on expression of the 
calpain system in muscle. Hilton et al. (2009) evaluated the withdrawal of monensin and 
tylosin while feeding zilpaterol hydrochloride (ZH) [Zilmax; Merck Animal Health] 
during the last 35 d prior to harvest, and determined expression of calpain or calpastatin 
was not influenced by removal of these products from the diet. However, the current 
study did not evaluate change in experession when these technologies were removed 
from the diet, which could explain the inconsistent results.  
Expression of calpastatin was upregulated (P < 0.05) in the IMBA treatment 
compared with NA. Others have also reported beta-adrenergic agonist (β-AA) 
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supplementation up-regulated calpastatin expression and confirmed that calpastatin 
expression increased with β-AA induced muscle hypertrophy (Killefer and Koohmaraie, 
1994). Walker et al. (2010) extracted muscle biopsies from the biceps femoris (BF) and 
longissimus muscle (LM) of 16 steers administered an implant (120 mg trenbolone 
acetate and 24 mg estradiol-17b) and fed 200 mg RHsteer-1 d-1 for 29 d.  Walker et al. 
(2010) did not observe any difference in expression of calpastatin when compared to 
steers only implanted and not fed RH. This result is similar to the current study and 
illustrates that implanting alone may not cause an increase in calpastatin expression. 
Marbling score, skeletal maturity, and color were evaluated to determine the 
influence of treatment on measures of carcass quality. Marbling has repeatedly been shown 
to be an important trait for consumer eating satisfaction in cooked beef (Hankins and 
Ellis, 1939; Cole and Badenhop, 1958; Webb et al., 2014). Carcasses from NA (554 ± 
18.140) and NHTC (562 ± 17.146) did not differ (P > 0.05) but were greater (P ≤ 0.05) in 
marbling than IMPL (486 ± 16.861) and IMBA (504 ± 17.141), which were similar (P > 
0.05; Table 3.4). The reduced (P ≤ 0.05) marbling score (-54 on average compared to NA, 
NHTC and IMBA) in IMPL translated into a reduced (P ≤ 0.05) USDA QG (Low Choice) 
in comparison with NA and NHTC. This reduction of marbling score and consequent 
lower QG caused by IMPL is not unexpected as the use of anabolic steroids has been well 
documented to decrease marbling score and consequently result in fewer carcasses 
grading USDA Choice, and an increase in the carcasses stamped a lower USDA QG 
(Kuhl, 1992; Bartle et al., 1992; Foutz et al., 1997; Preston, 1999; Platter et al., 2003; 
Bruns et al., 2005; Pritchard, 2008; Johnson, 2015). Duckett et al. (1996) conducted a 
review of 37 trials examining steers administered an anabolic steroid while on a finishing 
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diet and reported reductions a marbling score percent (24%) reduction that translated into 
a lower percentage (14.5%) of carcasses grading USDA Choice in comparison to a non-
implanted control. In contrast, some studies show that implants have no negative effect 
on marbling score or USDA QG (Johnson et al., 1996; Scheffler et al., 2003, Smith et al., 
2007). Differences among these studies are likely due to variations in genetics, the 
potency of the implant(s) utilized, and the number and timing of when implants were 
administered. The reduction in marbling score of carcasses in the IMBA treatment 
supplemented with 200 mg RHsteer-1 d-1 is also not unexpected as the use of RH has 
been shown to decrease (10%) marbling score in comparison with an non-supplemented 
control (Winterholler et al., 2006; Gruber et al., 2007). Boler et al. (2012) also reported 
equal response in QG to supplementation of either 300 or 200 mg RHsteer-1 d-1. 
Marbling combined with physiological maturity (vertebral ossification, size and 
shape of the ribs, and color and texture of the LM at the 12th rib) allows for the assignment 
of the voluntary USDA QG (USDA Prime, USDA Choice, USDA Select; USDA, 1997; 
Acheson et al., 2014). The USDA QG system utilizes physiological maturity to capture 
animal age-related differences that impact meat tenderness, flavor, and juiciness. Skeletal 
maturity is used to determine if an animal is less than 30 mo. of age and qualifies for A 
maturity unless, dentition or age documentation can be provided (USDA-AMS, 2017). The 
NA treatment produced carcasses that were least mature (117 ± 1.847), NHTC and IMPL 
were similar (P > 0.05) and intermediate (127 ± 1.746 and 126 ± 1.717, respectively), and 
IMBA (138 ± 1.746) was most advanced in maturity though, all production systems resulted 
in carcasses with A maturity (A17 to A38; Hale et al., 2013). In contrast others have reported 
no difference in skeletal maturity of cattle supplemented with RH in comparison to 
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implanted cattle (Scramlin et al., 2010; Woerner et al., 2011). Although harvest date was 
the same, the IMPL treatment was more skeletally mature in comparison with NA. This was 
not unexpected as administration of exogenous estrogenic steroids has been reported to 
increase skeletal maturity due to hyperestrogenism (Acheson et al., 2014) by 10 points on 
a scale of 100 per degree of maturity (Duckett et al. 1996). A Platter et al. (2003) 
determined overall maturity increased with successive implant administered. Skeletal 
maturity has also been known to increase as cattle age and a reduction in steak tenderness 
can occur (Acheson et al., 2014). In this study, the age of steers at harvest was 
approximately 13 mo. (419 ± 12 d of age; NA and IMPL) and 14 mo. (438 ± 12 d of age; 
NHTC and IMBA). Although cattle age was similar, research has shown that QG 
influences objective measures of beef tenderness (Smith et al., 1985; Gruber et al., 2006, 
and Garmyn et al., 2011) and that age is only responsible for 6% of the variation in 
tenderness (Palmer, 1963).  
Treatment influenced (P < 0.0001) L* values. Carcasses from NA and IMPL (44 ± 
0.327 and 44 ± 0.304, respectively) were similar (P > 0.05) and lightest in color, NHTC (43 
± 0.309) was intermediate (P < 0.05), and IMBA (42 ± 0.309) was darkest (P < 0.05) in color 
(Table 3.4). In contrast, Garmyn et al. (2014) reported L* values were similar between 
carcasses from steers fed RH and a non-supplemented control. Moreover, Avendaño-Reyes 
et al. (2006) observed lighter steaks from carcasses of cattle supplemented RH compared 
to a control. Differences in L* results among studies could be due to variations in breed 
(e.g. British type, Charolais and Brangus), or in the level and duration of RH 
supplementation. 
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Treatment influenced (P < 0.0001) a* values. Carcasses from NA and IMPL (26 ± 
0.271 and 27 ± 0.252, respectively) were similar (P > 0.05) and redder (P < 0.05) in color 
than NHTC and IMBA (25 ± 0.256 and 24 ± 0.256, respectively), which were not different 
(P > 0.05). Garmyn et al. (2014) also reported that a* values were decreased due to RH 
supplementation of steers in comparison to a non-supplemented control. In contrast, Reiling 
and Johsnon (2003) conducted a retail display study and determined steaks from implanted 
cattle had reduced a* values (at d 0) compared to steaks from the non-implanted control. 
Differences between studies could be related to the study conditions (retail diplay versus in- 
plant evaluation). 
 Carcasses from NA and IMPL (12 ± 0.129 and 12 ± 0.120, respectively) were similar 
(P > 0.05) and had increased (P < 0.05) b* values, or were yellower in color than NHTC (11 
± 0.122), which was intermediate and greater (P < 0.05) than IMBA (10 ± 0.122). At d 0 of 
retail display, Reling and Johnson (2003) determined that steaks from steers implanted with 
zeranol and re-implanted with a combination implant (trenbolone acetate and estradiol) had 
lower b* values compared to a non-implanted control however, steers implanted and re-
implanted with the same combination implant were similar to the control, which is consistent 
with the current study comparison between NA and IMPL. Hilton et al. (2009) evaluated 
carcass color from cattle that had monensin and tylosin removed during the finishing phase 
and determined b* values were not influenced. However as mentioned previously, the current 
study evaluated the supplementation of monensin and tylosin not the removal and due to no 
other research investigations of the influence of supplementation of monensin and tylosin on 
carcass color, this study is referenced as the only comparison. If the animal production goal 
is to improve carcass weight, it appears that the use of growth promoting implants is less 
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detrimental to steak color without a β-AA. Though in contrast to the results for IMBA, 
Avendaño-Reyes et al. (2006) found no difference in RH supplementation on a* or b* 
values in comparison to a non-supplemented control. Moreover, Woerner et al. (2011) 
determined initial implanting, terminal implanting, and RH supplementation did not 
influence color (L*, a*, b*) values. However, these studies (Avendaño-Reyes et al., 2006; 
Woerner et al., 2011) have variations in breed type (Charolais and Brangus), animal age 
(calf-fed), implant protocol (progesterone and estradiol benzoate) and timing of 
administration in comparison to the current study.  
Treatment influenced (P < 0.0001) percent crude fat (Table 3.4). The NA and NHTC 
(7.38 ± 0.307% and 7.11 ± 0.290%, respectively) treatments were similar (P > 0.05) but 
greater (P ≤ 0.05) than IMPL and IMBA (5.49 ± 0.285 % and 5.89 ± 0.290 %, respectively), 
which were not different (P > 0.05). Treatment also influenced (P < 0.0001) percent moisture. 
The NHTC, IMPL, and IMBA (70.39 ± 0.219 %, 71.23% ± 0.215 %, and 71.20 ± 0.219 %, 
respectively) treatments were similar (P > 0.05) and greater (P < 0.05) in moisture than NA 
(69.67 ± 0.232; Table 3.4). These results suggest that use of successive implantation with 
monensin and tylosin with and without RH decrease percent crude fat in comparison with a 
control receiving no growth promoting technologies. Moreover, the decrease in percent crude 
fat in IMPL and IMBA compared to NA is expected, and inversely so is the increased percent 
moisture in comparison to NA. Although utilizing nonpregnant cull cows, Cranwell et al. 
(1996) agreed that use of an implant (200 mg trenbolone acetate) decreased percent crude fat 
and inversely increased moisture. In contrast, Handcock et al. (2005) evaluated steaks from 
heifers supplemented RH (10, 20, or 30 ppm) in comparison to a non-supplemented control 
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and determined there was no influence on percent crude fat or moisture. This referenced study 
utilized heifers unlike the steers in the current analysis. 
To evaluate cooked steak quality, treatments were analyzed to determine percent 
cook loss and objective steak tenderness. Treatment did not influence (P = 0.680) percent 
cook loss (Table 3.4). There was no interaction (P = 0.52) between treatment and aging 
period, although tenderness of all steaks improved (P < 0.05) with aging (2.45 ± 0.048 kg at 
7 d vs. 2.21 ± 0.039 kg at 14 d vs. 2.14 ± 0.041 kg at 21 d). Steaks from NA (2.01 ± 0.075 
kg) and NHTC (1.94 ± 0.071 kg) were similar (P > 0.05) and more tender (P < 0.05) than 
IMPL (2.49 ± 0.070 kg) and IMBA (2.63 ± 0.071 kg), which were similar (P > 0.05). 
However, steaks from all treatments could be certified tender (< 4.4 kg) and very tender (< 
3.9 kg; ASTM, 2011). Several studies have also demonstrated a decrease in tenderness 
values of steaks from implanted cattle (Morgan et al., 1997; Roeber et al., 2000; Platter et 
al., 2003). The increase mean WBSF value from implant administration has also been 
demonstrated to cause less desirable consumer tenderness ratings (Platter et al., 2003). 
However, others have reported minimal negative influences on steak tenderness from 
cattle administered successive implants (androgenic, estrogenic, and combinations) 
(Nichols et al., 2002; Gerken et al., 1995). In contrast, Gerken et al. (1995) compared the 
effects of meat tenderness from administering Brangus steers with a single implant (either 
estrogenic, androgenic, or a combination) to a non-implanted control. Depending upon 
the implant, there were variations in steak tenderness. Brangus steers implanted with a 
single combination implant produced top sirloin steaks similar in tenderness to the non-
implanted control however, none of the single implant strategies decreased strip loin or 
top round steak tenderness values in comparison to the non-implanted control. 
  
 
 
166 
 Research has repeatedly demonstrated that RH supplementation negatively 
influences beef tenderness (Avendaño-Reyes et al, 2006; Gruber et al., 2007; Strydom et 
al., 2009; Scramlin et al., 2010; Boler et al., 2012; Arp et al., 2013). Moreover, trained 
sensory panels have detected an increase in connective tissue in steaks from carcasses of 
steers supplemented RH (400 mg RHsteer-1 d-1) and ultimalty found those steaks to be 
tougher in comparison with a control (Arp et al., 2013). However, a few studies 
(Schroeder et al., 2003; Arp et al., 2013) suggest that a low dose of RH (200 mg 
RHsteer-1 d-1) does not decrease steak shear force values in comparison with a non-
supplemented control. Perhaps the non-significant difference in tenderness from 
supplementation of a low dose of RH in Arp et al. (2013) is due to the control, which was 
implanted. Moreover, the current study detecting an increase in steak toughness from 
steers supplemented RH at a low dose, may have been more sensitive to differences in 
steak tenderness as all cattle were from a similar genetic population. 
Most similar to the design of the current research, Woerner et al. (2011) evaluated 
the combination of providing an initial and terminal implant then, supplemented calf-fed 
steers and heifers 200 mg RHhd-1 d-1. Overall, WBSF values were not influenced by the 
initial or terminal implants however, RH supplementation increased mean WBSF value 
by 0.23 kg, which tended to cause a loss in predicted consumer acceptance. This increase 
in toughness may be due to the negative effects of β-AA on postmortem tenderization. It 
is not suprising that use of β-AA in this study increased expression of calpastatin as it has 
repeatedly been documented to increase calpastatin activity and potentially cause new 
collagen cross-links, which may decrease meat tenderness (Goll et al., 1997; Strydom et 
al., 2009; and Roy et al., 2015). Tenderness variability is among the most critical issues 
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facing the beef industry today (Guelker et al., 2013), and it is necessary to fully 
understand the impact of use or absence of pre-harvest technologies on the palatability of 
beef derived from current and similar genetics that are managed to a comparable 
compositional endpoint. 
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IMPLICATIONS 
Animal gene expression of calpastatin may be an inconsistent predictor of objective 
measures for meat tenderness. Cattle “raised without antibiotics” (not supplemented with 
monensin and tylosin), or “raised without the use of hormones” (only using monensin and 
tylosin) produced steaks that contained more marbling, crude fat, and were more tender in 
comparison to steaks produced from carcasses of cattle additionally receiving growth 
promoting implants with and without ractomamine-HCl. Although there are performance 
benefits of supplying growth promoting implants and ractopamine-HCl there may be 
greater detriments to carcass quality and meat tenderness compared to cattle supplemented 
with or without monensin and tylosin. Research efforts to improve management of growth 
promotant technology use to prevent reductions in marbling score, crude fat, and steak 
tenderness are needed to ensure consumer satisfaction while improving carcass weight and 
production efficency. Although beyond the scope of this study, evaluating muscle fiber type, 
diameter, and collagen concentration could provide insight into the mechanism responsible 
for reduced tenderness in steaks produced with growth promoting implants and ractopamine 
HCl. 
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Table 3.1. Composition of finishing diet (% of DM) fed to steers1 
Item Composition2 
Ingredient composition  
Dry-rolled corn 47.76 
  Wet corn gluten 40.02 
Prairie hay 7.21 
Liquid supplement3 5.02 
Nutrient composition  
NEm, Mcal/kg 2.04 
NEg, Mcal/kg 1.38 
CP 13.93 
1 During finishing steers received four concentrate-adaptation diets over 
a period of 65 d (January 6 - March 11) fed for 7, 7, 40, and 11 d, 
respectively. 
2 Steers only within the treatment receiving 200 mghd-1 d-1 of 
ractopamine HCl were supplemented. 
3 Supplement contained 58.25% ground corn, 29.57% limestone, 5.59% 
iodized salt, 4.65% ammonia chloride, 0.93% trace mineral mix, 0.25% 
thiamine, and 0.21% Vitamins A, D, and E. Diet was formulated to 
provide 300 mg monensin (Elanco Animal Health, Greenfield, IN) and 
90 mg Tylan (Elanco Animal Health) per steer daily. 
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Table 3.2.  Primer sequences for housekeeping genes and genes of interest for Longissimus lumborum 
and muscle samples. 
Gene   Primer Sequence Accession Number  
EEF1A21,2 forward 5' - GGTACTGGACAAGCTGAAGG - 3' NM_001037464 
  
 reverse 5' - GCGTCGATGATGGTGATGTA - 3'  
  
 
SF3A1,3 forward 5’ - GCCCGTGGTGGGTATTATTTA -3’  NM_001081510 
  
 reverse 5’ - TGTTGATCTCGTTCTGTCGTATC - 3’  
  
 
Calpastatin forward 5’ - GCCAAAGGAACACACAGAGCCAAA - 3’ NM_001030318 
  
 reverse 5’ - TTCTCTGATGGTGGCTGCTCACTT -3’  
  
 
µ-Calpain forward 5' - ATTTCCAGCTGTGGCAGTTTGGTG - 3'     NM_174259 
  
 reverse 5' - TCACCTTGGCATAGGCTTTCTCCA - 3'  
  
 
m-Calpain forward 5' - TGACCCAAACTGGGCATCTGTCTA - 3' NM_001103086 
  
 reverse 5' - AAACAAGCTTGGGTGGTTTCCCTG - 3'  
  
 
1Housekeeping Gene. 
2EEF1A2 = Eukaryotic Translation Elongation Factor 1.  
3SF3A1 = Splicing Factor 3.  
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Table 3.3. Relative expression of genes in the Longissimus dorsi muscle of steers. 
 Treatment1 
 NHTC IMPL IMBA 
Gene Fold Change2 95% CI P-value 
Fold 
Change 95% CI P-value 
Fold 
Change 95% CI P-value 
µ-Calpain  0.886 0.177 – 5.110 0.840 1.266 0.568 – 2.823 0.519 1.595 0.789 – 2.574 0.110 
m-Calpain 1.601 0.932 – 3.997 0.081 1.020 0.718 – 1.447 0.784 1.120 0.365 – 3.520 0.733 
Calpastatin  1.560 1.095 – 2.266 0.010 1.042 0.853 – 1.187 0.631 1.615 1.318 – 2.029 0.025 
1 Treatments: 1) no antibiotics (NA, receiving no technology); 2) non-hormone treated cattle (NHTC), fed monensin 
(300 mg steer-1 d-1) and tylosin (90 mg steer-1 d-1) during finishing; 3) implant (IMPL), administered a series of 
three implants including a low-potency calf implant (36 mg zeranol), a moderate-potency initial feedyard implant (80 
mg trenbolone acetate and 16 mg estradiol), and a high potency finishing re-implant (200 mg trenbolone acetate and 
20 mg estradiol) and fed Rumensin (300 mg steer-1 d-1) and Tylan (90 mg steer-1 d-1) during finishing, and 4) 
implant plus fed the beta-agonist (IMBA) ractopamine hydrochloride (200 mg steer-1 d-1) for the last 30 d prior to 
harvest. 
2 Fold change compares steers within production system to steers receiving no technology (NA), fold change greater 
than 1 denotes increased expression within production system. 
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Table 3.4.  Main effect least square means for effect of production system on carcass characteristics, meat 
quality, and tenderness. 
 Treatment1 P-value2 
Variable NA NHTC IMPL IMBA  
Marbling score3,4 553.93b ± 18.140 561.61b ± 17.146 486.49a ± 16.861 503.67a ± 17.141 0.0044 
Skeletal Maturity3,5  116.51a ± 1.847  126.91b ± 1.746   126.35b ± 1.717   137.59c ± 1.746  < 0.0001 
L* 43.89c ± 0.327  42.69b ± 0.309 43.84c ± 0.304 41.81a ± 0.309 < 0.0001 
a* 26.36b ± 0.271           24.73a ± 0.256 26.72b ± 0.252 24.09a ± 0.256 < 0.0001 
b* 11.87c ± 0.129 10.57b ± 0.122 11.95c ± 0.120 10.02a ± 0.122 < 0.0001 
Ether, % 7.38b ± 0.307 7.11b ± 0.290 5.494a ± 0.285 5.894a ± 0.290 < 0.0001 
Moisture, % 69.67a ± 0.232 70.39b ± 0.219 71.23b ± 0.215 71.20b ± 0.219 < 0.0001 
Cook Loss, % 18.92 ± 0.596 19.67 ± 0.564 19.88 ± 0.555 19.39 ± 0.564 0.6762 
WBSF, kg 2.01a ± 0.075 1.94a ± 0.071 2.49b ± 0.070 2.63b ± 0.071 < 0.0001 
a,b,c Means lacking a common superscript differ (P < 0.05) 
1  Treatments: 1) no antibiotics (NA, receiving no technology); 2) non-hormone treated cattle (NHTC), fed 
Rumensin (300 mg steer-1 d-1) and Tylan (90 mg steer-1 d-1) during finishing; 3) implant (IMPL), 
administered a series of three implants including a low-potency calf implant (36 mg zeranol), a moderate-
potency initial feedyard implant (80 mg trenbolone acetate and 16 mg estradiol), and a high potency finishing 
re-implant (200 mg trenbolone acetate and 20 mg estradiol) and fed Rumensin (300 mg steer-1 d-1) and Tylan 
(90 mg steer-1 d-1) during finishing, and 4) implant plus fed the beta-agonist (IMBA) ractopamine 
hydrochloride (200 mg steer-1 d-1) for the last 30 d prior to harvest. 
2 Probability of a difference among least squares means. 
3 Measurements were determined by trained SDSU personnel according to USDA-AMS grading standards. 
4 Marbling score: 300 = Slight0; 400 = Small0; 500 = Modest0; 600 = Moderate0. 
5 Skeletal maturity: 100 = A0; 200 = B0; 300 = C0. 
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CHAPTER IV 
Identifying consumer preferences and willingness-to-pay for beef raised in different 
production systems  
Megan J. Webb 
Department of Animal Science 
South Dakota State University, 57007 
ABSTRACT 
The objectives of this study were to evaluate meat quality characterisitcs, identify 
consumer palatability preferences, willingness-to-pay (WTP), and label preferences for 
beef raised in different production systems. Untrained consumer panelists (n = 105) were 
recruited from the surrounding areas of St Paul, MN to determine their share of 
preference (SOP) for beef palatability, willingness-to-pay (WTP), and label preferences 
for beef raised from four treatments: 1) no antibiotics or growth promotants (“raised 
without antibiotics”; NA); 2) non-hormone treated (“raised without hormones”; NHTC); 
3) implant (IMPL); and 4) IMPL plus a beta-adrenergic agonist (IMBA). Carcasses were 
evaluated for marbling score, striploins were collected, steaks were fabricated (2.54 cm), 
vacuum packaged, and aged for 14 d before freezing for meat quality and consumer 
analyses. Steaks for the meat quality analyses were analyzed for percent lipid, moisture, 
cook loss, and Warner-Bratzler shear force (WBSF). During the consumer analysis, 
panelists participated in three consecutive panels to determine their SOP and change in 
SOP between panels including: 1) Undisclosed with Meat (samples provided with no 
production information); 2) Disclosed without Meat (only production information 
provided); and 3) Disclosed with Meat (samples provided along with production 
  
 
 
181 
information). Meat quality analyses for marbling score and percent lipid were similar (P 
> 0.05) between NA and NHTC and greater (P < 0.05) than IMPL and IMBA, which 
were similar (P > 0.05). The WBSF values of NA and NHTC were similar (P > 0.05) and 
more tender (P < 0.05) than IMPL and IMBA, which were similar (P > 0.05). During the 
Undisclosed without Meat panel treatment influenced (P < 0.05) panelist SOP. The NA 
was most preferred (P < 0.05) and IMBA was least preferred (P < 0.05), while NHTC 
and IMPL were intermediate and similar (P > 0.05). In the Disclosed without Meat panel 
each treatment influenced (P < 0.05) panelist SOP. The NA was most preferred (P < 
0.05), NHTC was intermediate (P < 0.05), and IMPL was more preferred (P < 0.05) than 
IMBA. In the Disclosed with Meat Panel, each treatment influenced (P < 0.05) panelist 
SOP. Treatment NHTC was most preferred (P < 0.05), NA was intermediate (P < 0.05), 
and IMPL was more preferred (P < 0.05) than IMBA. During the Undisclosed with Meat 
and Disclosed without Meat panel, treatment did not influence (P > 0.05) panelist WTP. 
However, during the Disclosed with Meat panel, each treatment influenced (P < 0.05) 
panelist WTP. Panelist were WTP more (P < 0.05) for NHTC, NA was second highest (P 
< 0.05) in value, and IMBA was higher valued (P < 0.05) than IMPL. In regard to 
panelists’ preference of labeling descriptions for each treatment, panelists’ preferences 
were not influenced (P > 0.05) by label descriptions within treatment. In conclusion, 
treatments utilizing growth promoting implants, with and without a beta-adrenergic 
agonist, increased WBSF, which may be detectable by untrained consumer panelists as 
NA and NHTC captured greater SOP in both Undisclosed and Disclosed with Meat 
panels. During the Disclosed with Meat panel, NHTC was the most preferred followed by 
NA, indicating that when information is provided consumers are accepting and WTP 
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more for beef judiciously provided an antimicrobial and antibiotic to ensure animal 
health. 
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INTRODUCTION 
Producing more food with fewer resources to feed 9 billion people by 2050 is a 
global goal (AgMRC, 2012). If cattle with the genetic potential to grow are provided 
adequate nutrition, growth promotant technologies (Rumensin, Tylan, anabolic implants, 
and beta-adrenergic agonist (β-AA)) can enhance beef production efficiency and 
contribute significantly to the goal of producing more food with fewer resources. Use of 
ractomamine-HCl (RH) has been shown to improve ADG and feed efficiency of cattle 
(Avendano-Reyes et al., 2006; Walker et al., 2006), while implants increase protein 
deposition by enhancing both the rate and efficiency of muscle growth (Dayton and 
White, 2014). These technologies have also been reported to mitigate NH3 and 
greenhouse gas emissions (Stackhouse et al., 2012). However, the benefits of these 
technologies on environmental measures and produciton efficiency may not be well 
understood by consumers (Troy and Kerry, 2010). In fact, consumers are increasingly 
demanding beef with credence attributes such as cattle “raised without antibiotics” and 
“raised without hormones” (Andersen, 1994; VanOverbeke, 2007; USDA-AgMRC, 
2017). Given this dichotomy between reducing resource utilization and decreasing the 
use of technology, it is critical to understand the influence of different growth promoting 
technologies on measures of meat quality and consumer preferences related to these traits 
(Mathews and Johnson, 2013). Providing consumer panelists beef with and without 
production information to identify shares of preference (SOP) and the change in SOP, 
willingness-to-pay (WTP), and identify label preferences will offer insight to more 
appropriately differentiate beef marketing. Therefore, the hypotheses are that objective 
measures of meat quality will differ among treatments and panelists will not be able to 
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detect these differences in palatability but will prefer treatments using less technology 
when production information is provided. Therefore, the objectives of this study were to 
evaluate meat quality characterisitcs, identify consumer palatability preferences, WTP, 
and label preferences for beef raised in different production systems with differing levels 
of growth promotant technology. 
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 MATERIALS AND METHODS 
 Research procedures involving human subjects at the commercial consumer 
testing center were exempt from the Common Rule (CFR 45 Part 46.101). All protocols 
were approved by South Dakota State University Human Subjects Committee (IRB-
1702018-EXM). 
Sample Collection 
 One hundred and twenty beef strip loins (IMPS #180; AMS, 2014) from the left 
side of carcasses representing four different treatments were collected for analysis. Prior 
to carcass fabrication, South Dakota State University (SDSU) personnel used official 
USDA grade standards to assign USDA marbling scores at a commercial beef processing 
facility in Lexington, NE. The beef striploins analyzed represented these four treatments: 
1) no-antibiotic and no technology utilized (NA; “raised without antibiotics” and serves 
as the control); 2) non-hormone treated, but fed Rumensin and Tylan during the finishing 
phase (NHTC; “raised without hormones”); 3) implanted with a series of three implants 
and fed Rumensin and Tylan during the finishing phase (IMPL); and 4) IMPL treatment 
plus fed ractopamine-HCI (RH) 200 mg • steer-1 • d-1 30 d prior to harvest (IMBA). The 
IMPL and IMBA treatments were administered a series of three implants including a 
low-potency calf implant [36 mg zeranol; Ralgro, Merck Animal Health, Madison, NJ] at 
an average of 74 ± 12 d of age, a moderate-potency initial feedyard implant [80 mg 
trenbolone acetate and 16 mg estradiol; Revalor-IS, Merck Animal Health] at an average 
of 235 ± 12 d of age, and a high potency finishing re-implant [200 mg trenbolone acetate 
and 20 mg estradiol; Revalor-200, Merck Animal Health] at an average of 330 ± 12 d of 
age. 
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Product Handling 
Striploins were transported under refrigeration (2°C) to the SDSU Meat 
Laboratory where the exterior fat was trimmed to 0.64 cm and the connective tissue, 
gluteus medius, and multifidus dorsi were removed. After trimming the loingissimus 
dorsi steaks were fabricated to 2.54 cm and individually vacuum-sealed and wet-aged in 
the absence of light at 2-3°C for 14 d. A sub-set (n = 72) of striploins representing the 
mean marbling score of each treatment were selected for meat quality and taste panel 
analyses. Marbling scores are provided in Table 4.1. In order to accommodate the 
experimental design, 16 striploins were included in the subsample for NA, NHTC, and 
IMBA and 24 striploins were selected from the IMPL treatment. The anterior face of the 
left striploin was removed and utilized to determine ether extractable fat and additional 
steaks from the right striploin were designated for Warner-Bratzler shear force (WBSF) 
analysis following the same procedures as described in Chapter III. The remainder of the 
left striploin was fabricated into 2.54 cm steaks and the first and second most anterior 
steaks per striploin were paired to minimize variation of anatomical location for the 
consumer panel composition, described below. Post fabrication, individual steaks were 
vacuum-sealed and checked regularly to ensure seal integrity. Immediately after wet-
aging for 14 d at 2-3°C, steaks were frozen (-20°C) and remained frozen until thawed. 
Panel Composition 
 Consumer sensory sessions were conducted at a private consumer research and 
testing facility (Food Perspectives Inc. (FPI), Plymouth MN). Untrained consumer 
panelists (n = 105) were recruited from the surrounding areas of St Paul, MN. Panelists 
were recruited so that sex (50% female and 50% male) was nearly proportional among 
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the analyses. Four sessions consisiting of approximately 26 confirmed beef consumers 
(consumed beef at least one time per week) per session participated for compensation. 
Within each session, there were three panels delivered in the following order: 1) 
Undisclosed with Meat (samples provided with no production information); 2) Disclosed 
without Meat (only production information provided); and 3) Disclosed with Meat 
(samples provided along with production information). Within each panel, three flights of 
treatments were delivered in a randomized set of three samples so that the four treatments 
could have direct comparison and panelists could select their most and least preferred 
sample among the three treatments or sample options per flight. Each session lasted 
approximately 1.5 h. Individual panelists were provided: an electronic survey on an iPad 
(Apple, Cupertino, CA); an expectorant cup; bottles of purified water and apple juice; 
and unsalted crackers. To reduce any bias of researcher presence, FPI staff instructed 
panelists to cleanse their palate between each sample and judge each sample on 
palatability. Researchers were able to confirm procedures by monitoring each session 
through visual mirrors and on a television screen.  
Sample Preparation  
Samples were thawed at 2-3°C for 24 h prior to cooking. All samples were 
monitored with a MicroNeedle probe AquaTuff thermometer (Model 35140, Cooper-
Atkins Corporation, Middlefield, CT) while cooking to monitor acheivemnt of the target 
peak temperature (71ºC; range = 69.3 – 74.8 ºC). Steaks were cooked on electric clamshell 
grills (George Forman 9 Serving Classic Plate Grill, Model GR2144P, Middleton, WI). All 
cooked steaks were allowed to rest for four min to allow juices to redistribute prior to 
cutting. To maintain an acceptable sample temperature all cutting and portioning was 
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conduted under heat lamps. Steaks were trimmed of external edges and connective tissue 
prior to being portioned into samples (1.27 x 1.27 cm). Each consumer was given two 
samples to represent each treatment for palatability evaluation within each flight. 
Immediately after portioning, samples were placed on plates and stored in a warming oven 
set at 50°C until serving. 
Consumer Panels 
On each plate, three treatments were represented according to a randomly generated 
number corresponding to the iPad survey instrument (Qualtrics, Provo, UT) to allow for 
direct comparison among treatments, as previously mentioned. During the Undisclosed 
and Disclosed with Meat panels, the FPI staff served prepared plates to each panelist. The 
sensory panel was designed such that panelists were asked to evaluate four treatments 
during flights 1 to 3. Panelist were asked by FPI staff to wait to evaluate the next sample 
until their palates were cleansed. After consuming the treatments represented on each 
plate, panelists were instructed by FPI staff to identify their most and least preferred 
sample during each flight’s randomized treatment comparison. Panelist were able to 
select their most and least preferred sample by touching the randomly generated number 
corresponding to their sample selection on an individual iPad. The Undisclosed with 
Meat panel was conducted to determine panelist palatability preference of treatments, 
with no other information provided. After making their most and least preferred sample 
selection, panelists were automatically asked to rate the tenderness, juiciness, beefy 
flavor, and overall acceptability of their most preferred sample. Attribute description 
responses were measured on a continuous line scale ranging from 0% to 100%.  
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Prior to indicating WTP for the most preferred sample, a cheap talk script was 
presented to panelists to reduce hypothetical bias. Hypothetical bias is the difference 
between hypothetical behavior and behavior under real economic consequences (Tonsor 
and Shupp, 2011). A WTP analysis emulating the procedures of Tonsor (2012) required 
panelists to answer a double-bounded, dichotomous choice question: ‘would you be 
willing-to-pay $10.35 for a 12 oz. boneless Beef Loin Top Loin Steak, also known as a 
Strip Steak, with the same characteristics as your most preferred sample?’ Based on the 
panelists “No” or “Yes” response, Qualtrics randomly generated a second value for 
consideration. If the panelist selected “No,” the new value ranged between $5.00 to 
$10.29/12 oz., or approximately 50% less than $10.35/12 oz. If the panelist selected 
“Yes,” the new value ranged between $10.40 to $15.00/12 oz., or approximately 50% 
more than $10.35/12 oz. Attribute description and WTP was not requested for the least 
preferred sample to prevent panelist fatigue. After each flight, any remaining samples and 
waste were discarded. 
For the second panel, Disclosed without Meat no beef products were provided but 
panelists were provided cattle raising information relative to each production system 
(Table 4.2). Consistently, three of the four treatments were provided within each flight so 
that direct comparisons between treatments could be made. Three flights were used to 
assess panelist preference of each treatment by selecting the most and least preferred 
sample using iPads. This panel was conducted to determine panelists’ perception of the 
treatment’s production information. Willingness-to-pay was requested for the panelists 
most preferred selection. 
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In the final panel, Disclosed with Meat, panelists were provided with both cattle 
raising information for each treatment and the corresponding beef samples to assess 
palatability. The FPI staff encouraged panelists to read each treatment production 
information first then, consume the sample to make selections of their most and least 
preferred sample within flight. This panel was conducted to determine both perception 
and palatability of treatments. As described previously, attribute description and WTP 
was determined for only the most preferred selection. At the conclusion of each session, 
all waste was discarded and serving areas were re-set. Qualtrics automatically saved 
individual consumer survey selections. 
Ranking of Labels 
Prior to the consumer panel, researchers developed product label claims and 
corresponding statements to represent each beef production system using animal 
performance data and environmental output estimates reported in Chapter II, claims and 
statements were developed according to the Animal Raising Claims for Label Submission 
Guidelines (USDA-FSIS, 2016). The claims and corresponding statements were reviewed 
by the United States Department of Agriculture-Food Safety Inspection Service (USDA-
FSIS) Labeling and Program Delivery Division (LPDD) to assess acceptability for 
commerce. Further, USDA (2002) has adopted the terms “no antibiotics added,” “no 
antibiotics administered,” or “raised without antibiotics” to replace “antibiotic free”, 
which is considered mislabeled as USDA cannot guarantee this due to limitations of 
scientific testing procedures. Utilizing LPDD staff to review label claims provided 
assurance that the novel labels were not mislabeled or false and misleading (U.S. Code, 
2012, tit. 21, §§333, 352). 
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An online pre-survey of ten labels (containing a claim and a corresponding 
statement) per treatment was conducted using an online survey software instrument 
(Decipher; Atlanta, GA). The pre-survey captured 500 beef consumer responses balanced 
across the Northeast, Midwest, Southern, and Western US to rank label descriptions for 
each treatment from 1 to 10 (1 = best representation through 10 = worst representation). 
Survey respondents were balanced by sex (50% female and 50% male) and selected from 
a population that was the primary household shopper or shared shopping responsibility. 
The survey response time (averaged 15.23 min) was monitored to ensure adequate 
surveys were collected for preference determination. The top five product label 
descriptions identified per treatment were re-assessed during the in-person FPI consumer 
panel. At the conclusion of the three panels, panelists were asked to rank product label 
descriptions 1 to 5 (1 = best representation through 5 = worst representation) according to 
preference for each of the four treatments using an individual iPad. 
Demographic Questionnaire  
At the conclusion of each session, panelists were asked to complete a 
demographic survey to quantify: a) sex; b) household size; c) marital status; d) age; e) 
household income; f) education level; g) weekly beef consumption; h) weekly physical 
activity; and i) eating habits. Panelists were also asked to identify their most trusted 
source for third-party process verification for products that require auditing such as 
Organic and Grass Fed beef.   
Focus Group 
 A sub-set (n = 18) of panelists were selected according to beef eater type (light = 
consumed beef 1 – 2 times per week; medium = consumed beef 3 – 4 times per week; and 
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heavy = consumed beef atleast 5 times per week) to participate in a 30 min focus group at 
the end of the third panel. Panelists were screened to ensure they would be wiling to 
verbally share their opinions for focus group qualification. Six compensated panelists 
from each beef eater type (light, medium, and heavy) with sex and income balanced as 
much as possible, participated. There were a total of three focus groups conducted. The 
focus group took place in a controlled room without distractions. Researchers watched 
the exchange through a one-way mirror and could listen to the discussion via a speaker 
system allowing for responses to be recorded. A recording of the sessions was also 
collected to allow the moderator to analyze and generate a report. A FPI professional 
moderator was used to ask panelists a series of questions to better understand consumer 
perceptions and marketing preferences. 
Statistical Analysis 
Meat quality analyses were statistically conducted as outlined in Chapter III. For 
the consumer panel analyses, the PROC OPTEX function of SAS 9.4 was used to 
determine the number of samples served per panel and the randomized sample serve 
order per flight. Four treatments were randomized into three flights, where each of the 
four treatments appeared randomly in an unbalanced, randomized complete design so that 
each treatment was compared to each other treatment at least once. Utilizing this method 
for selection reduced selection bias in comparison to alternative rating options because 
there was only one way to make selections (Cohen and Neira, 2003). These data were 
analyzed using a multinomial logit (MNL) model. The resulting MNL coefficient 
estimates were used to calculate the SOP, or the percentage of preference for each of the 
four treatments among the panelists (Wolf and Tonsor, 2013). Although the MNL 
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coefficient estimates have little to no economic interpretation, the SOP convey the 
importance, or relative liking, of treatments. The calculated SOP results in a percentage 
determined by the number of times a treatment was selected as best (j) and worst (k) 
collectively from all panelists (Wolf and Tonsor, 2013). The following SOP equation, j = 
elj / åjk = 1el, was used to calculate the SOP where l represents the coefficient estimate 
generated from the MNL output (Wolf and Tonsor, 2013). Following Wolf and Tonsor 
(2013), the SOP for each treatment were tested to see if they differed from each other 
treatment. Following Krinsky and Robb (1991) and Poe (2005), the MNL estimated 
coefficients and variance terms were simulated by 1,000 using a multivariate normal 
distribution and a complete combinational test was used to assess pairwise comparisons. 
Pairwise comparisons allowed researchers to empirically test if statistical differences 
existed among the SOP for all treatments within each panel. Significance was determined 
at P < 0.05. 
Consumer demographics were analyzed using a random effect binary logistic 
regression model that was fitted using the PROC GLIMMIX function of SAS 9.4. 
Treatment served as the fixed effect and panelists were included as a random intercept. 
The Tukey adjustment for multiple testing procedures was used to separate the factor 
levels (sex, household size, etc.) and the Loess Smooth function was used for model 
diagnostics. Least squares means were compared using the PDIFF option when F-tests 
were significant when P < 0.05 and tendencies were considered when P > 0.05 to < 0.10. 
Panelist ratings for descriptive attributes including: tenderness, juiciness, beefy 
flavor, and overall acceptability were analyzed using the PROC MIXED function of SAS 
9.4. Treatment served as the fixed effect and panelist was the random effect. The 
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denominator degrees of freedom were approximated by the Kenward-Roger option in the 
model statement. Least squares means were compared using the PDIFF option when F-
tests were significant when P < 0.05 and tendencies were considered when P > 0.05 to < 
0.10. 
Panelist WTP was analyzed using the PROC LIFEREG procedure by evaluating 
the double-bounded, dichotomous choice responses for the most preferred treatment per 
flight. To determine the influence of treatments within each panel, a pooled restricted 
model within treatment was compared to treatments unrestricted model as described by 
Tonsor (2012). Pooling within treatment allowed for determination of WTP difference 
among all treatments. A likelihood ratio test was used to test the null hypothesis to 
determine if WTP was the same per treatment, similar to Tonsor (2012). If the null was 
rejected, it implies that at least one of the treatments had a different WTP. Therefore, 
treatment mean WTP estimates were calculated and six comparisons were made among 
all possible treatment combinations. Significance was determined when P < 0.05. 
Treatment label descriptions were analyzed using a random effect multinomial 
logistic regression model with a cumulative logit link for ranking using labels as a factor. 
Least squares means were compared using the PDIFF option when F-tests were 
significant when P < 0.05 and tendencies were considered when P > 0.05 to < 0.10. 
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RESULTS AND DISCUSSION 
Meat Quality of Sensory Steaks 
 For the meat quality analysis, the same sub-set (n = 72) of striploins representing 
treatment mean marbling scores were analyzed to characterize the consumer sensory 
steaks. Treatment influenced (P < 0.05) percent crude fat and moisture (Table 4.3). 
Percent lipid was similar (P > 0.05) between NA and NHTC, which were 1.5% greater (P 
< 0.05) on average than IMPL and IMBA, which were similar (P > 0.05). However, all 
treatments had a fat percentage above 3%, which is proposed by Savell and Cross (1988) 
to be the minimal percentage of intramuscular fat necessary for consumer acceptability. 
As expected, percent moisture was inverse to percent lipid. The NA and NHTC were 
similar (P > 0.05) and had less (P < 0.05) percent moisture than IMPL and IMBA, which 
were similar (P > 0.05). In regard to IMPL and IMBA, Garmyn et al. (2014) also found 
no influence on percent crude fat or moisture when comparing British-type steers fed RH 
(308 mg • steer-1 • d-1) to implanted steers not fed RH. 
The percent cook loss was similar (P > 0.05) between IMPL and IMBA, though 
IMBA was not different from NA (P > 0.05; Table 4.3). In regard to IMPL and IMBA, 
Arp et al. (2013) also reported no difference in percent cook loss between treatments fed 
RH (200 mg • steer-1 • d-) and an implanted control not receiving RH. Though Garmyn 
(2014) reported steers fed RH (308 mg • steer-1 • d-) produced steaks that had a greater 
percent cook loss compared with a control. Perhaps this variation in percent cook loss is 
due to the differences in the level of RH supplemented.  
To determine objective tenderness for each production system, the right strip loin 
was used to obtain the three most anterior steaks for postmortem aging periods of 7, 14, 
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or 21 d as outlined in Chapter III. No interaction was detected for WBSF (P = 0.52) 
among treatments and aging period however, tenderness improved (P < 0.001) with 
postmortem aging (2.45 ± 0.05 kg, 2.21 ± 0.04 kg, 2.14 ± 0.04 kg for 3, 14, and 21 d 
respectively). Overall, steaks from NA and NHTC were more tender (P < 0.05) by 0.29 
kg than steaks from IMPL and IMBA, which were similar (P > 0.05; Table 4.4). In regard 
to IMPL being tougher than NA and NHTC, other studies have indicated that implants 
have minimal influences on beef tenderness in comparison to a non-implanted control 
(Belk and Cross, 1988; Duckett et. al., 1996; Pritchard, 2000). Moreover, Gerken et al. 
(1995) determined cloned Brangus steers administered a single androgenic and 
combination implant in comparison with a control were not tougher. Barham et al. (2003) 
implanted bos indicus influenced cattle and confirmed implant treatment did not increase 
WBSF in comparison with a non-implanted control. Perhaps variations in implant 
protocol, potency, breed, and postmortem aging duration is reasoning for these 
differences in comparison to the current study. Though consistent with the current study, 
Foutz et al. (1997) determined the use of two trenbolone acetate implants caused steers to 
produce carcasses with tougher steaks than steers only implanted once using trenbolone 
acetate, or twice with estradiol. Other research also confirms that the use of implants 
increased steak toughness (Morgan et al., 1997; Roeber et al., 2000; Platter et al., 2003a). 
Though in a review by Hutcheson (2008) implant treatment effects on WBSF gradually 
diminish with greater postmortem aging and conclude there are little negative effects 
from growth promotant implants on beef tenderness. Regardless, all treatment WBSF 
values were below 3.9 kg of shear force, which is the threshold value for consumer 
desirability (Shackelford et al., 1991) and the certified very tender claim (ASTM, 2011). 
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In regard to IMBA, a majority (approximately 60-80%) of cattle on feed in the US 
are fed RH (Chichester, 2017). The negative influence of RH on carcass tenderness has 
been described as minimal and manageable with adequate postmortem aging (Scramlin et 
al., 2010; Boler et al., 2012; Garymn et al., 2014). For example, Arp et al. (2013) fed 
steers RH at 200 mg • steer-1 • d-1 and discovered steaks were similar to the non-
supplemented control. However, steers fed RH at 300 and 400 mg • steer-1 • d-1 produced 
carcasses with steaks that were similar and tougher in WBSF values in comparison to the 
non-supplemented control (Arp et al., 2013). Multiple research studies have found an 
increase in shear force due to supplementation of RH in comparison to a non-
supplemented control (Avendaño-Reyes et al., 2006; Strydom et al., 2009; Scramlin et 
al., 2010; Boler et al., 2012; Garmyn et al., 2014). However, some of these studies have 
also concluded that postmortem aging 14 d or more mitigated differences in tenderness 
(Scramlin et al., 2010; Garmyn et al., 2014). Garymn et al. (2014) noted an interaction 
between RH supplementation and aging where, RH responded greater to 21 d aging and 
consequently resulted in the lowest WBSF values in comparison with a control. In the 
current study, aging steaks only 14 d did not improve tenderness of IMBA to the same 
level as steaks from non-RH supplemented steers. Perhaps aging more than 14 d would 
produce results more similar to Garymn et al. (2014).  
Demographics 
 Demographic information was obtained from 105 recruited panelists (Table 4.4), 
which have similar demographics to the US population according to the 2011-2015 
American Community Survey 5-year estimate (US Census Bureau, 2017). The sensory, 
perception, and beef production system marketing preferences were evaluated by male 
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(50.5%) and female (49.5%) panelists, which is similar to the US population (49.2% male 
and 50.8% female; US Census Bureau, 2017). The US Census Bureau (2017) median 
annual household income was $53,889, which represents 27.6% of recruited panelists and 
71% of all panelist households earned at least $50,000 annually. The median age of 
people living in the US is 37.6 years therefore, panelists in this study (mean = 50 yr) were 
older as the “Baby Boomer” generation (over 50 years of age) accounted for the greatest 
percentage (60%) of the sampled population, “Millennials” (ages 18 to 34) accounted for 
the second greatest percentage (23%), and “Generation X” (ages 35 to 50) accounted for 
the lowest percentage (17%) of the sampled population. The FPI recruitment process 
validated that all panelists consumed beef at least one time per week. The beef 
consumption group with the greatest percentage of participants (52%) was “Medium” 
beef-eaters who consumed beef 3 - 4 times per week. The “Light” beef-eaters consumed 
beef 1 - 2 times per week and comprised the second largest percentage (39%) of 
panelists. Therefore, 91% of panelists were considered “Medium to Light” beef eaters.  
Shares of Preference 
 Horsley (2015) described palatability-related preferences for beef branding and 
marketing for Certified Angus Beef (CAB) steaks. The CAB steaks were rated 10% 
higher for consumer overall liking when identified with the CAB Brand, indicating the 
potential to differentiate preferences based on label information. In effort to analyze beef 
consumer preferences and perception of different production systems, individual panelist 
results were combined and SOP for each treatment were determined (Fig. 4.1). In order to 
evaluate SOP for beef palatability, panelists were provided samples from each production 
system without any additional information.  During this Undisclosed with Meat panel 
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treatment influenced (P < 0.05) SOP. The NA had the greatest (P < 0.05) SOP, NHTC 
and IMPL were similar (P > 0.05) and intermediate (P < 0.05) to IMBA, which was least 
preferred (P < 0.05; Table 4.5). The order of preference by percentage was: 1) NA, 
27.82%; 2) NHTC, 26.39%; 3) IMPL, 25.91%); and 4) IMBA, 19.88%. Similar to the 
current findings for IMBA, Gruber et al. (2008) reported that trained sensory panelists 
rated steaks from steers fed RH (200 mg • steer-1 • d-1) lower for tenderness, juiciness, and 
slightly lower for beef flavor in comparison with a control. In the same study, untrained 
panelists agreed with trained panelists that there were differences in palatability from RH 
supplementation (Gruber et al., 2008). Though in the current study, consumers were 
unable to differentiate between NHTC (26.39%) and IMPL (25.91%) during the 
Undisclosed with Meat panel (P > 0.05). Similarly, Harsh et al. (2015) reported that 
natural (similar to NA treatment receiving no growth promotants and no Rumensin or 
Tylan) and conventionally implanted (similar to IMPL treatment receiving 40 mg of 
estradiol and 200 mg of trenbolone acetate on d 0 and fed 33 and 9 mg/kg of monensin 
and tylosin daily, respectively) steers produced carcasses with steaks that were similar in 
tenderness and palatability during trained and untrained consumer panels. However, 
Harsh et al. (2015) did not detect differences in tenderness or palatability for 
conventional plus fed zilpaterol hydrochloride (ZH), which is inconsistent with the 
current study as IMBA was least preferred (19.88%) by panelists during the Undisclosed 
with Meat panel (P < 0.05). Perhaps this inconsistency between ZH supplementation in 
Harsh et al. (2015) and the current study is due to the type of β-AA supplemented and its 
potency. However, Arp et al. (2013) used trained sensory panelists and determined 
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tenderness ratings for steaks from steers fed RH 300 and 400 mg • steer-1 • d-1 were rated 
lower in tenderness than steaks from steers not supplemented RH. 
 At retail, consumers must make meat purchases prior to tasting, based on 
appearance of the meat and evaluation of the label information (BrunsÆ et al., 2005; 
Grunert, 2005). Therefore, to determine if intrinsic cues influence behaviors and 
perceived satisfaction, treatment production system information was evaluated without 
sampling any beef. During this Disclosed without Meat panel, the same panelists 
participated and were asked to provide their preferences for production system 
information (Table 4.6). Each treatment’s production system information influenced (P < 
0.05) SOP among panelists in the follow order: 1) NA (50.41%); 2) NHTC (32.17%); 3) 
IMPL (11.88%); and 4) IMBA (5.53%). Consumer perception was responsible for these 
differences and has been shown to influence behavior (Troy and Kerry, 2010). In 
contrast, European studies indicate that origin labeling has no influence on consumer 
quality evaluations or impacts on purchasing preference (Bonnet and Simioni, 2001; 
Grunert 2005). Although consumers have differences in perception, they still find it 
challenging to predict eating quality prior to consumption (BrunsÆ et al., 2005). 
 To further investigate product palatability combined with product information, the 
same panelists participated in a Disclosed with Meat panel, which revealed treatment 
influenced (P < 0.05) panelists SOP for both palatability and perception (Table 4.7). 
Though USDA-FSIS has permitted products labeled as “raised without the use of 
antibiotics” to be marketed in effort to reduce potential development of antibiotic-
resistant bacteria from food products (Levitt, 2015). However, results of this study 
indicate a greater preference for NHTC (36.68%) compared with NA (34.01%; P < 0.05), 
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which indicates that when panelists are able to taste and evaluate production information 
they preferred the NHTC treatment. Further, panelists preferred IMPL (19.68%) to IMBA 
(9.63%; P < 0.05). The order of preference differed (P < 0.05) among each treatment as 
follows: 1) NHTC (36.68%); 2) NA (34.01%); 3) IMPL (19.68%); and 4) IMBA 
(9.63%). In comparison to the Undisclosed without Meat panel, when panelists were 
provided production system information in addition to product palatability SOP for NA 
lifted 6.19% and NHTC lifted 10.29%. Whereas, SOP for IMPL decreased 6.23% and 
IMBA decreased 10.25% (Fig. 4.1).  
The CAB study reported by Horsley (2015) determined that the CAB Brand 
disclosure largely influenced palatability ratings and resulted in a 10% brand lift for 
overall liking and 13% brand lift for overall flavor liking. However, steaks merchandized 
as USDA Select resulted in a 10% brand decrease in tenderness ratings. In a separate 
study conducted by BrunsÆ et al. (2005), consumers were evaluated ‘before purchase’ and 
‘after purchase’ for preferences of culled dairy cow beef from different fattening diets. To 
validate this study, Grunert (2005) evaluated additional fattening diets and determined 
consumers were subjectively influenced by visual quality perceptions. Moreover, 
consumers demand credence attributes for enhanced trust (Andersen, 1994). For growth 
promotant technology continued use, it is paramount to determine options for credence 
attribute development (Troy and Kerry, 2010). However, major American meat vendors 
are committing to not use antibiotics in animals that supply meat products (Strom, 2015; 
Centner, 2016). Though the current results agree with Troy and Kerry (2010) that 
consumers can recognize benefits and effective communication of risk must be 
transparent. Perhaps consumer messaging about the federal law inhibiting antibiotic drug 
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residues at an unsafe level in meat products is needed (U.S. CFR, 2016, tit. 21 § 
510.110).  
Influence of Consumer Demographics on Shares of Preference 
Results from the SOP for each panel and consumer demographic information for 
those corresponding selections were analyzed to determine if a relationship exists for 
preference. During the Undisclosed with Meat panel, preference for NA was influenced 
(P < 0.05) by beef eater type. The most preferred selection of NA, was more (P < 0.05) 
by heavy (33%) and light (30%) beef eaters compared with medium (19%) beef eaters 
(Table 4.8). Also during the Undisclosed with Meat Panel, household size, marital status, 
age, and beef consumption group tended (P < 0.10) to influence panelists least preferred 
selections (Table 4.9). Barham et al. (2003) also evaluated palatability among consumer 
demographics but determined additional education post-high school decreased beef 
attribute ratings for overall quality, flavor, juiciness, and tenderness. Perhaps these 
consumer panelists were more sensitive and had more developed beef quality desires that 
allowed them to be more particular in preference. In some similarly to the present study, 
family income did not influence overall quality, beef flavor, juiciness, or tenderness 
scores (Barham et al., 2003). 
Demographics were also evaluated to determine if there was an influence on 
preference based on production system information during the Disclsoed without Meat 
panel. Panelist demographics influenced (P < 0.05) the most preferred selection of NA 
and IMPL. Females (58%) were 14% more (P < 0.05) likely than males (44%) to select 
NA as the most preferred production system (Table 4.10), whereas males (17%) were 
12% more (P < 0.05) likely to prefer IMPL than females (5%). Verbeke and Ward (2005) 
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reported similar findings for males who had a lower interest in quality guarantees. Further 
in the Disclosed without Meat panel, sex tended (P < 0.10) to influence panelists least 
preferred selections of IMPL (Table. 4.11). Females (45%) were 8% more (P < 0.05) 
likely to dislike (P = 0.07) IMPL than males (37%). 
To determine the influence of palatability and production information, panelist 
demographics were evaluated following the Disclosed with Meat Panel. Demographics 
did not influence (P > 0.05) the most preferred selections of all production systems 
(Table 4.12). Though, panelist demographics did influence (P < 0.05) the least preferred 
selections for NHTC and IMPL (Table 4.13). Marital status influenced (P < 0.05) 
preference for NHTC, single (9%) panelists preferred NHTC 4% less than those who 
were married (5%). Also, heavy beef eaters (22%) preferred NHTC 17% less than 
medium (5%) beef eaters (P < 0.05), though light beef eaters were similar in preference 
(P > 0.05). Perhaps heavy beef consumers were less concerned about hormone use in 
beef production. Household size also influenced (P < 0.05) panelists’ least preferred 
selections of IMPL. Single households (40%) preferred IMPL 12% less (P < 0.05) than 
two-person households (28%), though households with three or more persons were 
similar (P > 0.05). Marital status and beef consumption group tended (P < 0.10) to 
influence panelists least preferred selections for IMPL (Table 4.13). Married persons 
(35%) were 2% more likely (P = 0.08) to dislike IMPL in comparison with single persons 
(33%). Medium beef eaters (37%) were most likely (P = 0.09) to dislike IMPL by 6% in 
comparison with Light beef eaters (31%), who were intermediate (P < 0.10) to Heavy 
beef eaters (26%) that were least likely (P < 0.10) to dislike IMPL.  
Consumer Sensory Attributes 
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Untrained sensory panelist ratings for tenderness, juiciness, flavor, and overall 
acceptability for the Undisclosed with Meat panel are provided in Table 4.14. Panelist 
ratings for subjective tenderness reflected the WBSF results with the exception that 
panelists found IMPL (76.34%) to be rated similar to NA (76.21%) and NHTC (77.52%) 
for tenderness (P > 0.05). Wheeler et al. (2004) determined untrained consumer panelists 
have the ability to repeatedly (80%) be accurate when evaluating tenderness of the 
longissimus and provide effective differentiation between tender, intermediate, and tough 
steaks. Similar to the current study, Barham (2003) also determined consumer panelists 
rated steaks from implanted animals tougher than an unimplanted control. Additionally, 
in the present study marbling scores were similar between NA and NHTC and previous 
research efforts have found greater marbling to be associated with improved consumer 
tenderness, juiciness, flavor, and overall palatability ratings (Smith et al., 1985, Lorenzen 
et al., 2003, and O’Quinn et al., 2015). Perhaps increased toughness found in this study 
for IMBA is due to the effects of β-AA on postmortem tenderization described by Goll 
(1997) and illustrated by Strydom et al. (2009) causing greater calpastatin activity and 
potentially increased collagen cross-links (Roy et al., 2015) causing a decrease in 
tenderness (Scramlin et al., 2010; Boler et al., 2012; and Garmyn et al., 2014). Though, 
Garmyn et al. (2014) determined that steaks supplemented with RH were similar to the 
control for consumer ratings of tenderness and overall liking. Also, Arp et al. (2013) 
found trained panelists to be unable to detect variations in the level of RH fed (200 vs. 
300 mg • steer-1 • d-1) on ratings for tenderness, juiciness, and flavor.  
In regard to juiciness, untrained panelists found NHTC (67.89%) to be juicier than 
IMBA (59.41%; P < 0.05). In contrast, Barham (2003) did not find steaks from 
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unimplanted control cattle to be juicier than steaks from implanted cattle. In the current 
study, beef flavor was consistent with juiciness, as NHTC (71.46%) was rated higher (P 
< 0.05) for beef flavor than IMBA (63.93%). Perhaps differences in consumer ratings for 
juiciness were influenced by consumer ratings for beef flavor and tenderness as described 
by O’Quinn et al. (2015). Though, juiciness and beef flavor were similar (P > 0.05) 
between NA, IMPL, and IMBA. Overall acceptability tended (P = 0.08) to be influenced 
by treatment (Table 4.14). Treatments NA, NHTC, and IMPL were rated similar (P > 
0.10) and tended to be rated higher (P = 0.08) in overall acceptability in comparison with 
IMBA. 
Production system information and palatability influenced overall acceptability 
during the Disclosed with Meat panel (Table 4.15). Panelists ranked NA (80.74%) greater 
(P < 0.05) in overall acceptability than IMPL (74.32%) though, NHTC (77.77%) and 
IMBA (74.26%) were similar to all treatments (P > 0.05). Beefy flavor tended (P = 0.08) 
to be influenced by treatment where NA tended to be greatest (P < 0.10) in beefy flavor 
in comparison with NHTC, IMPL, and IMBA, which were similar (P > 0.10; Table 4.15). 
However, treatment did not influence panelist ratings for tenderness or juiciness (P > 
0.10). In regard to the positive palatability contributions of NA for overall acceptability, 
O’Quinn et al. (2015) determined that as lipid level increased, consumer acceptability of 
tenderness, juiciness, flavor, and overall acceptability also increased, which indicates that 
lipid positively influences consumer palatability of beef strip steaks. However, NHTC 
had the same lipid content and marbling score as NA, therefore the discrepancy between 
NA and NHTC for reduced beef flavor may be due to individual consumer perceptions 
centered on health concerns and demographics (Resurreccion, 2004). 
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Willingness-to-pay 
 Panelist WTP during the Undisclosed with Meat panel is summarized in Table 
4.16 and no differences (P > 0.05) were detected as the hypothesis was not rejected from 
the pooled panelist responses. To further investigate WTP, additional models were 
estimated for the Disclosed panels, though due to panelists selecting different preferences 
across panels, results were not compared. The Disclosed without Meat panel (Table 4.17) 
also had no differences (P > 0.05) detected as the hypothesis was not rejected from the 
pooled panelist responses. However, panelist WTP during the Disclosed with Meat panel 
(Table 4.18) was valued differently (P < 0.05) for each treatment as the hypothesis for the 
model was rejected.  
As determined from the Disclosed with Meat panel, panelists’ WTP based upon 
perception and palatability differed (P < 0.05) for each treatment in this order: NHTC, 
$11.41; NA, $11.34; IMBA, $10.48; and IMPL, $10.36 per 12 oz serving. The greatest (P 
< 0.05) WTP was for NHTC ($11.41 per 12 oz. serving), which was valued $1.05 more 
per 12 oz. serving than IMPL. In comparison, panelists’ value differences between NA 
and NHTC were more similar (only differed by $0.07 per 12 oz serving), whereas 
treatments with more levels of technology (IMPL and IMBA) had larger value 
differences (differed by $0.12 per 12 oz. serving) when comparing between the lower and 
higher levels of growth promotant technology use. On average, panelists’ valued limited 
use of technology (NA and NHTC; $11.38 per 12 oz serving) $0.96 more per 12 oz. 
serving in comparison to treatments (IMPL and IMBA; $10.42) using increased levels of 
technology. These results are similar to Feuz et al. (2004) who determined WTP for 
palatability was influenced more by tenderness than marbling degree. Additionally, 
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Platter et al. (2005) found consumers to perceive differences in value for meat tenderness 
because they were likely to refuse purchasing of steaks if WBSF values increased. The 
IMPL and IMBA treatments had similar WBSF values, but were tougher than NA and 
NHTC, and consumers were WTP less for these treatments. However, when palatability 
and perception were evaluated together in the Disclosed with Meat panel, consumers 
were WTP more for beef provided an antibiotic and antimicrobial to maintain animal 
health and productivity. In other studies, consumers have been WTP more for meat 
products without antibiotics (McKendree et al., 2013; Sneeringer et al., 2015). 
Additionally, Farm News Media (2017) reported results from a Cargill Animal Nutrition 
survey that 54% of US consumers were willing to purchase beef raised without 
antibiotics. There may be a need to promote judicious antibiotic use to improve animal 
health and productivity. 
Label Ranking 
Beef labels provide extrinsic and intrinsic quality cues that guide consumers 
presumptions of product quality and allow them to form an expectation about the product, 
which relates to purchasing behavior, satisfaction, and future purchasing decisions 
(BrunsÆ et al., 2005; Grunert, 2005). Though, extrinsic label characteristics (i.e. color of 
the package) were not evaluated as the panel focused on intrinsic (i.e. production 
guarantees) characteristics. Further, intrinsic (i.e. guarantees to consumers) label 
guidance must be relevant to consumers for it to be effective and trustworthy (BrunsÆ, et 
al., 2005).  
Panelists were asked to rank product label descriptions 1 to 5 (1 = best 
representation through 5 = worst representation) according to preference for each of the 
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four treatments. Panelists rankings for label descriptions by treatment are presented in 
Tables 4.19 to 4.22. While no statistical differences (P > 0.10) were detected among 
treatments, panelists were able to distinguish product label rank per production system. 
The highest ranked label descriptions for IMPL and IMBA show that panelists were 
accepting of antibiotics and growth promotants when “optimally used to maintain animal 
health and improve productivity”, or “optimally used to maintain animal health in the 
event of illness and to increase productivity.” Panelists ranked environmental 
conservation label descriptions lower than hypothesized. However, the focus group 
alludes to the need for more tangible examples of emission reduction and water use on 
label descriptions for improved beef marketing. During label development for each 
treatment, the amount of information provided for each label description was considered. 
Research has demonstrated that too much information may risk panelist overload and 
yield boredom and impatience (Sal-aün and Flores, 2001). Further, the cognitive capacity 
to read and process information and the desire to do so were considered as described by 
(Caswell, 1998). Perhaps a reason why there was no significance per treatment in label 
preference was due to the conclusion of BrunsÆ et al. (2005) indicating that consumers 
are unique and may have different types of quality desires and not all labels are preferred 
the same to each panelist. In retail application, consumers may make label selections 
based upon additional factors besides intrinsic quality cues, such as brand and price 
(Bredahl, 2004). 
Trust in Third-Party Verification 
In regard to panelists’ trust and value for third-party process verification services 
of audited meat products (i.e. Organic and Grass Fed etc.), most panelists were likely 
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(85.7%) to prefer USDA followed by private agencies (2.9%). All other panelists either 
were not comfortable answering this question (6.7%), or thought these programs did not 
influence their purchases (4.8%). Similarly, Olynk and Ortega (2012) evaluated 
consumer WTP for verification preferences of dairy cattle management practices and 
determined USDA certification had the greatest WTP followed by the dairy industry in 
comparison with retailer certification. In this study, USDA is clearly the desired 
verification or certification entity trusted by panelists. 
Focus Group 
 Troy and Kerry (2010) describe the importance of “quality cues” as they relate to 
the belief and purchase choice of the consumer. To assist in “quality cue” discovery, 
focus groups were evaluated. The goal of these sub-sampled groups was to determine 
how the beef industry could enhance the perception of technology using scientific 
knowledge. Group discussion revealed that parents with pre-pubertal daughters perceived 
the term “hormones” negatively. Whereas the term, “growth promotants” is perceived by 
panelists to cause unusually large growth, which is not perceived as “natural” and 
therefore not desired. To panelists, “growth promotants” are perceived as only a producer 
benefit.  
Use of antibiotics also experienced some panelist resistance due to fears 
associated with antibiotic resistance. Some panelists were also concerned that an animal 
treated with an antibiotic may pass along the antibiotic to them through beef 
consumption. Panelists emphasized that due to human antibiotics becoming less effective, 
any method of transmission of antibiotics is worrisome. However, some panelists were 
more positive towards the use of antibiotics as they can relate to the need for antibiotic 
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treatment in the event of illness. Panelists can relate to the need for antibiotics themselves 
and can understand why an animal would need an antibiotic. In this instance, the use is 
acceptable as long as it is occasional. Though some very vocal participants stated, “I 
don’t want to see the word ‘illness’ and think I am eating an animal that was sick” while 
others stated; “It’s not like the animal was being raised with antibiotics. It only had it for 
the short time when it was sick.”  
Consumers place more concern about how the animal is raised in humane 
conditions than environmental influences from beef production. When developing labels, 
descriptions such as “less feed and water resources used” made panelists think that 
animals were deprived of water and resources. Also, the term, “efficiency” did not 
resonate well with panelists. This is because “efficiency” provides panelists with the 
perception that producers are focusing on raising the animal quickly and with less regard 
for animal care. Consumers prioritized their own health over environmental resources. 
Some panelists stated, “I think we are all probably concerned about our own health 
before, or at least as much as the environment” and “A 4% water reduction is a pretty 
minimal amount. Maybe if we lived in a drought stricken state this would be important, 
but we don’t.”  
Specifically, by beef consumption group, heavy beef eaters were permissive of 
the term ‘judicious use of antibiotics’. Panelists were willing to read additional 
information from web addresses on a label that describes how the animal was raised and 
why growth promotant technologies were used. Panelists stated that their most preferred 
way to gather information is from their friends and online resources (i.e. YouTube). 
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Panelists mentioned that free-range livestock may have tougher meat, though they were 
accepting of that product if the animal was taken care of in a better environment. 
Medium beef eaters indicated more concerns about antibiotic use and the 
possibility that antibiotic residue may be transferable to them through consumption. 
Panelists also mentioned that if animals are fed a nutritionally balanced diet they should 
not need growth promotants to support growth. However, some panelists mentioned that 
animal genetics have been adapted and the use of growth promotant technology should be 
used to reduce natural resources needed from the environment. When asked how to better 
market beef produced with growth promotant technology, panelists replied; “by showing 
a tangible example of how everyday use of the technology reduces an amount of water 
that is relatable to a physical example.” Lastly, the term “efficiency” should be avoided 
as it implies a producer benefit with no care for the animal.   
Light beef eaters were divided about the use of antibiotics. Some panelists did not 
want any use of antibiotics nor did they want to consume beef from an animal that had 
been sick. The words “antibiotics given in the event of illness” did not suit some panelists 
as they found it “creepy.” Whereas, other panelists thought it was polarizing that no 
antibiotics were given to an animal and sympathized the need for judicious antibiotic use 
for treatment. Panelists were also divided about the environmental impacts evaluated. 
Some panelists stated that they would be WTP more for beef that was grass-fed and 
perceived that to be more environmentally friendly, whereas others stated they would not 
due to budget constraints.  
 In summary, beef consumers use cues from their lives and other retail foods to 
provide awareness of health concerns when purchasing beef. BrunsÆ et al. (2005) describe 
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that product attributes are not meaningful themselves, but only to the extent that 
consumers expectations are for their undesired or desired consequences. Beef marketing 
should focus on the benefits that the product has for the consumer. A positive focus on 
consumer benefits should be more desirable than terms that resonate a producer benefit. 
Human health is prioritized before environmental gains in respect to the use of growth 
promotant technology. 
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IMPLICATIONS 
 Untrained panelists were able to differentiate treatments and prefered the 
palatability of beef from cattle raised without any technology when no beef production 
system information was provided. Panelists may be able to differentiate differences in 
meat tenderness, lipid, and moisture, as beef from cattle raised with full technology 
(monensin, tylosin, implants, and beta-adrenergic agonist) was consistently the least 
preferred. However, when provided both the production system information and samples 
to determine beef palatability, panelists preferred beef from cattle raised without 
hormones, but with judicious use of antibiotics and antimicrobials to maintain animal 
health and productivity. Overall, panelists disliked the use of hormones and were willing-
to-pay more for beef that ensured animal health and wellbeing, which was a priority over 
environmental conservation and may provide future opportunities for marketing beef 
raised with antibiotics and antimicrobials.   
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Table 4.1. Treatment abbreviations and determined marbling scores1. 
Trt. # Beef Production System Treatment Treatment Abbreviation 
Treatment (n = 120) strip 
loin Marbling Score 
Consumer Panel strip 
loin sub-set (n = 72) 
Marbling Score 
1 No technology utilized NA 554 551 
2 Non-hormone treated NHTC 562 558 
3 Implanted IMPL 487 493 
4 Implanted plus fed a beta-agonist IMBA 504 501 
1Marbling score determined by SDSU personnel using USDA-AMS grading standards where 200=Traces0, 
300=Slight0, 400=Small0, and 500=Modest0. 
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Table 4.2. Production system description provided to panelists1. 
Trt. # Production System Treatment Treatment  Abbreviation Description
1 
1 No technology utilized NA Beef produced from cattle never receiving 
antibiotics, added hormones, or other growth 
promoting products throughout their 
lifetime. 
 
2 Non-hormone treated NHTC Beef produced from cattle that never 
received added hormones or supplements 
that adjust fat to lean meat. Antibiotics and 
antimicrobials were used to maintain animal 
health and productivity.   
 
3 Implanted  IMPL Beef produced from cattle that never 
received supplements to adjust fat to lean 
meat but received other growth promoting 
technologies including use of antibiotics, 
antimicrobials, and added hormones. 
These technologies were used to maintain 
animal health and improve productivity. 
 
4 
 
Implanted plus fed a beta-agonist  
 
IMBA 
 
Beef produced from cattle that received 
growth promoting technologies including 
antibiotics, antimicrobials, added hormones, 
and supplements to adjust fat to lean meat. 
These technologies were used to maintain 
animal health and improve productivity. 
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Table 4.3.  Least squares means for percent lipid, moisture, cook loss and meat 
tenderness from steaks of carcasses represented in the consumer sensory analysis. 
Treatment1 Lipid, (%) Moisture, (%) Cook Loss (%)       WBSF, kg2 
NA 7.34b 69.79a 18.87ab 2.15a 
NHTC 7.27b 70.40a 17.61a 2.13a 
IMPL 5.58a 71.13b 20.31c 2.44b 
IMBA 5.92a 71.15b 19.29bc 2.42b 
SEM2 0.31 0.25   0.53 0.09 
P-value   < 0.0001   0.004     0.004   0.011 
a,b Least squares means in the same column lacking a common superscript differ (P < 
0.05) 
1 Four beef production systems: 1) NA (no technology utilized, control); 2) NHTC 
(non-hormone treated, fed Rumensin and Tylan during finishing); 3) IMPL 
(implanted, administered a series of three implants and fed Rumensin and Tylan 
during finishing); 4) IMBA (implanted plus fed a beta-agonist, same as treatment 
three plus, fed ractopamine hydrochloride (200 mg • steer-1 • d-1) for the last 30 d 
prior to harvest. 
2 Warner-Bratzler shear force (WBSF). 
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Table 4.4. Demographic characteristics of sampled participants (n = 105) 
Characteristic Response Percentage of participants 
Sex Male 50.5 
 Female 49.5 
Household Size 1 person 20.0 
 2 persons 39.0 
 3+ persons 41.0 
Marital Status  Single 50.5 
 Married 49.5 
Age Millennial 17.1 
 Generation X 22.9 
 Baby Boomer 60.0 
Annual Household Income Under $25,000 11.4 
 $25,000 to $49,999 18.1 
 $50,000 to $74,999 27.6 
 $75,000 to $100,000 28.6 
 $100,000 or more 14.3 
Education Did not graduate high school 1.0 
 High school graduate 6.7 
 Some college or technical school 37.1 
 College graduate 38.1 
 Post graduate 17.1 
Weekly Beef Consumption1 Light 39.0 
 Medium 52.4 
  Heavy 8.6 
Weekly Physical Activity None 1.9 
 < 2.5 hours 24.8 
 2.5 – 5 hours 38.1 
 Greater than 5 hours 35.2 
Eating Habits No restrictions 28.6 
 Some healthy foods 26.7 
 Mostly healthy foods 42.9 
 Only healthy foods 1.9 
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Table 4.5. Coefficient estimates and shares of preference from the undisclosed with 
meat consumer panel relative to beef from cattle receiving different levels of growth 
promotant technology. 
 Econometric Estimates Shares of Preference (%) 
Beef Category1 MNL  MNL 
NA       0.337*            27.8204a 
       (0.110)2             [1.729] 
     [0.000]3   
     
NHTC    0.284*  26.387b 
   (0.110)   [1.676] 
   [0.000]   
     
IMPL    0.266*  25.912b 
   (0.095)   [1.377] 
   [0.000]   
     
IMBA    0.000  19.881c 
   (0.000)   [1.395]    [0.000]   
N individuals 309    
N Choices                  1,854   
Log likelihood              -547.79   
Pseudo R2 0.01   
a,b,c Percentages in the same column lacking a common superscript differ (P < 0.05). 
1 Four beef production systems: 1) NA (no technology utilized, control); 2) NHTC 
(non-hormone treated, fed Rumensin and Tylan during finishing); 3) IMPL 
(implanted, administered a series of three implants and fed Rumensin and Tylan 
during finishing); 4) IMBA (implanted plus fed a beta-agonist, same as treatment three 
plus, fed ractopamine hydrochloride (200 mg • steer-1 • d-1) for the last 30 d prior to 
harvest. 
2 Numbers in ( ) are standard errors. 
3 Numbers in [ ] are standard deviations. 
4 Mean of simulated shares of preference of 1,000 observations drawn from a  
multivariate normal distribution parameterized using coefficients and variance- 
covariance terms. 
*Implies that the mean importance of the coefficient estimate is different from IMBA  
when (P < 0.05). 
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Table 4.6. Coefficient estimates and shares of preference from the disclosed without 
meat consumer panel relative to production information from cattle receiving different 
levels of growth promotant technology 
 Econometric Estimates Shares of Preference (%)  
Beef Category1 MNL  MNL 
NA 2.218*  50.4194a 
 (0.172)2   [3.085]  
 [0.000]3   
     
NHTC 1.767*  32.169b  
 (0.158)   [2.567] 
 [0.000]   
     
IMPL 0.769*  11.881c 
 (0.124)   [1.125] 
 [0.000]   
     
IMBA 0.000  5.530d 
 (0.000)  [0.754]  [0.000]   
N individuals     315   
N Choices  1,890   
Log likelihood    -402.59   
Pseudo R2         0.29   
a,b,c,d Percentages in the same column lacking a common superscript differ (P < 0.05). 
1 Four beef production systems: 1) NA (no technology utilized, control); 2) NHTC (non-
hormone treated, fed monensin and tylosin during finishing); 3) IMPL (implanted, 
administered a series of three implants and fed monensin and tylosin during finishing); 4) 
IMBA (implanted plus fed a beta-agonist, same as treatment three plus, fed ractopamine 
hydrochloride (200 mg • steer-1 • d-1) for the last 30 d prior to harvest. 
2 Numbers in ( ) are standard errors. 
3 Numbers in [ ] are standard deviations. 
4 Mean of simulated shares of preference of 1,000 observations drawn from a 
multivariate normal distribution parameterized by using the coefficients and 
variance-covariance terms. 
*Implies that the mean importance of the coefficient estimate is different from IMBA 
when (P < 0.05). 
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Table 4.7. Coefficient estimates and shares of preference from the disclosed with 
meat consumer panel relative to beef from cattle receiving different levels of 
growth promotant technology 
 Econometric Estimates Shares of Preference (%) 
Beef Category1 MNL  MNL
NA 1.265*  34.0074b 
 (0.132)2  [2.171] 
 [0.000]3   
     
NHTC 1.340*  36.676a 
 (0.134)  [2.271] 
 [0.000]   
     
IMPL 0.718*  19.684c 
 (0.111)  [1.275] 
 [0.000]   
     
IMBA 0.000  9.632d 
 (0.000)  [0.977]  [0.000]   
     
     
N individuals 315   
N Choices 1,890   
Log likelihood -485.39   
Pseudo R2       0.14   
a,b,c,d Percentages in the same column lacking a common superscript differ (P < 
0.05) 
1 Four beef production systems: 1) NA (no technology utilized, control); 2) 
NHTC (non-hormone treated, fed Rumensin and Tylan during finishing); 3) 
IMPL (implanted, administered a series of three implants and fed monensin and 
tylosin during finishing); 4) IMBA (implanted plus fed the beta-agonist 
ractopamine hydrochloride (200 mg • steer-1 • d-1) for the last 30 d prior to 
harvest. 
2 Numbers in ( ) are standard errors 
3 Numbers in [ ] are standard deviations 
4 Mean of simulated shares of preference of 1,000 observations drawn from a 
multivariate normal distribution parameterized by using the coefficients and 
variance-covariance terms 
*Implies that the mean importance of the coefficient estimate is different from 
IMBA when (P < 0.05) 
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Table 4.8. Probability of consumer demographic most preferred product category (mean ± 
SE) during the undisclosed with meat consumer panel. 
Effect N NA1 NHTC IMPL IMBA 
Sex  P = 0.298 P = 0.303 P = 0.611 P = 0.532 
Male  53    0.25 ± 0.03 0.25 ± 0.03 0.33 ± 0.04 0.17 ± 0.03 
Female  52    0.24 ± 0.03 0.24 ± 0.03 0.36 ± 0.04 0.16 ± 0.03 
Household Size  P = 0.753 P = 0.155 P = 0.337 P = 0.931 
1 Person 21 0.27 ± 0.06 0.24 ± 0.05 0.29 ± 0.06 0.21 ± 0.05 
2 Persons 41 0.27 ± 0.04 0.19 ± 0.04 0.41 ± 0.05 0.13 ± 0.03 
3+ Persons 43 0.21 ± 0.04 0.30 ± 0.04 0.32 ± 0.04 0.17 ± 0.03 
Marital Status  P = 0.782 P = 0.149 P = 0.495 P = 0.668 
Single 53 0.26 ± 0.03 0.25 ± 0.03 0.30 ± 0.04 0.20 ± 0.03 
Married 52 0.23 ± 0.03 0.25 ± 0.04 0.40 ± 0.04 0.12 ± 0.03 
Age2  P = 0.307 P = 0.656 P = 0.435 P = 0.291 
Millennial 18 0.35 ± 0.07 0.26 ± 0.06 0.22 ± 0.06 0.17 ± 0.05 
Generation X 24 0.25 ± 0.05 0.23 ± 0.05 0.30 ± 0.06 0.22 ± 0.05 
Baby Boomer 63 0.22 ± 0.03 0.25 ± 0.03 0.40 ± 0.04 0.14 ± 0.03 
Household Income  P = 0.947 P = 0.723 P = 0.742 P = 0.508 
< $25,000 12 0.28 ± 0.08 0.19 ± 0.07 0.25 ± 0.07 0.28 ± 0.08 
$25,000 - $49,999 19 0.22 ± 0.06 0.17 ± 0.05 0.31 ± 0.06 0.24 ± 0.06 
$50,000 - $74,999 29 0.25 ± 0.05 0.27 ± 0.05 0.38 ± 0.05 0.10 ± 0.03 
$75,000 - $100,000 30 0.22 ± 0.04 0.27 ± 0.05 0.37 ± 0.05 0.14 ± 0.04 
> $100,000 15 0.22 ± 0.06 0.29 ± 0.07 0.36 ± 0.07 0.13 ± 0.05 
Education Level  P = 0.648 P = 0.273 P = 0.991 P = 0.588 
Non-High School Graduate 1 0.67 ± 0.33 0.00 ± 0.00 0.00 ± 0.00 0.33 ± 0.33 
High School Graduate 7 0.10 ± 0.07 0.29 ± 0.10 0.33 ± 0.11 0.29 ± 0.10 
Some College/Tech School 39 0.26 ± 0.04 0.19 ± 0.04 0.38 ± 0.05 0.17 ± 0.04 
College Graduate 40 0.25 ± 0.04 0.27 ± 0.04 0.33 ± 0.04 0.15 ± 0.03 
Post Graduate 18 0.24 ± 0.06 0.31 ± 0.06 0.33 ± 0.06 0.11 ± 0.04 
Weekly Beef Consumption3  P = 0.005 P = 0.359 P = 0.204 P = 0.839 
Light 41 0.30 ± 0.04a 0.21 ± 0.04 0.31 ± 0.04 0.18 ± 0.03 
Medium 55 0.19 ± 0.03b 0.28 ± 0.04 0.38 ± 0.04 0.16 ± 0.03 
Heavy 9 0.33 ± 0.09a 0.22 ± 0.08 0.33 ± 0.09 0.11 ± 0.06 
Weekly Physical Activity  P = 0.165 P = 0.477 P = 0.634 P = 0.902 
None 2 0.50 ± 0.22 0.50 ± 0.22 0.00 ± 0.00 0.00 ± 0.00 
< 2.5 hours 26 0.19 ± 0.05 0.28 ± 0.05 0.32 ± 0.05 0.21 ± 0.05 
2.5 – 5 hours 40 0.28 ± 0.04 0.23 ± 0.04 0.34 ± 0.04 0.15 ± 0.03 
Greater than 5 hours 37 0.23 ± 0.04 0.23 ± 0.04 0.39 ± 0.05 0.15 ± 0.03 
Eating Habits  P = 0.707 P = 0.228 P = 0.810 P = 0.474 
No restrictions 30 0.26 ± 0.05 0.18 ± 0.04 0.33 ± 0.05 0.22 ± 0.04 
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Some healthy foods 28 0.22 ± 0.05 0.27 ± 0.05 0.37 ± 0.05 0.14 ± 0.04 
Mostly healthy foods 45 0.24 ± 0.04 0.28 ± 0.04 0.33 ± 0.04 0.14 ± 0.03 
Only healthy foods 2 0.33 ± 0.21 0.00 ± 0.00 0.50 ± 0.22 0.17 ± 0.17 
a,b Descriptive means in the same column within an effect lacking a common superscript 
differ (P < 0.05) after adjusted for multiplicity using the tukey procedure. 
 
     
1 Four beef production systems: 1) NA (no technology utilized, control); 2) NHTC (non-
hormone treated, fed Rumensin and Tylan during finishing); 3) IMPL (implanted, 
administered a series of three implants and fed Rumensin and Tylan during finishing); 4) 
IMBA (implanted plus fed the beta-agonist ractopamine hydrochloride (200 mg • steer-1 • 
d-1) for the last 30 d prior to harvest. 
2 Consumers identified age as either Millennial (18-34), Generation X (35-50), or Baby 
Boomers (over 50). 
3Consumption including ground beef, steak, pre-cooked and/or further processed beef either 
at home or dining out where Light is 1-2 per week, Medium is 3-4, and Heavy is 5 or more.  
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Table 4.9. Probability of consumer demographic least preferred product category  
(mean ± SE) during the undisclosed with meat consumer panel.   
Effect N NA1 NHTC IMPL IMBA 
Sex  P = 0.965 P = 0.476 P = 0.663 P = 0.236 
Male  53    0.21 ± 0.03 0.21 ± 0.03 0.31 ± 0.04 0.28 ± 0.04 
Female  52    0.17 ± 0.03 0.22 ± 0.03 0.31 ± 0.04 0.30 ± 0.04 
Household Size  P = 0.053 P = 0.102 P = 0.650 P = 0.579 
1 Person 21 0.19 ± 0.05 0.16 ± 0.05 0.35 ± 0.04 0.30 ± 0.06 
2 Persons 41 0.14 ± 0.03 0.26 ± 0.04 0.30 ± 0.04 0.30 ± 0.04 
3+ Persons 22 0.23 ± 0.04 0.21 ± 0.04 0.29 ± 0.06 0.27 ± 0.04 
Marital Status  P = 0.717 P = 0.071 P = 0.608 P = 0.107 
Single 52 0.16 ± 0.03 0.24 ± 0.03x 0.35 ± 0.04 0.26 ± 0.03 
Married 53 0.22 ± 0.03 0.19 ± 0.03y 0.27 ± 0.04 0.32 ± 0.04 
Age2  P = 0.086 P = 0.374 P = 0.164 P = 0.699 
Millennial 18 0.07 ± 0.04 0.24 ± 0.06 0.37 ± 0.07 0.31 ± 0.06 
Generation X 24 0.17 ± 0.05 0.16 ± 0.04 0.39 ± 0.06 0.28 ± 0.05 
Baby Boomer 63 0.23 ± 0.03 0.23 ± 0.03 0.26 ± 0.03 0.28 ± 0.03 
Household Income  P = 0.166 P = 0.580 P = 0.626 P = 0.811 
< $25,000 12 0.06 ± 0.04 0.31 ± 0.08 0.44 ± 0.08 0.19 ± 0.07 
$25,000 - $49,999 19 0.19 ± 0.05 0.24 ± 0.06 0.31 ± 0.06 0.26 ± 0.06 
$50,000 - $74,999 29 0.19 ± 0.04 0.17 ± 0.04 0.33 ± 0.05 0.31 ± 0.05 
$75,000 - $100,000 30 0.19 ± 0.04 0.20 ± 0.04 0.28 ± 0.05 0.33 ± 0.05 
> $100,000 15 0.29 ± 0.07 0.24 ± 0.06 0.20 ± 0.06 0.27 ± 0.07 
Education Level  P = 0.408 P = 0.346 P = 0.633 P = 0.477 
Non-High School Graduate 1 0.00 ± 0.00 0.00 ± 0.00 0.67 ± 0.33 0.33 ± 0.33 
High School Graduate 7 0.29 ± 0.10 0.29 ± 0.10 0.29 ± 0.10 0.14 ± 0.08 
Some College/Tech School 39 0.18 ± 0.04 0.24 ± 0.04 0.33 ± 0.04 0.24 ± 0.04 
College Graduate 40 0.17 ± 0.03 0.21 ± 0.04 0.27 ± 0.04 0.36 ± 0.04 
Post Graduate 18 0.22 ± 0.06 0.17 ± 0.05 0.33 ± 0.06 0.28 ± 0.06 
Weekly Beef Consumption3  P = 0.095 P = 0.516 P = 0.724 P = 0.854 
Light 41 0.17 ± 0.03 0.21 ± 0.04 0.33 ± 0.04 0.28 ± 0.04 
Medium 55 0.21 ± 0.03 0.21 ± 0.03 0.29 ± 0.04 0.29 ± 0.04 
Heavy 9 0.11 ± 0.06 0.30 ± 0.09 0.30 ± 0.09 0.30 ± 0.09 
Weekly Physical Activity  P = 0.453 P = 0.960 P = 0.195 P = 0.423 
None 2 0.17 ± 0.17 0.17 ± 0.17 0.00 ± 0.00 0.67 ± 0.21 
< 2.5 hours 26 0.20 ± 0.05 0.21 ± 0.05 0.36 ± 0.06 0.23 ± 0.05 
2.5 – 5 hours 40 0.17 ± 0.03 0.18 ± 0.03 0.35 ± 0.04 0.31 ± 0.04 
Greater than 5 hours 37 0.20 ± 0.04 0.27 ± 0.04 0.24 ± 0.04 0.29 ± 0.04 
Eating Habits  P = 0.835 P = 0.633 P = 0.967 P = 0.538 
No restrictions 30 0.17 ± 0.04 0.26 ± 0.05 0.32 ± 0.05 0.24 ± 0.05 
Some healthy foods 28 0.20 ± 0.04 0.16 ± 0.04 0.32 ± 0.05 0.32 ± 0.05 
Mostly healthy foods 45 0.19 ± 0.03 0.21 ± 0.04 0.29 ± 0.04 0.31 ± 0.04  
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Only healthy foods 2 0.33 ± 0.21 0.33 ± 0.21 0.33 ± 0.21 0.00 ± 0.00  
x,y Descriptive means in the same column within an effect lacking a common superscript tend 
to differ (P > 0.05 to 0.10) after adjusted for multiplicity using the tukey procedure. 
1 Four beef production systems: 1) NA (no technology utilized, control); 2) NHTC (non-
hormone treated, fed Rumensin and Tylan during finishing); 3) IMPL (implanted, 
administered a series of three implants and fed Rumensin and Tylan during finishing); 4) 
IMBA (implanted plus fed the beta-agonist ractopamine hydrochloride (200 mg • steer-1 • 
d-1) for the last 30 d prior to harvest. 
2 Consumers identified age as either Millennial (18-34), Generation X (35-50), or Baby 
Boomers (over 50). 
3Consumption including ground beef, steak, pre-cooked and/or further processed beef either 
at home or dining out where Light is 1-2 per week, Medium is 3-4, and Heavy is 5 or more.  
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Table 4.10. Probability of consumer demographic most preferred product category  
(mean ± SE) during the disclosed without meat consumer panel.   
Effect N NA1 NHTC IMPL IMBA  
Sex  P = 0.018 P = 0.644 P = 0.002 P = 0.983  
Male  53 0.44 ± 0.04b 0.34 ± 0.04 0.17 ± 0.03a 0.05 ± 0.02  
Female  52 0.58 ± 0.04a 0.33 ± 0.04 0.05 ± 0.02b 0.04 ± 0.02  
Household Size  P = 0.615 P = 0.983 P = 0.699 P = 0.202  
1 Person 21 0.46 ± 0.06 0.32 ± 0.06 0.11 ± 0.04 0.11 ± 0.04  
2 Persons 41 0.57 ± 0.05 0.33 ± 0.04 0.08 ± 0.02 0.03 ± 0.01  
3+ Persons 43 0.48 ± 0.04 0.35 ± 0.04 0.14 ± 0.03 0.03 ± 0.02  
Marital Status  P = 0.891 P = 0.895 P = 0.946 P = 0.991  
Single 52 0.50 ± 0.04 0.35 ± 0.04 0.09 ± 0.02 0.07 ± 0.03  
Married 53 0.51 ± 0.04 0.33 ± 0.04 0.13 ± 0.03 0.03 ± 0.01  
Age2  P = 0.901 P = 0.873 P = 0.443 P = 0.672  
Millennial 18 0.52 ± 0.07 0.35 ± 0.07 0.07 ± 0.04 0.06 ± 0.03  
Generation X 24 0.51 ± 0.06 0.33 ± 0.06 0.13 ± 0.04 0.03 ± 0.02  
Baby Boomer 63 0.51 ± 0.04 0.33 ± 0.03 0.11 ± 0.02 0.05 ± 0.02  
Household Income  P = 0.881 P = 0.831 P = 0.700 P = 0.351  
< $25,000 12 0.48 ± 0.08 0.31 ± 0.08 0.11 ± 0.05 0.08 ± 0.05  
$25,000 - $49,999 19 0.45 ± 0.07 0.37 ± 0.07 0.07 ± 0.04 0.07 ± 0.04  
$50,000 - $74,999 29 0.53 ± 0.05 0.37 ± 0.05 0.14 ± 0.04 0.04 ± 0.02  
$75,000 - $100,000 30 0.60 ± 0.07 0.32 ± 0.05 0.12 ± 0.03 0.02 ± 0.02  
> $100,000 15 0.60 ± 0.07 0.29 ± 0.07 0.07 ± 0.04 0.04 ± 0.03  
Education Level  P = 0.573 P = 0.887 P = 0.609 P = 0.977  
Non-High School Graduate 1 0.00 ± 0.00 0.33 ± 0.33 0.33 ± 0.33 0.33 ± 0.33  
High School Graduate 7 0.43 ± 0.11 0.29 ± 0.10 0.24 ± 0.10 0.05 ± 0.05  
Some College/Tech School 39 0.48 ± 0.05 0.38 ± 0.05 0.11 ± 0.03 0.04 ± 0.02  
College Graduate 40 0.59 ± 0.05 0.33 ± 0.04 0.05 ± 0.02 0.03 ± 0.01  
Post Graduate 18 0.44 ± 0.07 0.28 ± 0.06 0.19 ± 0.05 0.09 ± 0.04  
Weekly Beef Consumption3  P = 0.364 P = 0.676 P = 0.732 P = 0.062  
Light 41 0.53 ± 0.05 0.30 ± 0.04 0.11 ± 0.03 0.07 ± 0.02xy  
Medium 55 0.51 ± 0.04 0.36 ± 0.04 0.11 ± 0.03 0.02 ± 0.01y  
Heavy 9 0.41 ± 0.10 0.37 ± 0.09 0.11 ± 0.06 0.11 ± 0.06x  
Weekly Physical Activity  P = 0.937 P = 0.713 P = 0.389 P = 0.806  
None 2 0.67 ± 0.21 0.17 ± 0.17 0.00 ± 0.00 0.17 ± 0.17  
< 2.5 hours 26 0.48 ± 0.06 0.35 ± 0.06 0.13 ± 0.04 0.04 ± 0.02  
2.5 – 5 hours 40 0.48 ± 0.05 0.33 ± 0.04 0.14 ± 0.03 0.05 ± 0.02  
Greater than 5 hours 37 0.55 ± 0.05 0.35 ± 0.05 0.06 ± 0.02 0.04 ± 0.02  
Eating Habits  P = 0.280 P = 0.919 P = 0.648 P = 0.926  
No restrictions 30 0.46 ± 0.05 0.34 ± 0.05 0.15 ± 0.04 0.05 ± 0.02  
Some healthy foods 28 0.48 ± 0.06 0.35 ± 0.05 0.12 ± 0.04 0.05 ± 0.02  
Mostly healthy foods 45 0.57 ± 0.04 0.32 ± 0.04 0.07 ± 0.02 0.04 ± 0.02  
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Only healthy foods 2 0.17 ± 0.17 0.50 ± 0.22 0.17 ± 0.17 0.17 ± 0.17  
a,b Descriptive means in the same column within an effect lacking a common superscript 
differ (P < 0.05) after adjusted for multiplicity using the tukey procedure. 
x,y Descriptive means in the same column within an effect lacking a common superscript tend 
to differ (P > 0.05 to 0.10) after adjusted for multiplicity using the tukey procedure.  
1 Four beef production systems: 1) NA (no technology utilized, control); 2) NHTC (non-
hormone treated, fed Rumensin and Tylan during finishing); 3) IMPL (implanted, 
administered a series of three implants and fed Rumensin and Tylan during finishing); 4) 
IMBA (implanted plus fed the beta-agonist ractopamine hydrochloride (200 mg • steer-1 • 
d-1) for the last 30 d prior to harvest. 
2 Consumers identified age as either Millennial (18-34), Generation X (35-50), or Baby 
Boomers (over 50). 
3Consumption including ground beef, steak, pre-cooked and/or further processed beef either 
at home or dining out where Light is 1-2 per week, Medium is 3-4, and Heavy is 5 or more.  
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Table 4.11. Probability of consumer demographic least preferred product category  
(mean ± SE) during the disclosed without meat consumer panel.   
Effect N NA1 NHTC IMPL IMBA 
Sex  P = 0.195 P =.318 P = 0.067 P = 0.620 
Male  53    0.10 ± 0.02 0.07 ± 0.02 0.37 ± 0.04y 0.46 ± 0.04 
Female  52     0.04 ± 0.02 0.03 ± 0.01 0.45 ± 0.04x 0.48 ± 0.04 
Household Size  P = 0.632 P = 0.494 P = 0.387 P = 0.576 
1 Person 21 0.10 ± 0.04 0.05 ± 0.03 0.40 ± 0.06 0.46 ± 0.06 
2 Persons 41 0.04 ± 0.02 0.03 ± 0.01 0.44 ± 0.05 0.49 ± 0.05 
3+ Persons 43 0.09 ± 0.03 0.07 ± 0.02 0.38 ± 0.04 0.46 ± 0.04 
Marital Status  P = 0.526 P = 0.511 P = 0.208 P = 0.237 
Single 52 0.07 ± 0.02 0.06 ± 0.02 0.39 ± 0.04 0.50 ± 0.04 
Married 53 0.07 ± 0.02 0.05 ± 0.02 0.43 ± 0.04 0.45 ± 0.04 
Age2  P = 0.675 P = 0.480 P = 0.562 P = 0.963 
Millennial 18 0.02 ± 0.02 0.04 ± 0.03 0.46 ± 0.07 0.48 ± 0.07 
Generation X 24 0.09 ± 0.03 0.03 ± 0.02 0.41 ± 0.06 0.48 ± 0.06 
Baby Boomer 63 0.08 ± 0.02 0.06 ± 0.02 0.39 ± 0.04 0.47 ± 0.04 
Household Income  P = 0.416 P = 0.736 P = 0.335 P = 0.439 
< $25,000 12 0.03 ± 0.03 0.06 ± 0.04 0.44 ± 0.08 0.47 ± 0.08 
$25,000 - $49,999 19 0.11 ± 0.04 0.06 ± 0.03 0.35 ± 0.07 0.48 ± 0.07 
$50,000 - $74,999 29 0.06 ± 0.03 0.05 ± 0.02 0.35 ± 0.05 0.55 ± 0.05 
$75,000 - $100,000 30 0.09 ± 0.03 0.03 ± 0.02 0.47 ± 0.05 0.41 ± 0.05 
> $100,000 15 0.04 ± 0.03 0.07 ± 0.04 0.44 ± 0.07 0.44 ± 0.07 
Education Level  P = 0.227 P = 0.476 P = 0.484 P = 0.822 
Non-High School Graduate 1 0.00 ± 0.00 0.33 ± 0.33 0.67 ± 0.33 0.00 ± 0.00 
High School Graduate 7 0.10 ± 0.07 0.19 ± 0.09 0.29 ± 0.10 0.43 ± 0.11 
Some College/Tech School 39 0.06 ± 0.02 0.00 ± 0.00 0.42 ± 0.05 0.51 ± 0.05 
College Graduate 40 0.03 ± 0.02 0.04 ± 0.02 0.47 ± 0.05 0.46 ± 0.05 
Post Graduate 18 0.17 ± 0.05 0.09 ± 0.04 0.28 ± 0.06 0.46 ± 0.07 
Weekly Beef Consumption3  P = 0.977 P = 0.594 P = 0.820 P = 0.907 
Light 41 0.05 ± 0.02 0.07 ± 0.02 0.42 ± 0.04 0.46 ± 0.05 
Medium 55 0.09 ± 0.02 0.03 ± 0.01 0.40 ± 0.04 0.48 ± 0.04 
Heavy 9 0.04 ± 0.04 0.07 ± 0.05 0.37 ± 0.09 0.52 ± 0.10 
Weekly Physical Activity  P = 0.269 P = 0.764 P = 0.456 P = 0.734 
None 2 0.00 ± 0.00 0.00 ± 0.00 0.50 ± 0.22 0.50 ± 0.22 
< 2.5 hours 26 0.09 ± 0.03 0.04 ± 0.02 0.36 ± 0.06 0.51 ± 0.06 
2.5 – 5 hours 40 0.09 ± 0.03 0.06 ± 0.02 0.46 ± 0.05 0.45 ± 0.05 
Greater than 5 hours 37 0.04 ± 0.02 0.05 ± 0.02 0.38 ± 0.04 0.47 ± 0.05 
Eating Habits  P = 0.240 P = 0.658 P = 0.898 P = 0.950 
No restrictions 30 0.13 ± 0.04 0.03 ± 0.02 0.37 ± 0.05 0.47 ± 0.05 
Some healthy foods 28 0.06 ± 0.03 0.05 ± 0.02 0.40 ± 0.05 0.49 ± 0.06 
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Mostly healthy foods 45 0.04 ± 0.02 0.06 ± 0.02 0.44 ± 0.04 0.46 ± 0.04 
Only healthy foods 2 0.17 ± 0.17 0.00 ± 0.00 0.33 ± 0.21 0.50 ± 0.22 
x,y Descriptive means in the same column within an effect lacking a common superscript 
tend to differ (P > 0.05 to 0.10) after adjusted for multiplicity using the tukey procedure. 
1 Four beef production systems: 1) NA (no technology utilized, control); 2) NHTC (non-
hormone treated, fed Rumensin and Tylan during finishing); 3) IMPL (implanted, 
administered a series of three implants and fed monensin and tylosin during finishing); 4) 
IMBA (implanted plus fed the beta-agonist ractopamine hydrochloride (200 mg • steer-1 • 
d-1) for the last 30 d prior to harvest. 
2 Consumers identified age as either Millennial (18-34), Generation X (35-50), or Baby 
Boomers (over 50). 
3Consumption including ground beef, steak, pre-cooked and/or further processed beef either 
at home or dining out where Light is 1-2 per week, Medium is 3-4, and Heavy is 5 or more. 
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Table 4.12. Probability of consumer demographic most preferred product category 
(mean ± SE) during the disclosed with meat consumer panel. 
Effect N NA1 NHTC IMPL IMBA 
Sex  P = 0.399 P = 0.895 P = 0.529 P = 0.805 
Male  53 0.33 ± 0.04 0.34 ± 0.04 0.24 ± 0.03 0.08 ± 0.02 
Female  52 0.39 ± 0.04 0.32 ± 0.04 0.24 ± 0.03 0.05 ± 0.02 
Household Size  P = 0.836 P = 0.752 P = 0.476 P = 0.116 
1 Person 21 0.40 ± 0.06 0.29 ± 0.06 0.21 ± 0.05 0.11 ± 0.04 
2 Persons 41 0.34 ± 0.04 0.35 ± 0.04 0.25 ± 0.04 0.06 ± 0.02 
3+ Persons 43 0.37 ± 0.04 0.33 ± 0.04 0.25 ± 0.04 0.05 ± 0.03 
Marital Status  P = 0.847 P = 0.411 P = 0.332 P = 0.583 
Single 52 0.39 ± 0.04 0.31 ± 0.04 0.24 ± 0.03 0.06 ± 0.02 
Married 53 0.33 ± 0.04 0.35 ± 0.04 0.25 ± 0.04 0.07 ± 0.02 
Age2  P = 0.933 P = 0.579 P = 0.806 P = 0.453 
Millennial 18 0.37 ± 0.07 0.33 ± 0.06 0.28 ± 0.06 0.02 ± 0.02 
Generation X 24 0.36 ± 0.06 0.30 ± 0.06 0.26 ± 0.05 0.07 ± 0.03 
Baby Boomer 63 0.36 ± 0.04 0.34 ± 0.03 0.23 ± 0.03 0.08 ± 0.02 
Household Income  P = 0.635 P = 0.636 P = 0.399 P = 0.263 
< $25,000 12 0.42 ± 0.08 0.42 ± 0.08 0.17 ± 0.06 0.00 ± 0.00 
$25,000 - $49,999 19 0.44 ± 0.07 0.26 ± 0.06 0.24 ± 0.06 0.06 ± 0.03 
$50,000 - $74,999 29 0.36 ± 0.05 0.31 ± 0.05 0.27 ± 0.05 0.06 ± 0.03 
$75,000 - $100,000 30 0.36 ± 0.05 0.37 ± 0.05 0.21 ± 0.04 0.07 ± 0.03 
> $100,000 15 0.24 ± 0.06 0.31 ± 0.07 0.31 ± 0.07 0.13 ± 0.05 
Education Level  P = 0.185 P = 0.578 P = 0.651 P = 0.138 
Non-High School Graduate 1 0.33 ± 0.33 0.67 ± 0.33 0.00 ± 0.00 0.00 ± 0.00 
High School Graduate 7 0.38 ± 0.11 0.24 ± 0.10 0.29 ± 0.10 0.10 ± 0.07 
Some College/Tech School 39 0.38 ± 0.05 0.33 ± 0.04 0.25 ± 0.04 0.04 ± 0.02 
College Graduate 40 0.41 ± 0.05 0.33 ± 0.04 0.21 ± 0.04 0.05 ± 0.02 
Post Graduate 18 0.22 ± 0.06 0.33 ± 0.06 0.30 ± 0.06 0.15 ± 0.05 
Weekly Beef Consumption3  P = 0.825 P = 0.264 P = 0.141 P = 0.228 
Light 41 0.32 ± 0.04 0.35 ± 0.04 0.28 ± 0.04 0.06 ± 0.02 
Medium 55 0.39 ± 0.04 0.34 ± 0.04 0.21 ± 0.03 0.06 ± 0.02 
Heavy 9 0.41 ± 0.10 0.19 ± 0.08 0.26 ± 0.09 0.15 ± 0.07 
Weekly Physical Activity  P = 0.661 P = 0.468 P = 0.753 P = 0.586 
None 2 0.33 ± 0.21 0.17 ± 0.17 0.33 ± 0.21 0.17 ± 0.17 
< 2.5 hours 26 0.33 ± 0.05 0.37 ± 0.06 0.25 ± 0.05 0.04 ± 0.02 
2.5 – 5 hours 40 0.35 ± 0.04 0.35 ± 0.04 0.24 ± 0.04 0.06 ± 0.02 
Greater than 5 hours 37 0.40 ± 0.05 0.29 ± 0.04 0.23 ± 0.04 0.08 ± 0.03 
Eating Habits  P = 0.317 P = 0.834 P = 0.460 P = 0.275 
No restrictions 30 0.39 ± 0.05 0.31 ± 0.05 0.26 ± 0.05 0.03 ± 0.02 
Some healthy foods 28 0.27 ± 0.05 0.37 ± 0.05 0.26 ± 0.05 0.10 ± 0.03 
Mostly healthy foods 45 0.40 ± 0.04 0.32 ± 0.04 0.21 ± 0.04 0.07 ± 0.02 
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Only healthy foods 2 0.33 ± 0.21 0.33 ± 0.21 0.33 ± 0.21 0.00 ± 0.00 
1 Four beef production systems: 1) NA (no technology utilized, control); 2) NHTC (non-
hormone treated, fed monensin and tylosin during finishing); 3) IMPL (implanted, 
administered a series of three implants and fed monensin and tylosin during finishing); 4) 
IMBA (implanted plus fed the beta-agonist ractopamine hydrochloride (200 mg • steer-1 • d-
1) for the last 30 d prior to harvest. 
2 Consumers identified age as either Millennial (18-34), Generation X (35-50), or Baby 
Boomers (over 50). 
3Consumption including ground beef, steak, pre-cooked and/or further processed beef either at 
home or dining out where Light is 1-2 per week, Medium is 3-4, and Heavy is 5 or more. 
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Table 4.13. Probability of consumer demographic least preferred product category  
(mean ± SE) during the disclosed with meat consumer panel.   
Effect N NA1 NHTC IMPL IMBA 
Sex  P = 0.496 P = 0.663 P = 0.107 P = 0.527 
Male 53 0.17 ± 0.03 0.08 ± 0.02 0.31 ± 0.04 0.44 ± 0.04 
Female 52 0.12 ± 0.03 0.07 ± 0.02 0.36 ± 0.04 0.46 ± 0.04 
Household Size  P = 0.066 P = 0.261 P = 0.040 P = 0.256 
1 Person 21 0.16 ± 0.05 0.06 ± 0.03 0.40 ± 0.06a 0.38 ± 0.06 
2 Persons 41 0.19 ± 0.04 0.06 ± 0.02 0.28 ± 0.04b 0.47 ± 0.05 
3+ Persons 22 0.10 ± 0.03 0.09 ± 0.03 0.36 ± 0.06ab 0.46 ± 0.04 
Marital Status  P = 0.528 P = 0.010 P = 0.075 P = 0.426 
Single 36 0.13 ± 0.03 0.09 ± 0.02a 0.33 ± 0.04y 0.45 ± 0.05 
Married 52 0.17 ± 0.03 0.05 ± 0.02b 0.35 ± 0.04x 0.44 ± 0.04 
Age2  P = 0.470 P = 0.583 P = 0.129 P = 0.769 
Millennial 18 0.11 ± 0.04 0.11 ± 0.04 0.26 ± 0.06 0.52 ± 0.07 
Generation X 24 0.19 ± 0.05 0.04 ± 0.02 0.35 ± 0.06 0.42 ± 0.06 
Baby Boomer 63 0.14 ± 0.03 0.07 ± 0.02 0.35 ± 0.04 0.44 ± 0.04 
Annual Household Income  P = 0.607 P = 0.431 P = 0.225 P = 0.862 
< $25,000 12 0.06 ± 0.04 0.03 ± 0.03 0.44 ± 0.08 0.47 ± 0.08 
$25,000 - $49,999 6 0.13 ± 0.05 0.11 ± 0.04 0.33 ± 0.06 0.43 ± 0.07 
$50,000 - $74,999 29 0.12 ± 0.04 0.10 ± 0.03 0.32 ± 0.05 0.46 ± 0.05 
$75,000 - $100,000 30 0.17 ± 0.04 0.06 ± 0.02 0.31 ± 0.05 0.47 ± 0.05 
> $100,000 15 0.24 ± 0.06 0.04 ± 0.03 0.33 ± 0.07 0.38 ± 0.07 
Education Level  P = 0.289 P = 0.132 P = 0.869 P = 0.822 
Non-High School Graduate 1 0.00 ± 0.00 0.00 ± 0.00 0.33 ± 0.33 0.67 ± 0.33 
High School Graduate 7 0.10 ± 0.07 0.24 ± 0.10 0.33 ± 0.11 0.33 ± 0.11 
Some College/Tech School 39 0.13 ± 0.03 0.05 ± 0.02 0.32 ± 0.04 0.50 ± 0.05 
College Graduate 40 0.13 ± 0.03 0.06 ± 0.02 0.36 ± 0.04 0.45 ± 0.05 
Post Graduate 18 0.24 ± 0.06 0.07 ± 0.04 0.31 ± 0.06 0.37 ± 0.07 
Weekly Beef Consumption3  P = 0.575 P = 0.016 P = 0.086 P = 0.366 
Light 41 0.15 ± 0.03 0.07 ± 0.02ab 0.31 ± 0.04 0.47 ± 0.05 
Medium 55 0.16 ± 0.03 0.05 ± 0.02b 0.37 ± 0.04 0.42 ± 0.04 
Heavy 9 0.04 ± 0.04 0.22 ± 0.08a 0.26 ± 0.09 0.48 ± 0.10 
Weekly Physical Activity  P = 0.637 P = 0.380 P = 0.782 P = 0.672 
None 2 0.17 ± 0.17 0.00 ± 0.00 0.50 ± 0.22 0.33 ± 0.21 
< 2.5 hours 26 0.13 ± 0.04 0.07 ± 0.03 0.32 ± 0.05 0.48 ± 0.06 
2.5 – 5 hours 40 0.17 ± 0.03 0.05 ± 0.02 0.35 ± 0.04 0.43 ± 0.05 
Greater than 5 hours 37 0.13 ± 0.03 0.10 ± 0.03 0.32 ± 0.05 0.44 ± 0.05 
Eating Habits  P = 0.652 P = 0.480 P = 0.888 P = 0.401 
No restrictions 30 0.18 ± 0.04 0.09 ± 0.03 0.34 ± 0.05 0.38 ± 0.05 
Some healthy foods 28 0.16 ± 0.04 0.06 ± 0.03 0.35 ± 0.05 0.43 ± 0.06 
Mostly healthy foods 45 0.12 ± 0.03 0.07 ± 0.02 0.33 ± 0.04 0.49 ± 0.04 
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Only healthy foods 2 0.00 ± 0.00 0.00 ± 0.00 0.33 ± 0.21 0.67 ± 0.21 
a,b Descriptive means in the same column within an effect lacking a common superscript 
differ (P < 0.05) after adjusted for multiplicity using the tukey procedure.  
x,y Descriptive means in the same column within an effect lacking a common superscript 
tend to differ (P > 0.05 to 0.10) after adjusted for multiplicity using the tukey procedure. 
1 Four beef production systems: 1) NA (no technology utilized, control); 2) NHTC (non-
hormone treated, fed monensin and tylosin during finishing); 3) IMPL (implanted, 
administered a series of three implants and fed monensin and tylosin during finishing); 4) 
IMBA (implanted plus fed the beta-agonist ractopamine hydrochloride (200 mg • steer-1 • 
d-1) for the last 30 d prior to harvest. 
2 Consumers identified age as either Millennial (18-34), Generation X (35-50), or Baby 
Boomers (over 50). 
3Consumption including ground beef, steak, pre-cooked and/or further processed beef either 
at home or dining out where Light is 1-2 per week, Medium is 3-4, and Heavy is 5 or more. 
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Table 4.14. Effect of levels of growth promotant technology on undisclosed with meat 
consumer sensory analysis of attributes among the most preferred samples of the 
longissimus muscle derived from carcasses of a subsample of steers. 
 Treatment 
Trait1 NA2 NHTC IMPL IMBA SEM P - Value 
Tenderness 76.21b 77.52b 76.34b 69.03a 2.02 0.009 
Juiciness 63.30ab 67.89b 63.52ab 59.41a 2.38 0.036 
Beefy Flavor 66.86ab 71.46b 68.23ab 63.93a 2.25 0.042 
Overall Acceptability 76.23b 76.50b 75.02b 70.06a 2.33 0.076 
a,b Values that do not share a common superscript in the same row differ (P < 0.05 to P 
< .10). 
1 Sensory panel scale (0-100%, continuous line scale): tenderness (0% = extremely 
tough, 100% = extremely tender); juiciness (0% = extremely dry, 100% = extremely 
juicy); flavor (0 % = no presence, 100% = very strong presence; overall acceptability 
(0% = not acceptable, 100% = very acceptable). 
2 Four beef production systems: 1) NA (no technology utilized, control); 2) NHTC 
(non-hormone treated, fed monensin and tylosin during finishing); 3) IMPL 
(implanted, administered a series of three implants and fed monensin and tylosin 
during finishing); 4) IMBA (implanted plus fed the beta-agonist ractopamine 
hydrochloride (200 mg • steer-1 • d-1) for the last 30 d prior to harvest. 
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Table 4.15. Effect of levels of growth promotant technology on subsequent 
disclosed with meat consumer sensory analysis of attributes among the most 
preferred samples of the longissimus muscle derived from carcasses of a 
subsample of steers. 
 Treatment 
Trait1 NA2 NHTC IMPL IMBA SEM P - Value 
Tenderness 79.11 77.37 74.49 74.85 2.31 0.175 
Juiciness 73.66 72.46 69.60 69.52 2.45 0.264 
Beefy Flavor 75.23b 74.04a 71.18a 69.03a 2.29 0.079 
Overall 
Acceptability 80.74
a 77.77ab 74.32b 74.26ab 2.44 0.015 
a,b Values that do not share a common superscript in the same row differ (P < 0.05 to 
P < .10). 
1 Sensory panel scale (0-100%, continuous line scale): tenderness (0% = extremely 
tough, 100% = extremely tender); juiciness (0% = extremely dry, 100% = extremely 
juicy); flavor (0 % = no presence, 100% = very strong presence; overall 
acceptability (0% = not acceptable, 100% = very acceptable). 
2 Four beef production systems: 1) NA (no technology utilized, control); 2) NHTC 
(non-hormone treated, fed Rumensin and Tylan during finishing); 3) IMPL 
(implanted, administered a series of three implants and fed monensin and tylosin 
during finishing); 4) IMBA (implanted plus fed the beta-agonist ractopamine 
hydrochloride (200 mg • steer-1 • d-1) for the last 30 d prior to harvest. 
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 Table 4.16. Undisclosed with meat consumer panel hypotheses tests 
pooling across treatments 
Models and Hypothesis Tests   n1 LL1 WTP1 P-value 
All consumers  309 -361.44 10.53 -  
All consumers, NA2  76 -93.77 10.59 -  
All consumers, NHTC2 
All consumers, IMPL2 
 76 
107 
-89.39 
-116.34 
10.69 
10.18 
- 
- 
 
All consumers, IMBA2 
Ho: Pooling across four treatments is okay 
 50 
 
-58.84 
 
11.11 
 
- 
>.05 
 
1 Here n, LL, and WTP denotes the number of respondents in each subsample, log-
likelihood value of interval-censored models, and point estimates of willingness to pay 
(US$ per 12 oz. strip steak at a base price of $10.35), respectively. Models 
summarized are pooled across treatments and specified to include intercept and scale 
parameters only, and were estimated with PROC LIFEREG in SAS. Presented P-
values report results of log-likelihood ratio tests of whether respondents from different 
subsamples of the examined population can be pooled. 
2 Four beef production systems: 1) NA (no technology utilized, control); 2) NHTC (non-
hormone treated, fed Rumensin and Tylan during finishing); 3) IMPL (implanted, 
administered a series of three implants and fed Rumensin and Tylan during finishing); 
4) IMBA (implanted plus fed the beta-agonist ractopamine hydrochloride (200 mg • 
steer-1 • d-1) for the last 30 d prior to harvest. 
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 Table 4.17. Disclosed without meat consumer panel hypotheses tests of 
pooling across treatments 
Models and Hypothesis Tests   n1 LL1 WTP1 P-value  
All consumers  315 -378.70 11.36 -  
All consumers, NA2  159 -194.06 11.41 -  
All consumers, NHTC2 
All consumers, IMPL2 
 105 
37 
-126.15 
-40.43 
11.02 
11.64 
- 
- 
 
All consumers, IMBA2 
Ho: Pooling across four treatments is okay 
 14 
 
-16.09 
 
12.85 
 
- 
>.05 
 
1 Denotes the number of respondents in each subsample, log-likelihood value of 
interval-censored models, and point estimates of willingness to pay (US$ per 12 oz. 
strip steak at a base price of $10.35), respectively. Models summarized are pooled 
across treatments and specified to include intercept and scale parameters only, and 
were estimated with PROC LIFEREG in SAS. Presented P-values report results of 
log-likelihood ratio tests of whether respondents from different subsamples of the 
examined population can be pooled. 
2 Four beef production systems: 1) NA (no technology utilized, control); 2) NHTC (non-
hormone treated, fed Rumensin and Tylan during finishing); 3) IMPL (implanted, 
administered a series of three implants and fed Rumensin and Tylan during finishing); 
4) IMBA (implanted plus fed the beta-agonist ractopamine hydrochloride (200 mg • 
steer-1 • d-1) for the last 30 d prior to harvest. 
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Table 4.18. Disclosed with meat consumer panel hypotheses tests of pooling across  
treatments 
Models and Hypothesis Tests    n1 LL1 WTP1 P-value  
All consumers  315 -391.39 11.07 -  
All consumers, NA2  115 -144.36 11.34 -  
All consumers, NHTC2 
All consumers, IMPL2 
 105 
74 
-131.15 
-84.69 
11.41 
10.36 
- 
- 
 
All consumers, IMBA2 
Ho: Pooling across four treatments is okay 
 21 
 
-22.31 
 
10.48 
 
- 
<.001 
 
Ho: Pooling across NA and NHTC is okay     <.001  
Ho: Pooling across NA and IMPL is okay     <.001  
Ho: Pooling across NA and IMBA is okay     <.001  
Ho: Pooling across NHTC and IMPL is okay     <.001  
Ho: Pooling across NHTC and IMBA is okay      <.001  
Ho: Pooling across IMPL and IMBA is okay     <.001  
1 Denotes the number of respondents in each subsample, log-likelihood value of interval-
censored models, and point estimates of willingness to pay (US$ per 12 oz. strip steak at 
a base price of $10.35), respectively. Models summarized are pooled across treatments 
and specified to include intercept and scale parameters only, and were estimated with 
PROC LIFEREG in SAS. Presented P-values report results of log-likelihood ratio tests 
of whether respondents from different subsamples of the examined population can be 
pooled. 
2 Four beef production systems: 1) NA (no technology utilized, control); 2) NHTC (non-
hormone treated, fed Rumensin and Tylan during finishing); 3) IMPL (implanted, 
administered a series of three implants and fed Rumensin and Tylan during finishing); 4) 
IMBA (implanted plus fed the beta-agonist ractopamine hydrochloride (200 mg • steer-1 • d-
1) for the last 30 d prior to harvest. 
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Table 4.19. Consumer mean rank of novel label claims and statements within NA production system1 
Rank2,3 Label Claim Corresponding Statement Mean + SE4 
1 Raised Without Antibiotics and Added Growth Promotants 
Never Administered Antibiotics, Added Hormones, or Other 
Growth Promotants 2.12 + 0.125 
2 Conscientiously Raised Never Administered Antibiotics, Added Hormones, or Other Growth Promotants 2.66 + 0.125 
3 No Antibiotics Ever Never Administered Antibiotics 3.00 + 0.125 
4 Protectively Raised Never Administered Antibiotics, Added Hormones, or Other Growth Promotants 3.32 + 0.125 
5 Cautiously Raised Never Administered Antibiotics, Added Hormones, or Other Growth Promotants 3.92 + 0.125 
1 Treatment NA is the control group receiving no technology. 
2 Described to consumers as beef produced from cattle never receiving antibiotics, added hormones, or other growth 
promoting products throughout their lifetime. 
3 Label rank within treatment did not differ P = 0.149. 
4 Descriptive means and calculated SE. 
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Table 4.20. Consumer mean rank of novel label claims and statements within NHTC production system1 
Rank2,3 Label Claim Corresponding Statement Mean + SE4 
1 Responsibly Raised 
Never Administered Hormones or Other Growth Promotants, 
Antibiotics Provided in The Case of Illness to Maintain Optimal 
Animal Health and Productivity 
2.15 + 0.127 
2 Raised Without Added Growth Promotants Never Administered Hormones or Other Growth Promotants  2.81 + 0.127 
3 Raised Without Added Hormones Never Administered Hormones 3.85 + 0.127 
4 Raised With Care Antibiotics Used to Prevent Illness 3.33 + 0.127 
5 Raised With Judicious Use of Antibiotics 
Antibiotics Optimally Used In the Case of Illness to Maintain 
Animal Health and Productivity  3.86 + 0.127 
1 Treatment NHTC is non-hormone treated but fed Rumensin and Tylan during finishing. 
2 Described to consumers as beef produced from cattle that never received added hormones or supplements that adjust fat to 
lean meat. Antibiotics and antimicrobials were used to maintain animal health and productivity. 
3 Label rank within treatment did not differ P = 0.159. 
4 Descriptive means and calculated SE. 
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Table 4.21. Consumer mean rank of novel label claims and statements within IMPL production system1 
Rank2,3 Label Claim Corresponding Statement Mean + SE4 
1 Thoughtfully Raised Antibiotics and Growth Promotants Optimally Used to Maintain Animal Health and Improve Productivity 
2.35 + 0.130 
2 Environmentally Friendly Raised with Growth Promoting Technologies to Reduce Carbon Footprint by 8% and Water Utilization by 4%  
2.62 + 0.130 
3 Efficiently Raised Raised Efficiently to Reduce Carbon Footprint, Water Use, Energy Utilization, and Nitrogen Emissions  
3.86 + 0.130 
4 Efficiently Raised Reduced Feed and Water Use for Animal Production 3.51 + 0.130 
5 Renewably Raised Raised with Growth Promoting Technologies to Reduce Water Utilization by 4% 
3.66 + 0.130 
1 Treatment IMPL is administered a series of three implants and fed Rumensin and Tylan during finishing. 
2 Described to consumers as beef produced from cattle that never received supplements to adjust fat to lean meat but received other 
growth promoting technologies including use of antibiotics.  
3 Label rank within treatment did not differ P = 0.178. 
4 Descriptive means and calculated SE. 
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Table 4.22. Consumer mean rank of novel label claims and statements within IMBA production system1 
Rank2,3 Label Claim Corresponding Statement Mean + SE4 
1 Responsibly Raised Antibiotics and Growth Promotants Optimally Used to Maintain Animal Health in the Event of Illness and to Increase Productivity 
2.11 + 0.127 
2 Environmentally Conscious Raised Efficiently to Reduce Carbon Footprint, Energy Utilization, and Nitrogen Emissions  
2.65 + 0.127 
3 Efficiently Raised Antibiotics and Growth Promotants Optimally Used to Maintain Animal Health and Improve Productivity  
3.04 + 0.127 
4 Raised with Environmental Stewardship 
Raised with Growth Promoting Technologies to Conserve 
Environmental Resources  
 
3.50 + 0.127 
5 Wisely Raised Raised with Growth Promoting Technologies to Conserve Environmental Resources  
3.70 + 0.127 
1 Treatment IMPL is administered a series of three implants and fed Rumensin and Tylan during finishing. 
2 Described to consumers as beef produced from cattle that never received supplements to adjust fat to lean meat but received other 
growth promoting technologies including use of antibiotics. 
3 Label rank within treatment did not differ P = 0.156. 
4 Descriptive means and calculated SE. 
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Figure 4.1. Comparison of consumer preferences for beef from different production systems among 
three consecutive panels1 
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1Influence of pre- and post- production information on consumer preferences for beef palatability. 
Treatments include a control group where steers were provided no technology (NA); steers provided 
monensin and tylosin (NHTC), a series of three implants, Rumensin and Tylan (IMPL), or a beta-agonist, 
three implants, Rumensin and Tylan (IMBA). Bars within panel signify simulated shares of preference from 
1,000 observations drawn from multivariate normal distribution parameterized using the coefficients and 
variance-covariance terms estimated by a random parameter logit model in SAS MDC. Standard error is 
indicated by error bars and percentages without a common letter within panel differ (P ≤ 0.05). 
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